University of Rhode Island

DigitalCommons@URI
Open Access Dissertations
1995

Stages of Change, Dropouts, and Outcome in Substance Abuse
Treatment
Janice Yusze Tsoh
University of Rhode Island

Follow this and additional works at: https://digitalcommons.uri.edu/oa_diss

Recommended Citation
Tsoh, Janice Yusze, "Stages of Change, Dropouts, and Outcome in Substance Abuse Treatment" (1995).
Open Access Dissertations. Paper 1063.
https://digitalcommons.uri.edu/oa_diss/1063

This Dissertation is brought to you for free and open access by DigitalCommons@URI. It has been accepted for
inclusion in Open Access Dissertations by an authorized administrator of DigitalCommons@URI. For more
information, please contact digitalcommons@etal.uri.edu.

STAGES OF CHANGE, DROPOUTS, AND OUTCOME
IN SUBSTANCE ABUSE TREATMENT

BY
JANICE YUSZE TSOH

A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY
IN
PSYCHOLOGY

UNIVERSITY OF RHODE ISLAND
1995

ABSTRACT

Despite the extensive evidence of the beneficial aspects of substance abuse treatment ,
questions on what contributes to successful outcome continue to arise. It is important to research
who will be more likely to benefit from which modalities of treatment programs and for what
length of treatment. Systematic investigations that include individuals' attitudes, intention and
behavior towards their drug use are necessary to better understand the interaction between
individual characteristics and treatment factors, as well as their effects on treatment retention and
outcome. The Transtheoretical Model of Change offers a promising systematic framework for
this purpose (Prochaska & DiClemente, 1983, 1984, 1992).

.

This study examined the predictive values of two constructs of the Transtheoretical
model: stages of change and decisional balance on dropouts and outcome in substance abuse
treatment (N=710). Both dynamic and static predictors of treatment dropouts and outcome were
investigated . The current investigation is divided into four studies. The Change Assessment for
Drug Use (CAD) was developed with sound psychometric properties in Study I. Study II
searched for the best stage allocation method in using the CAD and its validation. Findings
indicated that cluster analysis was the best stage allocation method. Study III investigated
predictors for treatment dropouts and continuers . Dropouts were defined as individuals who
dropped out of treatment within the first 60 days of the program. Significant predictors for
dropouts included being in precontemplation, lower education, more previous treatment
experience and perceiving treatment for social problems as more importance. In Study IV, both
predictors at admission and discharge were examined for short-term (3-month post discharge)
treatment outcome. Successful outcome was defined as abstinence of drug use since exit of
treatment. Being in the preparation stage of change at baseline , having lower depression level at
discharge and longer length of stay in treatment were significant predictors for successful
outcome . Results indicated that dynamic predictors such as stages of change, length of stay and

depression level outweighed all static variables, such as subject characteristics, for
prediction of short-term outcome. Implications of current and future directions of research were
discussed.
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PREFACE
Stages of Change, Dropouts, and Outcome in Substance Abuse Treatment: Overview
Before the first generation of drug abuse treatment appeared, which was in a form of
therapeutic communities, "Once an addict, always an addict" was widely presumed (Hubbard,
Marsden, Rachal, Harwood, Cavanaugh, & Ginzburg, 1989). The first generation of programs
provided treatment primarily to heroin addicts. Addiction was viewed as a reflection of
fundamental defects in character and maturation. Therapeutic community (TC) approach
therefore geared toward lifestyles and required long-term stays in residential facilities with
highly structured environment. Not until positive results were reported from the first therapeutic
community, Synanon, which claimed that former heroin users were free of drugs for more than a
year, did the new generation of treatment modalities begin to proliferate. In 1965, Dole and
Nyswander introduced methadone maintenance as an alternative to heroin addiction treatment.
This treatment approach was based on a very different understanding of addiction as a metabolic
disease. Although treatment outcome was generally favorable with sustainable heroin reduction,
decreased criminality and general health improvements (Dole & Nyswander, 1965; Dole,
Nyswander & Warner, 1968), doubts still remain as the possibility of discontinuing methadone
has not been clear (Hubbard et al., 1989). With growing needs for treatment for a variety of
illicit drug use, a third treatment modality, outpatient drug-free treatment that served both opioid
and non-opioid addicts began to flourish. Treatment approaches that might reduce the cost of
drug abuse in society started to expand.
In late 1970s', with the blooming of cognitive-behavioral approaches drawn from social
learning theory, behavior therapy and cognitive and social psychology (Bandura, 1977, 1982;
Rosenstock, Strecher, & Becker, 1988), the etiology of addiction was formulated as a learned
behavior addicts use to cope with stressful situations. Intervention was geared toward
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substituting positive behaviors for drug use behaviors through teaching coping skills to
appropriately handle high risk situations for drug use. Sustaining abstinence was viewed as a
result of increased self efficacy for avoiding drug use in high risk situations.
Increases in understanding of drug addiction and its recovery has helped interventionists
recognize the importance of dealing with lapses and relapses. A new approach for addiction
treatment, relapse prevention, was introduced (Marlatt & Gordon, 1985). This approach focused
on preventing a lapse from becoming a full relapse through reframing lapses as opportunities to
learn about triggers and high risk situations. Individuals are taught to identify triggers for drug
use and coping strategies to avoid or to cope with those triggers. The major modalities of current
drug abuse treatment take the form of methadone maintenance, drug-free residential treatments
(including therapeutic communities, and cognitive-behaviorally oriented residential programs),
and outpatient drug-free programs (Hubbard et al., 1989).
The fast growing substance abuse treatment approaches over a short history of 30 years
reflects the increasing burdens of substance abuse on society. In 1988, it was estimated that the
costs of alcohol abuse and the abuse of other drugs in the US. were $86 billion and $58 billion
respectively (Stimmel, 1991). As of 1990, the estimated costs increased to $99 billion and $67
billion for alcohol and other drug abuse respectively (Institute for Health Policy, 1993). The
core costs of substance abuse fall in medical expenses, illness, premature deaths, and criminality .
Given the role ofIV drug users in the spreading of AIDS and the high association of drug use
and crime, drug addiction is not only a health concern at an individual level but also a broad
social problem. The threat imposed by drug users on both public health and safety has
encouraged civil commitment practices directed toward drug users. Drug abuse treatment
programs nowadays serve multiple purposes of protecting societies and promoting individual
well-being (Brown , 1988; Platt, Buhringer, Kaplan, Brown, & Taube, 1988). There has been
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extensive evidence showing that most drug addiction treatments , regardless of modalities,
benefit their clients ( e.g. , Institute of Medicine , 1990). However, questions as to what
contributes to successful treatment, and to successful outcome continue to arise.
Research on predictors for treatment outcome has yielded divergent results. Some
studies have found that positive outcomes appear to relate to subjects who are older, male, white ,
being employed full time, being first time in treatment, and having lower ratings on severity of
drug use . However, some experts suggest there is little relationship between most
sociodemographic variables and outcome (e.g., Gorelick, 1992; Hubbard et al., 1989; Kosten,
Rounsaville, & Kleber, 1987). Regarding sources ofreferrals (legal versus self), the literature
has not shown consistent support for an association between legal referral and outcome success
(Hubbard, Colline, Rachal, & Cavanaugh , 1988). Research has begun to examine relationships
between HIV status and treatment outcome, but no substantial relationship with outcome has
been reported. However, HIV positive individuals appear to be more motivated (Mccusker,
Bigelow, Frost, Hindin, Vickers-Lahti, & Zorn, 1994) and tend to more likely complete
treatment (Weddington, Haertzen, Hess & Brown, 1991). In one study, increased self-efficacy
during treatment has been found to be higher among abstainers than relapsers at follow-up
(Burling, Reilly, Moltzen, & Ziff, 1989). However, no relationship was found between selfefficacy ratings and outcome status in another study (Mayer & Koeningsmark, 1991 ). Other
subject characteristics such as psychiatric status, cognitive functioning, and their relationships
with outcome have also been studied. Relatively poor treatment outcomes appear to be related to
impaired cognitive functioning, major depressive disorder, and antisocial personality disorder
(e.g., Pals-Stewart & Schafer, 1992; Kay, 1985).
One of the major problems of finding reliable predictors for treatment outcome across
studies is the high dropout rates in these treatment programs. Indeed, the length of stay in
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treatment has been shown to be the single most consistent predictor of outcome (Charuvastra ,
Dalali , Cassuci , & Ling, 1992; DeLeon, 1988; DeLeon & Jainchill , 1-986; French , Zarkin ,
Hubbard, & Rachal , 1993; Hubbard et al., 1989) across all treatment modalities. For example ,
from the data of the Drug Abuse Reporting Program (DARP) , the first large scale national study
on treatment effectiveness for drug abusers , a minimum of three months was found to be
necessary to produce positive changes, and outcomes improved with the onset of time staying in
treatment after the first three months . Similarly , the second national study, the Treatment
Outcome Perspective Study (TOPS) that tried to assess effective elements in treatment , has also
found that treatment tenure relates positively to treatment success (Hubbard et al., 1988). The
TOPS data suggested that treatment lengths of six months or more were necessary to produce
reductions in drug use. Research comparing treatment outcome of dropouts versus completors
has been able to consistently yield more favorable outcome for treatment completors (e.g.,
Baekeland & Lundwell, 1975, Hubbard et. al., 1989, Stark, 1992). The positive relationship
between treatment retention and successful outcome is also a reason why treatment retention has
been commonly used as a measure or an indicator of treatment outcome.
Unfortunately , like treatment of other psychological problems , dropout is prevalent in all
drug abuse treatment programs (DeLeon & Jainchill, 1986). The majority of clients drop out of
treatment prematurely , i.e., most clients drop out well before treatment takes full effect. Review
of research findings has shown that the highest dropout rates are found in outpatient drug-free
programs, with at least 50% dropping out during the first month and over 80% within three
months (Agosti , Nunes, Stewart & Quitkin, 1991; Baekeland & Lundwall; 1975, Stark, 1992).
The base rates of 12-month retention among therapeutic communities surveyed ranged from 4%
to 21 % (DeLeon & Schartz, 1984). In other residential settings, completion rates for 4-6 month
programs have been reported as less than 30% (Sidall & Conway, 1988; Stahler , Cohen , Shipley
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& Bartelt , 1993 ). Dropout rates in outpatient methadone programs appear the lowest but still
endorse a high rates range from 7% to 64% within the first 6 months (Baekeland & Lundwall ,
1975). Among outpatient detoxification programs , dropout rates ranged from 26% to 69%
(Baekeland & Lundwall, 1975). Investigators have been trying to search for characteristics of
dropouts such as demographics, addiction severity , drug related behavior, and legal status , but no
powerful and reliable predictors have been identified (Condelli & DeLeon , 1993; Craig , 1984;
DeLeon, 1985; De Leon & Jainchill , 1986; Hubbard et al., 1989).
Despite the finding that treatment retention is one of the few consistent predictors of
outcome, the true relationship between retention and outcome is not well understood. Research
continues to show contradictory findings. For example , no association was reported between
number of treatment sessions and improved outcomes in outpatient treatment for cocaine addicts
(Kang, Kleinman , Woody & Millman , 1991). Carroll, Power, Byrant, & Rounsaville (1993)
have found that variables associated with longer retention in treatment tend to predict poorer
outcome at a one-year follow-up of cocaine addicts. In TOPS , the second largest nationwide
study on substance abuse treatment effectiveness, Hubbard et al. (1989) reported significant
relationships between treatment retention and outcome for use of posttreatment marijuana but
not for the use of heroin and cocaine. The findings from research on treatment effectiveness
have revealed that an "appropriate" or to some extent "minimum" exposure to treatment is
necessary to produce positive outcome , rather than there being a causal relationship between
longer retention and better outcomes as loosel y implied by most literature on retention and
treatment. In other words , some individuals may benefit from longer treatment , but some may
have equally successful outcomes with a shorter length of stay. Furthermore, longer retention
also means more drug addicts will have to wait on line for treatment given that treatment
resources are limited. It is important to research who will be more likely to benefit from which
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modalities of treatment programs and for how long of treatment. Some systematic investigations
are therefore necessary to better understand the interaction between individual characteristics
and treatment factors and their effects on retention and outcome in order to maximize treatment
effectiveness .
Research investigating predictors for treatment retention and outcome has exhausted its
use of different types of traditional fixed variables , such as demographics and drug use history
without yielding consistent and productive findings. The field has therefore begun to explore the
relative importance of dynamic predictors in comparison to the traditional fixed variables
(Anglin, 1988; Condelli & DeLeon, 1993; DeLeon & Jainchill , 1986). Dynamic predictors are
changeable characteristics of clients, such as their perception and experiences of current and
previous treatment, and motivations (most commonly indicated by reasons for entering
treatment). Findings have generally favored the use of dynamic variables to account for more of
the variances in treatment retention and/ or outcome. Some examples of the dynamic
parameters that have been researched include psychological disturbance and symptoms (DeLeon,
1989; Carroll et al, 1993 ), clients' own estimate of how long they need to stay in treatment
(DeLeon, 1991 ), and circumstances, motivation, readiness and suitability (DeLeon & Jainchill,
1986) . Unfortunately, most of the dynamic variables researched are not easily standardized to
enable replication across studies as well as cross validation using different treatment settings.
In order to advance the research in this area and to obtain better understanding of the
contributors of treatment effectiveness, the use a systematic framework capturing individuals'
attitudes, intentions and behavior related to their drug use will be necessary. The
Transtheoretical Model of Change (Prochaska & DiClemente, 1983, 1984, 1992) offers a
promising systematic framework for this purpose. The Transtheoretical Model has provided a
useful conceptual framework in understanding how people change behaviors . It has been
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successfully applied to a broad range of problem behaviors such as smoking (Prochaska &
DiClemente, 1983), alcohol (DiCiemente & Hughes, 1990), weight control (O'Connell &
Velicer, 1988), drug abuse (Rosenbloom, 1991; Martin, Rossi, Rohsenow, Monti , &
Rosenbloom, 1994; Tsoh, 1993), psychotherapy (Prochaska, Rossi, & Wilcox, 1991), and to
some preventive behaviors including mammography, sunscreen use, and exercise (e.g.,
Rakowski. Dube, Marcus , Prochaska, Velicer , & Abrams, 1992; Rossi , 1989; Marcus , Rossi ,
Selby, Niaura & Abrams , 1992).
The Transtheoretical Model has found that as people change, they go through a series of
stages that include Precontemplation (not intending to change in the foreseeable future),
Contemplation (considering changing in the foreseeable future) , Preparation (intending to change
in the near future with a specific plan or some steps towards action taken), Action (actively
engaged in changing a behavior) and Maintenance (sustaining the change and preventing relapse)
(Prochaska & DiClemente, 1992). These stages of change capture specific constellations of
attitudes, intentions and behavior of individuals going through the process of change. The
progress from one stage to another may not necessarily be linear, but may be cyclical in many
cases. Many people relapse several times and recycle back to earlier stages before they succeed
in changing their problem behavior. Even for individuals who enter the same kind of treatment
programs dealing with .the same kind of problem behavior , their readiness to change may vary
widely. As reasons or motivations to enter treatment are different among individuals, people
enrolled in treatment may be in different stages of change ranging from Precontemplation to
Maintenance. In the case of drug abuse treatment, precontemplators may be those clients who
are not ready to change but they are forced to enter treatment against their own desires by factors
such as the legal systems (Tsoh, 1993). On the other hand, some clients may be in action and
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maintenance who have quit using drugs but need some support for sustaining the change
(Rosenbloom, 1991; Tsoh, 1993).
Using the Transtheoretical Model of Change, 92% of the clients' continuation and
termination status in psychotherapy was correctly predicted(Medeiros & Prochaska, 1991).
Predictors were stages of change, processes of change, and decisional balance which are some of
the core dimensions of behavior change as identified by the model (Prochaska & DiClemente,
1983, 1984, 1992). Most therapy continuers are found to be in the contemplation stage of
change (Medeiros & Prochaska, 1991). On the other hand, premature terminators or dropouts
are more likely to be in the precontemplation stage and tend to be more oriented toward
changing their environment than themselves. It is also one of the key features of most
precontemplators that they try to use defenses such as changing their environment in order to
deny that they have a problem. Early but appropriate terminators were found to highly endorse
the Action stage and were ready to take action when entering treatment. Therefore, they required
fewer therapy sessions to achieve their therapeutic goals. Assessing stages of change and change
processes at midtreatment predicted both attendance and outcome in worksite weight control
programs, with both accounting for over 30% of the attendance variance and over 40% of the
variance for the amount of weight loss during treatment. Higher endorsement of the action stage
of change and the use of action-oriented strategies was found to enhance attendance and
outcome(Prochaska, Norcross, Fowler, Follick & Abrams, 1992).
This study was a secondary data analysis on 710 drug addicts seeking treatment from 2
residential settings. The purpose of the current study was to examine the applicability of the
Transtheoretical model for predicting treatment dropouts and outcome in the area of drug
addiction.

Dynamic predictors of treatment dropouts and outcome namely stages of change and

decisional balance, were compared to other traditional fixed variables such as demographics and
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history variables. Based on previous findings, the following hypotheses were tested in relation
to the role of the stages of change in predicting retention and outcome.
1.

Clients who were further along in the stages of change at admission would be less likely

to drop out from treatment .
2.

Clients who were further along in the stages of change at admission would be more

likely to have better treatment outcome.
3.

Clients who were further along in the stages of change at discharge would be more likely

to have better treatment outcomes.
4.

The predictive value of stages of change on treatment outcome would increase from

admission to discharge
The current investigation is divided into four discrete but related studies and are presented in
separate manuscript formats. Study I focused on instrument refinement of the Stages of Change
Assessment Scale (URICA) and the Decisional Balance Scale. Study II evaluated various stage
allocation methods using the URI CA and their validation; stage membership of subjects at each
time point was established for further analyses . Study III investigated predictors for treatment
retention . Study IV examined predictors for treatment outcome. Lastly, a general discussion is
presented based on findings from all four studies.
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STUDY 1 APPLYING STAGES OF CHANGE TO SUBSTANCE ABUSE TREATMENT:
INSTRUMENT REFINEMENT
Introduction
Drug addiction is frequently described as a chronic, relapsing disorder characterized by
strong desire, or craving for drugs, and difficulty in extinguishing the behavior completely
(Institute of Medicine, l 990). Similar to other addictive behaviors, "relapse is the rule rather
than the exception with addictions" as Prochaska, DiClemente, and Norcross (1992) pointed out.
Despite the development of treatment techniques and the blooming of a treatment industry for
substance abuse, the need for more effective treatments continues to rise. The growth of
substance use as well as the extensive phenomenon of high relapse rates among substance
abusers have created a growing yet unmet need for more effective substance abuse treatment.
Although research has generally suggested that treatment yields positive outcomes, however,
between 10% to 20% of drug addicts complete treatment and about 70% of drug addicts relapse
within the first year post treatment (Mejta, Naylor & Maslar, 1994).
As with many other addictive behaviors, substance abuse presents a challenge to
researchers to understand the process of change that underlies successful recoveries. The
Transtheoretical Model of Change developed by Prochaska and DiClemente (1983, 1984, 1992),
which underscores the recycling process of behavioral change, provides a promising integrative
framework to systematically study how people change addictive behaviors. The Transtheoretical
Model has provided a useful conceptual framework in understanding how people change
behaviors. It has been successfully applied to a broad range of problem behaviors such as
smoking (Prochaska & DiClemente, 1983), alcohol (DiClemente & Hughes, 1990), weight
control (O'Connell & Velicer, 1988), drug abuse (Rosenbloom, 1991; Martin, Rossi, Rohsenow,

Monti & Rosenbloom , 1994; Tsoh , 1993 ), psychotherapy (Prochaska , Rossi , & Wilcox, 1991 ),
and to such preventive behaviors as mammograph y, sunscreen use, and exercise (e.g . Rakowski ,
Dube , Marcus, Prochaska , Velicer, & Abrams , 1992; Rossi, 1989; Marcus, Rossi, Selby, Niaura
& Abrams , 1992) .
The Transtheoretical Model has found that as people change, they go through a series of
stages that include Precontemplation (not intending to change in the foreseeable future) ,
Contemplation (considering changing in the foreseeable future), Preparation (intending to change
in the near future with a specific plan or some steps towards action taken) , Action (actively
engaged in changing a behavior) and Maintenance (sustaining the change and preventing relapse)
(Prochaska & DiClemente, 1992; Prochaska, DiClemente, & Norcross, 1992). These stages of
change capture specific constellations of attitudes, intentions and behavior of individuals going
through the process of change . The progress from one stage to another may not necessarily be
linear , but may be cyclical in many cases. Many people relapse several times and recycle back
to earlier stages before they succeed in changing their problem behavior.
Other dimensions of the Transtheoretical Model of Change include the processes of
change , decisional balance , as well as self-efficacy . Processes of change represent the different
strategies or techniques that people use at each stage of change and enable them to move from
one stage to the next. Ten processes are currently included in the model underlying basic
principles of change, which fall into two major constructs: experiential and behavioral processes
(Prochaska & DiClemente, 1992) . Experiential processes, such as consciousness raising,
dramatic relief , environmental reevaluation, self-reevaluation and social liberation, have been
found essential for producing movements across the early stages. Behavioral processes,
including countercondit ioning , stimulus control , reinforcement management, self-liberation , and
helping relationships are strong predictors of successful action and maintenance of change. The
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construct of decisional balance (pros and cons of a behavior) is another stage dependent
construct of the model. This dimension, developed from Janis and Mann's (1977) model of
voluntary decisional making model, denotes the relative rating of the pros and cons of changing
a behavior. The consideration of pros and cons for a behavior is particularly relevant to the early
stages of change such as precontemplation, contemplation and preparation. Self-efficacy,
another construct of the model adapted from Social learning theory (Bandura, 1977, 1982)
underlies the precepts of personal efficacy influencing motivations and behavior. It is examined
under confidence of carrying out the new acquired behavior or avoiding the problem behavior, as
well as temptation. This construct has been found successful in predicting movement in later
stages, such as action to maintenance.
The key to apply the model is by first accurately accessing the stages of change. There
is no single way to achieve this purpose (Prochaska & DiClemente, 1992). Generally, the ways
of accessing stages of change can be achieved through a categorical algorithm or a continuous
measure. The categorical stage assessment involves a stage algorithm which consists of
dichotomous questions to assess persons' readiness for change, or a series of statements
describing each different operational definition of stages. Each stage is operationalized by
intention and behavior within a certain time frame. (Prochaska & DiClemente, 1992). When
applied to a substance use problem such as smoking, Precontemplation is operationalized as no
intention to quit smoking in the next 6 months. Contemplation involves intending to quit
smoking in the next 6 months. Preparation involves intending to quit in the next 30 days plus a
24-hour quit attempt within the last year. Action is defined as having .quit for less than 6 months.
Lastly, Maintenance is operationalized as having quit for more than 6 months.
Previous studies have applied similar forms of stage algorithm to assess stages of change
in cocaine use and other drug use ( e.g., Rosenbloom, 1991; Tsoh, 1993). However, several
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problems have been noted in applying the current algorithm to drug addicts in treatment. Under
the algorithm , drug addicts who are seeking drug-free treatment are automatically classified into
"action " because of being in a controlled, drug-free environment . Therefore , over-classification
of individuals into "action" may occur simply by assuming that individuals are ready and
prepared to change when they are in treatment . For example , over 85% of the subjects in
Rosenbloom ' s study ( 1991) were classified into either action or maintenance. In addition , using
the stage algorithm method in this population seems to posit an accuracy problem in assessing
readiness for change. In a previous study on 230 drug addicts recruited from various residential
and outpatient settings (Tsoh, 1993), 50% of subjects who claimed to be in action or
maintenance also reported simultaneous use of illicit drugs. When compared to the assessment
of stages using a continuous measure, such as the University of Rhode Island Change
Assessment Scale (URICA, McConnaughy, Prochaska, & Velicer , 1983), the stage algorithm
was shown to be less capable of producing distinguished stages of change (Tsoh, 1993).
The URI CA (McConnaughy et al., 1983, McConnaughy, DiClemente , Prochaska, &
Velicer , 1989) was originally designed as a clinical tool to assess readiness for change among
clients seeking psychotherapy. The measure consists of four scales representing the
precontemplation, contemplation, action and maintenance stages of change. Assessment of
stages is achieved through grouping individuals based on their profiles on these four scales
through cluster analysis techniques . Assessing stages of change based on a continuous measure
that consists of a number of items has an advantage of increased reliability . The validity of the
self-report responses increases since the URI CA is a much more subtle assessment.
Furthermore , a continuous measure enables the development of typologies of change by
considering an individual ' s degree of endorsement in each of the stages of change , which a
discrete stage algorithm can not provide . The change assessment measure has been shown to be
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a valid measure to capture stages of change in psychotherapy, as well as in a number of health
behavior problems including drug addiction, alcohol use, weight control, smoking acquisition,
and exercise (e.g., Di Clemente & Hughes, 1990; Martin et al., 1994; Prochaska et al., 1992;
Reed, 1995; Rossi et al., 1994; Tsoh, 1993). The purpose of this study was to refine the stages of
change instrument for use in drug addicts at admission and during treatment, as well as at post
treatment.
Methodology

Participants
Participants were 710 former addicts (30% females) recruited for the study from two
residential facilities: 493 from a cognitive-behavioral relapse prevention program and 217 from
a therapeutic community. Mean age was 29.8 years (SD= 6.1). The ethnicity composition of
the sample was 74.8% Caucasian, 18.2% Black, 5.9% Hispanic, and 1.2% other. The mean
education level was 12th grade.

There were 35.5% who had a full time job at the time of

treatment and 37 .8 % were unemployed, while others worked part time, or had retired. The
majority (86 %) of the subjects had previous admissions to drug abuse treatment programs prior
to the study. Main drugs of choice for the sample were heroin only (22.1 %), cocaine
only(26.4%), alcohol and drugs (24.5%), and polydrug (21.8%), with 43% IV drug users.

Procedures
Participants were recruited during intake interviews that took place within 14 days
before or on the day of admission. Clients who were eligible to participate in the present study
were all former drug abusers who completed detoxification or withdrawal, and were admitted to
the facilities on a voluntary basis. Monetary incentives for participation (see below) were
offered. Data were collected during admission, exit, and a 3-month follow-up post discharge.
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Participants received $15 for each research interview at admission and at exit of treatment , and
$25 for each post-treatment interview.
At the relapse prevention facility, clients were randomized to receive either a 3- or a 6month program regardless of their participation in the study. The treatment programs were based
on a relapse prevention / health education model focusing on teaching coping skills for managing
clients' addictive attitudes and behaviors in order to cope with high risk situations for relapse .
Subjects recruited from the therapeutic community were randomly assigned to receive a 6-month
or a 12-month therapeutic community program . Both programs aimed at introducing clients to a
highly structured life-style provided in a communal living setting. In both facilities, the
components of the short and the long programs (3- vs. 6-month in Spectrum and 6- vs. 12-month
in Marathon) were the same but they differed in duration with each component in the long
program lasting twice as long as in the short programs. Eight-two subjects were recruited before
the randomization of treatment duration began, and these subjects were included in measurement .
analysis and instrument validation of the Stages of Change Assessment Scale.
Admission interview took place in 2 to 3 sessions that occurred during the first 8 days
after admission. Data at exit were obtained from 7 days before anticipated day of discharge to 3
weeks after discharge, 70% of the total subjects were interviewed within this window . The 3month interview occurred between 2 to 6 months post-treatment with a follow-up rate of 86%.

Measures
Variables of interest for the current study are obtained from the following measures. Not
all the measures were administered at all time points. Appendix A shows a summary of the
measures and the time points where each was administered.
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Change Assessment of Drug Use (CAD)
Modified from the University of Rhode Change Assessment Questionnaire (URICA),
CAD is a 32-item questionnaire developed to assess subjects' readiness to change their problem
behavior (McConnaughy, Prochaska, Velicer, 1983; McConnaughy, DiClemente, Prochaska &
Velicer, 1989). For the purpose of the present study, instructions were modified to ask subjects
to refer to their drug use as the problem behavior during the interviews. Some minor changes
were made in the wordings relating to the place of treatment in order to make the instrument
more applicable for follow-up interviews when subjects were no longer in treatment. For
example, "I'm hoping this place will help me to better understand myself'' ( original) was changed
to "I'm working on my problem to better understand myself''. Subjects were asked to respond on
a 5-point Likert Scale ranging from 1= strongly disagree to S=strongly agree. Eight items
comprised each of the four stages of change: Precontemplation (PC), Contemplation (C), Action
(A) and Maintenance (M). The Change Assessment Questionnaire has been shown to be a valid
measure to capture the stages of change in psychotherapy as well as in various health behavior
problems including alcohol use, drug addiction, and weight control (e.g., DiClemente & Hughes,
1990; Martin, Rossi, Rohsenow, Monti & Rosenbloom, 1994; Prochaska, V elicer et al., 1992;
Tsoh, 1993). Bellis (1993) has refined the 32-item URICA into a 18-item URICA from various
samples of psychotherapy outpatients (n=310) including the original samples from
McConnaughy et al's studies (McConnaughy et al., 1983; 1989). The refined version
demonstrated good psychometric properties. In applying the URICA to cocaine use, Martin and
colleagues (1992, 1994) derived a 16-item version of Cocaine Change Assessment
Questionnaire.

The psychometric properties of the measure were further examined and refined

in the present study. Items of the measure are shown in Appendix B.

Decisional Balance Inventory
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The 12-item scale modified from the Cocaine Decisional Balance Inventory (Rossi,
Rosenbloom, et al. 1993) was used . With some wording changes replacing "cocaine use" with
"drug use", this 12-item version has been shown to be a valid measure for the decisional
balance construct in a sample of drug addicts in treatment (Tsoh, 1993). Subjects were asked
to rate each item on a 5-point Likert scale ranging from 1 = not important to 5 = extremely
important. The items represent PROS and CONS for drug use with 6 items on each dimension.
The psychometric properties of this measure was further examined in this study . Items of the
measure are shown in Appendix C.
Self-efficacy to avoid drugs
This self-efficacy scale contains 5 items assessing subjects' confidence in their ability to
avoid drug use in high risk situations during the next 3 months. Subjects were asked to respond
on a four point Likert Scale: 1=extremely confident to 4=not at all confident. Total score is the
sum of all 5 items reverse scored, with the higher total score indicating higher confidence. The
scale was developed based on data collected in this study at admission through various versions
of the instrument with an item pool of 11 or 24 items. The factor structure was refined using the
shorter version (n=370) and was confirmed using the long version (n=2 l 7). The internal
consistency of the measure, Cronbach's alpha was .82 (Rubin, 1993). Items are shown in
AppendixD.
Social Desirability Scale
Jackson's Social Desirability Scale (Jackson, 1967) was used to assess response bias
due to social desirability. This instrument consists of 20 items that are presented in a true-false
format. It has been found to be a valid and reliable measure to determine if a response set
tends toward the direction of social desirability. The measure was administered at admission
only.
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Other variables
Data on other variables that have some association with outcomes or retention from
previous studies were also collected . Those variables include HIV status, sources of referrals,
length of stay in treatment, and status of completion .
Analyses
The purpose of this study was to refine and to examine the psychometric properties of
the Stages of Change Assessment for Drug Use Scale (CAD) as well as the Decisional Balance
Inventory for drug use. Even though the factor structure of both scales validated and replicated
across studies (McConnaughy et al., 1983, 1989; Rosenbloom, 1991; Tsoh, 1993), examination
and revision of the instruments were necessary, because some wordings were changed on both
scales for the current study and the instruments were used at various time points both at
admission, discharge and post-treatment. Half of the sample was used as an exploratory sample
for item reduction, and the remaining half was used as a confirmatory sample . Both scales were
obtained at all time points . Data used for instrument development were based on the data
collected at a time point that offered the best statistical distribution (means, skewness, and
kurtosis) for each item.
Item reduction
Half of the sample were used for the following analyses. Item selection was based on
item analysis, principal component analyses (PCA), confirmatory factor analyses (CF A)
techniques, and internal consistency . Velicer's (1976) minimum average panial (MAP)
procedure and parallel analysis using Lautenschlager's (1989) guidelines based on Monte Carlo
analyses were used to help determine the number of components to be retained. Both MAP
and the parallel analysis have been shown to be the most accurate procedure for determining
the number of components to retain across a wide range of simulated situations (Zwick &
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Velicer, 1986). The number of components to be retained were based on both statistical and
theoretical considerations. Item deletion was based on one of the three criteria including factor
loadings (from both PCA and CFA), coefficient alphas and item analysjs . Items with loadings
less than .50, loadings on a non-target component (theoretically wrong component), or items
that are complex (load on more than 2 components with loadings greater than .40) were
eliminated. Coefficient alphas were computed to indicate the internal consistency of each
component. Items with low or negative total-item correlations, which lowered the internal
consistency of a subscale, were deleted. In addition, items that had a highly skewed
distribution, high (4.0 or greater) or low (2.0 or less) mean endorsement, and / or significantly
high correlation (.30 or greater) with the Jackson Social Desirability Scale (Jackson, 1967)
were candidates for deletion.

Confirmation of factor structure
_ The factor structure of each refined instrument was evaluated by confirmatory factor ·
analysis using structural equation modeling techniques on the remaining half of the sample.
Studies on measurement analyses based on the Transtheoretical Model have been able to use
such techniques successfully (e.g. Bellis, 1993; Blais, 1991; Marcus, Rossi, Selby, Niuara, &
Abrams 1992). Maximum Likelihood (ML) was employed as an estimation procedure based on
its robustness against small sample sizes (Boomsma, 1987). The plausibility of the proposed
model was evaluated by the measures of goodness of fit including the chi-square statistic (x2),
the root mean square residual (RMSR), and comparative fit index (CFI) (Bentler, 1990).
Furthermore, significance of individual parameters (e.g. loadings of items) were assessed.
The chi-square statistic is an absolute measure of fit. A non-statistically significant and
small chi-square relative to its degree of freedom is generally considered as a good fit.
However, as chi-square statistic is not robust to violations of its assumptions such as non-
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normality and is therefore not to be used as the only goodness of fit measure (Long, 1983).
The RMSR is a measure of the amount of variance unexplained by the model . Generally, a
RMSR of 0 .06 or less indicates an acceptable fit (Hayduk, 1987). The CFI is an index that
measures the relative fit of the model as compared to the null model in which no factor
structure is assumed to exist among the items. This index ranges from Oto 1 with the latter
being a perfect fit. A CFI of .90 or above is generally considered an excellent fit of the model
to the data.
In addition, the proposed structure was compared to alternative models, and the
differences among the fit indices were compared and further used to evaluate the factor structure
of the scale. Model comparisons included a series of alternative models ranging from a null
model (for CFI calculations), a one-factor model (where a single latent factor is hypothesized to
explain all items) to a one hierarchical factor model (where a second-order latent construct is
hypothesized to underlie the first-order factors).
Results

ChangeAssessmentfor DrugUse(CAD)
Item analyses of the 32 items were conducted on baseline, exit and follow-up data in
order to select the most appropriate item pool for the item reduction process based on item
characteristics (mean, skewness and kurtosis). A mean of less than 1.0 or more than 4.0 (on a
were considered inappropriate item
scale range of 1-5), skewness or kurtosis greater than 121
characteristics with potential for item deletion. Item analyses of both baseline and exit data
showed that a majority (27 out of the total 32 items, 84% at baseline, and 25/32, 78% at exit) of
the items were excessively skewed or kurtotic, which suggested that data at baseline or at exit
were not appropriate for instrument refinement using PCA or CF A procedures. The follow-up
data, however, showed that 23 out of the 32 items (72%) had a reasonable statistical distribution
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and therefore, the instrument refinement procedures proceeded using data collected at follow-up.
Subjects with complete data were randomly split into an exploratory sample (n=304) and a
confirmatory sample (n=298). Statistical comparisons across these two samples suggested they
were similar in all characteristics as well as item statistical distribution. Therefore they were
appropriate for cross validation purposes.

Exploratory analysis
A principal components analysis (PCA) was conducted on the URI CA using the
exploratory sample (n=304). A 32 X 32 matrix of interitem correlations was used as input for
each analysis based on 304 subjects. The number of components to retain was determined by
Velicer's (1976) minimum average partial (MAP) procedure and parallel analysis using
Lautenschlager's (1989) guidelines based on Monte Carlo analyses for determining parallel
analysis criteria. Both MAP and the parallel analysis have been shown to be the most accurate
procedures to determine the number of components to retain across a wide range of simulated
situations (Zwick & Velicer, 1986).
A three-factor solution was suggested by MAP, while a 4-factor solution was supported
by the parallel analysis. Both solutions were considered. The 3-factor solution yielded a
Precontemplation component, an Action component and a component that consisted of items
from the Contemplation and Maintenance scales as originally proposed. Both varimax and
oblique rotations yielded consistent results. The 4-factor solution resulted in a clear 4-factor
structure which was consistent with the originally proposed factor-structure using both varimax
or oblique rotations. Given that the 4-factor structure was more meaningful and of theoretical
relevance, the 4-component solution was used to proceed with item reduction.
Item deletion was based on one of the three criteria including factor loadings, coefficient
alphas and item analysis. A confirmatory factor analysis (CF A) based on the correlated 4-factor
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model originally proposed by the questionnaire was performed on the 32 items using Maximum
Likelihood (ML) estimation procedure. Items that had low loadings(< .50) in both PCA and
CFA, and loaded on a non-target component (theoretically proposed component), or items that
were complex (loaded on more than 2 components with loadings greater than .40) were deleted.
Coefficient alpha was also computed to indicate the internal consistency of each component.
Items with low or negative total-item correlations, which lowered the internal consistency of a
subscale were deleted. In addition, items were not retained if they had a highly skewed
distribution, high (4.0 or greater) or low (2.0 or less) mean endorsement. Further PCA's using
oblique rotations and CF A's were conducted. A final 16-item version of the Change Assessment
for Drug Use (CAD) was derived.
Results of PCA: The four factors, Precontemplation, Contemplation, Action, and
Maintenance represented perception of one's readiness for quitting drug use. All four
components accounted for 59% of the item variance. Items loadings were high, ranged from .59
to .85. Table 1-1 presents the final 16 items and their loadings on each component.
Results of CFA: Assessment of the goodness of fit measures indicated the four-factor
correlated structure of the final 16-item was an acceptable factor structure, with the chi-square
statistic x.2 (98)

= 184.50, RMSR = .057, GFI = .93 and CFI = .93.

All factor loadings were

statistically significant(~< .001), ranging from .45 to .82 with a mean of .65. The factor
loadings and error variances are shown in Table 1-2.
The coefficient alphas for the Precontemplation, Contemplation, Action, and
Maintenance subscales were .71, .76, .85, and .63 respectively.
Confirmatory Analysis
In order to test adequately the four-factor model derived from the exploratory analyses
above, a series of alternative models representing potential factor structures of the measure were
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imposed on the independent confirmatory sample (n=298). A confirmatory factor analysis based
on structural equation modeling was conducted using the LISREL VII statistical package
(Joreskog & Sorbom , 1989) on a l 6xl 6 correlation matrix generated from the confirmatory
sample. Maximum Likelihood (ML) was employed as an estimation procedure based on its
robustness against small samples (n

~

200) (Boomsma , 1987). The plausibility of this four-

factor correlated model was evaluated by the measures of goodness of fit available in LISREL
VII including the chi-square statistic (x2) , the root mean square residual (RMSR) , the goodness
of fit index (GFI), comparative fit index (CFI) (Bentler , 1989; 1990), and the parsimony fit
index. The alternative models tested are described below.

Null Model This model assumed no relationship existed among the factors or items . It
was used to be compared against a proposed model to yield the comparative fit index . It is not a
proposed alternative model.

One Factor Model The one factor model postulated the underlying structure of the
measure was unidimensional. Support for this model would suggests that individuals do not
differentiate among various stages of readiness in their attempts to change their drug use .

Two Factors Uncorrelated Model This model proposed that individuals are
differentiated between 2 discrete stages with respect to change of drug use : a Pre-action
(Precontemplation + Contemplation) and an Action stage (Action+ Maintenance) . The twofactor model conceptualizes drug addicts into two distinct groups . They are either in denial of
their drugs problems with no intention to quit or are considering changing and/or are in the
process of quitting. The uncorrelated structure of the model indicates that the two stages
proposed are independent of each other.

Two Factors Correlated Model This model was almost identical to the above model
except that the two factors were proposed to be correlated. Therefore , individuals were viewed
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as progressing continuously from one stage to the next depending on endorsement on each of the
scales.
'-

Three Correlated Factors Model Previous study in smoking acquisition among
adolescents supported a three correlated factors model (Stem, Prochaska, Velicer & Elder,
1987) . This model posited 3 stages of change: Precontemplation, Decision Making
(Contemplation + Action), and Maintenance. It suggests that individuals could either l) have no
intention to quit using drugs; 2) be in the process of considering quitting and/or have initiated
some changes; or 3) have already quit using drugs and are working actively on maintaining
abstinence.

Four Uncorrelated Factors Model This model was identical to the four-factor structure
supported by the exploratory analyses, except that the four factors were proposed to be
Uncorrelated.

The four factors model suggests that individuals can be differentiated across four

independent stages of change: Precontemplation, Contemplation, Action, and Maintenance.

Four Co"elated Factors Model This model was derived from the previous exploratory
analyses. It is similar to the previous model, except that the four factors are proposed to be
correlated. The model suggested that individuals differ across four correlated stages of change,
which was consistent with previous findings for other health behaviors such as in psychotherapy
(Bellis, 1993; McConnaughy et al., 1983; Mcconnaughy et al., 1989), alcoholism (DiClemente
& Hughes, 1990), and sun exposure (Blais, 1991). Support for this model would warrant the
examination of a hierarchical factor model.

Single Hierarchical Factor Model This model suggested that there was a second order
latent factor accounting for the variances in the four first-order factors. A hierarchical factor
"Stage" was imposed on the four-correlated-factor structure tested above . Support for this model
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would indicate that the Change Assessment for Drug Use scale (CAD) could be used as a single
continuous measure.
Table 1-3 presents the results of the model comparisons . Findings suggested that the
four correlated factors model provide the best fit of the data observed , with the chi-square
statistic x2 (98) = 211.74, RMSR = .060, GFI = .92 and CFI = .90. All factor loadings were
statistically significant (p < .001), and ranged from .34 to .80 with a mean of .63. The factor
loadings and error variances are shown in Table 1-4. Internal consistency coefficient alphas for
Precontemplation, Contemplation, Action and Maintenance scales were .74, .68, .85 & .60
respectively. The absolute value of the correlations among the four factors ranged from .11 to
.52 implying the existence of a hierarchical factor structure.
Evaluation of the single hierarchical factor model indicated an acceptable factor
structure for the data with good assessment of the goodness of fit measures : chi-square statistic x
2 (100) = 238.08, RMSR = .068, GFI = .91 and CFI = .89 (Table 1-3). The variances of all
factors accounted for by the second order hierarchical factor were significant (p < .001), with R2
for PC, C, A,:& M = .23,.99,.23, & .23 respectively. Results provided preliminary support for
the hierarchical factor structure of the CAD and a CAD total score was created by the sum of the
final 16 times with the Precontemplation items reverse-scored. Internal consistency of the 16item CAD scale based on the confirmatory was .79.
Scale means, standard deviations, coefficient alphas and scale correlations based on the
combined sample at each time point: admission, discharge, and follow-up are presented in Tables
1-5, 1-6, &1-7 respectively. Correlations between each of the scale and the Jackson Social
Desirability Scale (Jackson, 1967) were also calculated (Table 1-5) at baseline. Two of the scales
A & M were found to be significantly correlated with the Social Desirability Scale; however, the

correlation was in an acceptable range (<.15).
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DecisionalBalanceforDru~Use
A principal components analysis was performed on a 12 X 12 matrix of interitem
correlations from the 12-item questionnaire using the whole sample at admission with complete
data (N=636). A two-component solution was suggested by both MAP (Velicer , 1976) and
parallel analysis using Lautenschlager's (1989) guidelines. The two components accounted for
51% of the total variance. The factor solution reflected a Pros and a Cons components as shown
in previous studies (Rosenbloom, 1991; Tsoh, 1993). Each of the Pros and Cons components
contained the six items that originated from the Pros and Cons scales, respectively , of the
instrument. The 12 items and their loadings on each scale based on varimax rotation are shown
in Table 1-9. Both scales showed an acceptable internal consistency with coefficient alphas of
.71 and .86 for Pros and Cons scales respectively (Table 1-8). Internal consistency for each
scales at other time points of discharge and follow-up were calculated and found to be acceptable
across each time point (Table 1-8). The coefficient alpha of the Cons scale showed a gradual
increase from .71 at admission to .83 at follow-up . Both scales were significantly correlated
with the Social Desirability Scale (Jackson, 1967) at admission but the correlation was
acceptable (<.32) (see Table 1-8). Findings suggested that no further instrument refinement was
necessary. Pearson correlations among CAD, decisional balance, and self-efficacy measures at
admission, discharge, and follow-up-up are presented in Table 1-10,Table 1-11, and Table 1-12
respectively.
Discussion
Results provided support for the application of the measures based on the
Transtheoretical Model in the area of substance abuse treatment. A 16-item Stages of Change
Assessment for Drug use (CAD) was developed from the original 32-item URICA scale . The
scale demonstrated reasonable psychometric properties across admission , discharge and follow-
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up in the present study. The measure of Decisional Balance Inventory for Drug Use was shown
to be reasonabl y successful in adapting to the drug addict population in the current investigation
given some modifications in wordings of the items which is consistent with findings from a
previous study (Tsoh, 1993). Some scales from the measures based on the Transtheoretical
Model of Change were found to have significant but relatively weak correlations with the
Jackson Social Desirability Scale (1967) , all of which were less than +/- .32, i.e. with less than
9% of the variance associated with social desirability .
The analyses of the CAD revealed a four-factor structure that was consistent with the
originally proposed scales in previous studies (Bellis , 1993; DiClemente & Hughes, 1990;
McConnaughy et al., 1983, 1989). The four-correlated factor structure was cross-validated using
two independent samples. When compared to the 18-item refined version ofURICA (Bellis ,
1993) derived from various psychotherapy outpatient samples, 11 out of the final 16 items of
CAD overlapped with the 18-item URICA scale. As compared to the Cocaine Change
Assessment Questionna ire (Martin et al., 1992; 1994), a 16-item version of the URICA refined
from a cocaine user sample which has 9 items overlapped with the 18-item URICA (Bellis ,
1993), the current version based on a mixed drug users sample indicated an overlap of 10 items
with Cocaine Change Assessment . The large amount of overlap in items indicated the
generalizability of the stages of change assessment measure across different problems areas.
Scale statistics indicated a rather positively skewed distribution on the PC scale.
Subjects tended to disagree with PC items, and to agree with C, A, and M items. Previous
studies have indicated a slightly skewed distribution particularly with the PC scale. It is
therefore recommended that the use of the scale is more meaningful and practical when scores
are standardized as opposed to raw scores due to response bias (Prochaska & DiClemente ,
1992).
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Previous studies using URICA in psychotherapy have demonstrated a simplex structure
of the measure (Bellis, 1993; McConnaughy et al., 1983, 1989). A simplex pattern is indicated
by higher correlations between adjacent stage (factor) as compared to non-adjacent stage. This
pattern has been found to support the theory proposed by the Transtheoretical Model of Change
that individuals progress from one stage to the next, where PC, C, A & M indicated the anchor
points of stages in a continuum. In a simplex pattern, PC is expected to be more highly
correlated with C, C with A, and A with M . In the current study, a simplex pattern was observed
among the PC, C and A scales at all time points . However, the M scale did not demonstrate a
simplex pattern as proposed. Indeed, it was the mostly highly correlated with C (.32 to .34)
instead of A as proposed; and it was weakly correlated with A (.03 to .22) across all time points.
A previous study using the original 32-item URI CA with refinement on a sample of drug addicts
in treatment demonstrated a simplex pattern (Tsoh, 1993). However, the high inter-correlations
among C, A, & M (ranging from .61 to .81) were indicative of significant "complex" items
(highly loaded on more than one scale) that called for further refinement of the instrument for a
drug-user population. Other studies on "acquisition" type behaviors such as exercise (Reed,
1995), sun exposure (Blais, 1992) and adolescent cigarette smoking (Stern et al., 1987) did not
demonstrate a simplex pattern of the measure. Indeed, it has been recently demonstrated and
validated that the URICA measure had a circumplex structure when applied to exercise
behaviors (Reed, 1995).
Nevertheless, the lack of relationship between the Maintenance and Action scales
suggested potential problems in which individuals who endorse highly on M might not necessary
have worked through the problems, or were working actively on quitting drugs ( endorsement on
Action). By inspecting the content of the Maintenance scale items , it concentrated mostly on

whether someone was aware of and/or were experiencing a relapse concurrently. There was not
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much indication of individuals' experience in successfully progressing through maintaining the
changes as shown by the Maintenance scale items. Therefore, it might be necessary to revise the
M items by including items that describe successful progress and experience in maintaining the
change.
Results of the confirmatory factor analysis using structural equation modeling provided
support for a single hierarchical factor. Carbonari and colleagues (Carbonari , DiClemente , &
Zweben, 1994) employed a single score of readiness based on the URI CA refined for alcohol
outpatients (DiClemente & Hughes, 1990) and demonstrated preliminary support for the use of
the readiness score. Further validation on using CAD as a single continuous measure will
require comparison of scores across stages and validation with other Transtheoretical Model
measures such as pros, cons, self-efficacy. Based on the current findings, correlations among the
scales indicated preliminary support of the CAD score based on summing all items with PC
reverse-scored suggesting a reasonable relationship with the Decisional Balance measure . CAD
consistently showed a significant positive correlation with the Cons scale with a reasonable
magnitude (.32 to .46) across time points and a weak correlation with the Pros, which in tum has
been found to have a generally weaker relationship with the URI CA scales. Consistent with the
implication of the Strong Principle (Prochaska, 1994) that Cons of a problem behavior
differentiate stages of change better wi!h a minimum of 1 SD change from PC to A based on
cross-sectional data. Therefore , the stronger relationship between the Cons and the CAD score
might provide some support for CAD being a reasonable index for readiness of change. On the
other hand, the lack of relationship between CAD and self-efficacy is somewhat puzzling. At
admission, there was no relationship found between CAD and self-efficacy, and indeed the
correlation between self-efficacy and CAD scales were rather weak . Comparatively, there was a
stronger positive relationship yet still small in magnitude (. 15 at discharge and .21 at follow-up)
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atother time points.

The lack of correlation at admission may be due to the problems of

assessing self-efficacy. Subjects were asked to rate their confidence to avoid drug use in the
following 3 months after they had committed themselves to treatment that was supposed to last
for at least 3 months, therefore it would seem irrelevant to ask these individuals their confidence
to avoid drug use in a controlled environment. The increase in correlation at later time points (at
discharge, and post-treatment) supported the speculation. Future studies focused on the external
validity of CAD total score as its ability to differentiate individuals across stages will help
understand the usefulness of this scale.
Analysis on the Decisional Balance for Drug Use has also demonstrated its internal
validity and reliability. The 12-item measure adapted from Rossi et al. 's (1993) Cocaine
Decisional Balance Inventory was shown to be appropriate for the drug addicted population in
the current study. The results have supported that these two scales, Pros and Cons of decisional
balance can be used to test the external validity of the stages of change. It has been consistently
demonstrated in previous studies based on the Transtheoretical Model of Change in a number of
different areas (Prochaska, Velicer et al., 1994). The pros and cons components emerged as the
only components from the principal components analysis. Coefficient alphas for each scale have
also demonstrated the reliability of this instrument .
The findings of the current study suggest that CAD is applicable for various occasions
including treatment admission, discharge, and post-treatment follow-up. In addition to
classifying individuals into various stages of change through cluster analyses (e.g.,
McConnaughy et al., 1983, 1989), previous studies have used the original version of CAD, the
URI CA, to assess treatment outcome and progress based on changes on each scale (Prochaska &
DiClemente, 1992). Future studies should further assess the application of CAD by comparing
various methods to assess stages of change . The application of the Transtheoretical Model of
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Change is highly dependent upon whether stages of change can be accurately assessed . Study 2
focused on examining various methods of using the CAD to assess stages of change among
clients in substance abuse treatment.
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Table 1-1

ChangeAssessment
forDrugUseCCAD):Final16itemsandLoadingsbasedon

Exploratory
SampleCn-304)
CAD Scales / Items
Precontemplation
11. Working on problems is preny much of a waste of time for me because
the problem doesn 't have to do with me .

I

Components
II
m

IV

.80

23. I may be part of the problem, but I don't really think I am.

.75

13. 1 guess I have faults, but there's nothing that I really need to change .

.73

5 . I'm not the problem one. It doesn't make much sense for me to be here.

.60

II . Contemplation
24. I hope that someone will have some good advice for me .

.76

8. I've been thinking that I might want to change something about myself .

.72

15. I have a problem and I really think I should work on it.

.70

21. Maybe someone will be able to help me.

.69

m.

Action
7. I am finally doing some work on my problem.

.84

30. I am actively working on my problem .

.82

14. I am really working hard to change.

.80

3 . I am doing something about the problems that had been bothering me .

.78

IV. Maintenance
18.1 thought once I had resolved the problem I would be free of it, but
sometimes I still find myself struggling with it.

.72

32. After all I had done to try and change my problem , every now and again
it comes back to haunt me.

.67

16. I'm not following through with what I had already changed as well as I
had hoped , and I'm working to prevent a relapse of my problem .

.67

28 . It is frustrating , but I feel I might be having a recurrence of a problem I
thought I had resolved.
Note : Varimax Rotation

.64
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Table 1-2

ChangeAssessment
forDrugUse<CAD): FactorLoadingsandErrorVariance

of the Final16itemsobtainedfromConfrimatocy
FactorAnalysisbasedon Exp)oratocy
Sample
<n==304)
CAD Scales

Factor
Loadings

Error
Variance

I. Precontemplation
11. Working on problems is pretty much of a waste of time for me because
.the problem doesn 't have to do with me .

.80

.26

23. I may be part of the problem, but I don't really think I am.

.63

.25

13. I guess I have faults , but there's nothing that I really need to change.

.61

.25

5. I'm not the problem one. It doesn't make much sense for me to be here .

.45

.27

II. Contemplation
24. I hope that someone will have some good advice for me .

.61

.25

8. I've been thinking that I might want to change something about myself.

.69

.24

15. I have a problem and I really think I should work on it.

.67

.24

21. Maybe someone will be able to help me.

.67

.24

ID. Action
7. I am finally doing some work on my problem .

.82

.20

30. I am actively working on my problem.

.76

.21

14. I am really working hard to change.

.73

.22

3. I am doing something about the problems that had been bothering me.

.76

.21

IV. Maintenance
18. I thought once I had resolved the problem I would be free of it, but
sometimes I still find myself struggling with it.

.58

.27

32 . After all I had done to try and change my problem , every now and again
it comes back to haunt me.

.52

.27

16. I'm not following through with what I had already changed as well as I
had hoped , and I'm working to prevent a relapse of my problem.

.52

.27

28. It is frustrating , but I feel I might be having a recurrence of a problem I
thought I had resolved.

.59

.27
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Table 1-3

MQd~ICQmi;mrisQnsJ.1siniCEAQfth~ Chan~~ Ass~ssm~nt for Orn~Us~ S!;.;al~
2

df

RMSR

Null

1398.80

120

0.232

0.52

I-factor

712.55

104

0.142

2-factor, uncorrelated

506.81

104

2-factor, correlated

571.28

3-factor, uncorrelated (PC,

Model Comparisons

CFI

PF!

0.73

0.52

0.45

0.145

0.81

0.69

0.60

103

0.131

0.80

0.63

0.54

414.62

104

0.134

0.84

0.76

0.66

3-factor, correlated

376.63

101

0.097

0.85

0.78

0.66

4-factor , uncorrelated

362.35

104

0.148

0.87

0.80

0.69

4-factor, correlated

229.00

98

0.062

0.92

0.90

0.75

I-hierarchical factor

238.08

100

0.068

0.91

0.89

0.74

X

GFI

(PC+C, A+M)

C+A,M)

~:

Model comparisons indices -

1. RMSR: Root mean squared residuals
2. GFI: Goodness of fit index
3. CFI: Comparative fit index
4. PFI: Parsimony fit index (based on CFI)
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Table 1-4

ChangeAssessmentfor DrugUse{CAQ):FactorLoadingsandErrorVariance

obtainedfromConfrimatocy
FactorAnalysisbasedon ConfinnatorySample{n-298)
CAD
Scales
I. Precontemplation
11. Working on problems is pretty much of a waste of time for me
because the problem doesn't have to do with me.

Factor
Loadings

Error
Variance

.81

.24

23. l may be part of the problem, but I don't really think I am.

.53

.25

13. I guess I have faults, but there's nothing that I really need to
change .

.58

.26

5 . I'm not the problem one. It doesn't make much sense for me to be
here .

.66

.24

.59

.25

8. I've been thinking that I might want to change something about
myself.

.54

.26

15. I have a problem and I really think I should work on it.

.53

.26

21. Maybe someone will be able to help me.

.60

.25

ID. Action
7. I am finally doing some work on my problem.

.80

.20

30. I am actively working on my problem.

.76

.21

14. I am really working hard to change.

.75

· .21

3. I am doing something about the problems that had been bothering
me.

.71

.22

.53

.27

32. After all I had done to try and change my problem, every now and
again it comes back to haunt me.

.62

.28

16. I'm not following through with what I had already changed as well
as I had hoped, and I'm working to prevent a relapse of my
problem .

.33

.27

28 . It is frustrating, but I feel I might be having a recurrence of a
problem I thought I had resolved.

.57

.28

II. Contemplation
24. I hope that someone will have some good advice for me.

IV. Maintenance
18. I thought once I had resolved the problem I would be free of it,
but sometimes I still find myself struggling with it.
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Table 1-5

CADCibeChangeAssessment
for DrugUse): mean,StandardDeviations,

at Baseline.N=617
CoefficientAlphas& ScaleCorrelations
Correlations
Scales

M

SD

Alpha

PC

C

A

M

Social
Desir-

(number of items)

ability

Precontemplation (4)

17.64

2.48

.57

1.00

Contemplation (4)

17.66

2.06

.69

-.40*

1.00

16.84 2.43

.73

-.30*

.57*

1.00

Maintenance (4)

15.22

2.79

.57

-.12*

.33*

.22*

1.00

.14*

CAD- all items (16)

67.36

6.79

.80

.64*

.79*

.73*

.64*

.03

Action (4)

.02

.02

-.12*

* PC items reversescored

Note:

1. Scale scores range from 4 to 20; CAD scores range from 16 to 80.
2. All PC items are reverse-scored

* p < .01
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Table 1-6

CADCiheChangeAssessment
for DrugUse): mean.StandardDeviations,

at *Exit<discharge),
N=438
CoefficientAlphas& ScaleCorrelations

Correlations

M

M

SD

Alpha

PC

Precontemplation (4)

17.14

3.11

.75

1.00

Contemplation (4)

16.93

2.59

.75

-.45*

1.00

Action (4)

17.12

2.91

.83

-.42*

.73*

1.00

Maintenance (4)

13.96

2.90

.56

-.05

.34*

.22*

1.00

CAD - all items (16)

65.16

8.36

.85

.68*

.86*

.82*

.55*

Scales

C

A

CAD

(number of items)

* PC items reversescored

Note:

1. Scale scores range from 4 to 20; CAD scores range from 16 to 80.
2. All PC items are reverse-scored

* p < .01

33

1.00

Table 1-7

CAD CJhe Change Assessment for Drug Use): mean. Standard Deviations,

Coefficient Alphas & Seate Correlations at *Follow-up C3-month post discharge)

N-602

Correlations
Scales

M

SD

Alpha

PC

16.92

2.91

.72

1.00

16.52

2.39

.72

-.27**

1.00

15.83

3.33

.85

-.22**

.34**

1.00

14.26

2.96

.62

-.10*

.32**

.03

1.00

63.52

7.53

.85

.63**

.71 **

.67**

.55**

C

A

M

CAD

(number of items)

Precontemplation (4)

Contemplation

(4)

Action (4)

Maintenance

(4)

CAD - all items (16)

* PC items reversescored

Note:

1. Scale scores range from 4 to 20 ; CAD scores range from 16 to 80.
2. All PC items are reverse-scored
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1.00

Table 1-8

Decisional
BalanceScaleforDru~Use:Itemsandloadin~s
Component

Scales / Items

II

Pros
I feel more confident when I use drugs.

.85

Drugs make me feel more confident and sociable.

.84

I feel better about myself while using drugs.

.76

Drugs give me that extra boost of energy .

.73

Drugs help me relieve tension.

.72

I am more fun to be with when I use drugs.

.71

Cons
Buying drugs has contributed to my experiencing some financial

.71

strain.
When using drugs I fail to keep up with bills.

.70

When using drugs , I borrow money that I fail to pay back .

.67

As I became more involved with drugs , I pulled away from people I

.64

was once close to .
My drug use has led me to act irresponsibly .

.56

I experience sleeping problems when I use drugs.

.5 I
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Table 1-9

DecisionalBalanceInventory:AlphasacrossAdmission,
Pischar~eandFoIIow-

up CAIisubjects)
Scales

Admission

Discharge

Follow-up

(number of items)

(n=636)

(n=449)

(n=621)

Pros (6)

.86

.85

.86

Cons (6)

.71

.77

.83

36

Table 1-10

PearsonCorrelation
Coefficients
amonfiChanfieAssessment
for DrufiUse

<CAD),Decisional
BalanceforDrufiUse,Self-Efficacy
forAvoidingDrugUseandSocial

Desirability
at Baseline
PC

C

A

M

CAD

PROS

CONS

Self-

Social

Efficacy

Desirability

CAD subscales

PC

1.00

C

-.40*

A

-.30*

.56*

1.00

M

-.12*

.33*

.22

.64*

.78*

.73

.64*

PROS

-.25*

.26*

.16

.23*

.32*

CONS

-.04

.10*

-.06

.17*

.09*

CAD

1.00

1.00
1.00

Decisional Balance
for Drug Use
1.00
.13*

1.00

Self-Efficacy for
Avoiding Drugs
-.01

-.03

.10

-.13*

-.02

-.08*

-.02

.03

-.11

.15*

.04

.20*

-.20**3

1.00

Social Desirability

*12< .05
**12< .01
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.32**

-.23**

1.00

Table 1-1 I

PearsonCorrelation
Coefficients
amongChangeAssessment
for DrugUse

for AvoidingDrugUseat Exit
(CAD),DecisionalBalancefor DrugUse,andSelf-Efficacy
PC

C

A

M

CAD PROS CONS

SelfEfficacy

CAD subscales
PC

1.00

C

-.45*

A

-.42*

.73*

M

-.05

.34*

.22*

.86*

.82*

.55*

1.00

-.15*

.22*

-.05

.19*

CAD

.68*

1.00
1.00
1.00

Decisional Balance
for Drug Use
PROS

.14*

CONS

-.31 *

.43*

.42*

-.07

.12

.30*

-.05

1.00

.46*

.01

1.00

.15*

.04

-.32*

Self-Efficacy for
Avoiding Drugs
-.04

*p < .05
**12< .01
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1.00

Table 1-12

PearsonCorrelation
Coefficients
amongChangeAssessment
forDrugUse

<CAD),
Decisional
BalanceforDrugUseandSetf..Efficacy
forAvoidingDrugUseat Follow-up
PC

C

A

M

CAD

PROS CONS

SelfEfficac y

CAD subscales

PC

1.00

C

-.27*

A

-.22*

.34*

1.00

M

-.10*

.32*

.03

.63*

.71 *

.67*

.55*

1.00

-.24*

.13*

-.09*

CAD

1.00

1.00

Decisional Balance
for Drug Use

PROS

-.05

-.03

CONS

-.30*

.28*

.17*

.15*

.35*

.06

.03

.55*

-.18*

.21 *

1.00
.15*

1.00

Self-Efficacy for
A voiding Drugs

*p < .05

**p < .01
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-.01

-.36*

1.00

STUDY 2

ASSESSING STAGES OF CHANGE AMONG DRUG ADDICTS IN
TREATMENT

Introduction
Research in substance abuse treatment retention and outcome has been hampered by the
lack of standardized assessment measures. Specifically , investigators have started focusing on
dynamic , non-traditional characteristics of clients in the hope for further understanding the
treatment process of substance abuse (e.g., Condelli & Deleon, 1993). The Transtheoretical
Model of Change (Prochaska & DiClemente , 1982, 1984, 1992), which has been successfully
applied across a number of behavioral change areas, offers a promising systematic framework to
assess individuals intentions, attitudes and behaviors regarding changing a behavior. The key of
applying the Transtheoretical Model of Change to the area of substance abuse is to first
accurately assess stages of change . Stages of change is a temporal constellation of an
individual's intention , attitudes and behavior related to change . Assessment of stages of change
can be achieved through a discrete categorical algorithm or a continuous measure (Prochaska &
DiClemente, 1992). The categorical stage assessment involves a stage algorithm which consists
of dichotomous questions to assess the person ' s readiness for change, or a series of statements
describing each different operational definition of stages . Previous studies have applied similar
forms of stage algorithm to assess stages of change in cocaine use and other drug use (e.g.,
Rosenbloom , 1991; Tsoh , 1993). However , several problems have been noted in applying the
stage algorithm to drug addicts in treatment such as the high tendency of over-classifying
individuals in treatment in action or maintenance (see Study 1). When compared to the
assessment of stages using a continuous measure , the University of Rhode Island Change
Assessment Scale (URICA ; McConnaughy , Prochaska , & Velicer , 1983), stage algorithm was
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shown to be less capable in producing distinguished stages of change (Tsoh , 1993 ). The Change
Assessment for Drug Use (CAD ) was developed in Study I targeting the stages of change among
drug addicts who are in treatment.
In order to determine individuals ' stages of change using a continuous measure , a cluster
analytic procedure has been used as the staging method. Owing to the complexity of cluster
analysis , researchers have recently suggested using other methods to classify individuals into
different stages based on their scale scores (see below). The purpose of this study was to
compare and evaluate each of the stage allocation methods , to arrive at the "best" method for
applying this instrument among drug abusers , as well as to establish stage membership of
subjects for further analyses.

Methodsof Stageallocationusingthe Stagesof ChangeAssessment
Scale
Cluster analysis This stage allocation method involves grouping individuals on their
profiles of these four scales: Precontemplation, Contemplation , Action , and Maintenance of the
Change Assessment Scale. Cluster analysis is used in order to classify subjects into subgroups
based on the similarities they share on their responses to the Stages of Change Scale. It requires
the scale scores to be converted into standardized I-scores with a mean of 50 and a standard
deviation of 10. The number of clusters is determined by interpretability of distinct clusters ,
visual inspection of the cluster dendrogram (Aldenderfer & Blashfield , 1984), as well as the
Cubic Clustering Criteria (Sarle, 1983; Milligan & Cooper , 1985). The resulting profiles from
the cluster analyses were compared to the those obtained from previous studies using the same
procedure in substance abuse as well as in other areas (e.g., DiClemente & Hughes , 1990;
Mcconnaughy, et al., 1983, 1989; Tsoh , 1993).

Highest Score Methods In applying a 12-item stages of change scale developed among
excessive drinkers in medical settings and who were not seeking treatment for alcohol, Rollnick,
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Heather, Gold and Hall (1992) proposed a "Quick Stage Allocation Method " . The scale was
modified from the original 32-item URI CA especially for that population . Three factors were
validated: Precontemplation , Contemplation and Action . Stage assignment is based on the
highest raw scale score obtained among the three scales. In case of a tie between two scale
scores , the one further along the continuum of the stages of change is chosen. Item scores range
from -2 (strongly disagree) to 2 (strongly agree). Rollnick and colleagues ( 1992) found that
using standardized item means yielded similar results as using raw scores. In this study , the use
of both raw and standardized scores were evaluated . Stage assignment was based on the highest
mean scores among the four scales of CAD (Precontemplation, Contemplation, Action &
Maintenance) refined in Study I. For simplicity purposes, the stage allocation methods are
named as Highest Raw Score and the High Z-score Method (when a standardized score is used) .

Profile Score Methods This approach allocates stages based on pre-assigned profiles
across the scales. Using the 3-scale Stages of Change measure , Rollnick and colleagues (1992)
allocated stages based on some "pre-assigned" profiles . Each scale has a mean ranged from -2 to
+2, and they assigned "+" (mean value of agree to strongly agree) or "-"(mean value of disagree
to strongly disagree) to each scale . Each of the stages to be allocated has a "pre-assigned"
profile of scales scores across the 3 scales of PC, C & A: Precontemplation stage"+--";
Contemplation stage"-+-"; Preparation stage"-++ with C > A"; and Action stage"-++ and C <
A". Other profiles were considered as invalid or uninterpretable. Stages allocated using this
approach outweigh the Highest Raw Score Method (Rollnick et al., 1992 ) in predicting followup outcome.
In this study, new "pre-assigned" profiles were used because the Stages of Change scale
has four scales instead of three. Item scores were transformed linearly from " I - 5" to "-2 - +2"
and scale means were coded to "+" (mean greater than 0) or "-" (negative scores of mean of 0).
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The following "pre-assigned" profiles across all four scales (PC, C, A, & M) of each stage were
proposed: Precontemplation stage"+,- ,-,-"; Contemplation stage"- ,+,-,+/-" ; Preparation stage",+,+ ,-"; Action stage"-,+,+,+" with A< M; and Maintenance stage"-,+ ,+,+" with M > C, A.
Individuals were assigned to one of the five stages based on the above profiles and other profiles
were considered as invalid.
Using the above pre-assigned profiles, a similar stage reallocation method using z-score
instead of raw score was examined . Each scale score was transformed into z-score, scale means
were coded to"+" or"-" according to the sign of the score ("+" if z-score is equal to or above Othe mean, and"-" if z-score was negative/less than 0)
Method

Participants
Seven hundred and ten (30% female) clients seeking drug addiction treatment from two
drug-free residential settings participated in the study. One residential setting focused on
cognitive-behavioral relapse prevention treatment program. Clients who sought treatment
between June 1991 to August 1993 were randomized into a 3-month or a 6-month program
regardless of their participation in the study. The other treatment setting was a therapeutic
community , and similarly, clients were randomized into a 6-month or a 12-month programs . All
clients were detoxified and free from withdrawal when they were presented to treatment. Data
were collected at admission, discharge and 3-month post-discharge . They received $15 for
interviews at admission and discharge, and $25 for the follow-up interview. Admission data
were collected with the first week after admission, exit data were collected 7 days before
anticipated discharge date to 3 weeks post-discharge, and finally follow-up data were collected
between 2 to 6 months after discharge. The current investigation focused on data at baseline
only . Table 2-1 presents characteristics of participants . Seventy-two individuals were excluded
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due to incomplete data . Therefore, data analyses were based on data from the 638 individuals
who provided complete data on all CAD scales .

Measures
Addiction Severity Index (ASI)
The Addiction Severity Index (ASI) (McLellan , Luborsky, Woody , & O'Brien , 1980;
McLellan et al., 1985; McLellan et al., 1992) is a semistructured interview that collects data
from substance abusers in seven problems areas: medical , employment , legal, alcohol, drug use ,
family-social functioning , and psychological status. The primary goal of developing the ASI
was to provide an instrument to assess treatment outcomes over a broad range of potential areas
which could be affected by substance abuse treatment and can be applied across different
treatment settings (McLellan et al., 1992). The latest version, the fifth edition of the ASI was
used (McLellan et al., 1992), with the addition of questions on personal and family psychiatric
history. ASI covers general sociodemographics , as well as past and present information of each
area. Composite scores can be computed from each area.
ASI is the most widely used clinical and research instrument in the area of substance
abuse . The instrument has been validated across hundreds of studies during the past 14 years
across different populations of substance abusers ( e.g. Brown, Alterman , Rutherford , Cacciola &
Zaballero, 1993; Hendriks, Kaplan , Limbeek, & Geerlings , 1989; Hodgins & Guebaly, 1992;
McLellan et al., 1992). Studies in the area of substance abuse have frequently used ASI scale
scores for evaluation treatment efficacy and to validate newly developed scales for this area ( e.g.,
Darke , Ward, Zador, & Swift, 1991; Kang , Klinman, Woody , & Millman., 1991; Kosten,
Rounsaville & Kleber , 1987).
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ChangeAssessment of Drug Use (CAD)
This 16-item questionnaire refined in Study I was used to assess subjects' readiness to
change their problem behavior. Subjects were asked to respond on a 5-point Likert Scale
ranging from I= strongly disagree to S=strongly agree . Four items comprised each of the
four stages of change: Precontemplation (PC}, Contemplation (C}, Action (A) and Maintenance
(M) . This measure was administered at both admission and discharge interviews. The
psychometric properties of the measure have been demonstrated in Study I with coefficient
alphas ranging from .57 to .73 at baseline and .56 to .83 at exit. The application of the
measure in assessing stages of change of drug use was examined in this study.
Decisional Balance Inventory

The 12-item scale modified from the Cocaine Decisional Balance Inventory (Rossi,
Rosenbloom, et al. 1993) was used. With some wording changes replacing "cocaine use" with
"drug use", this 12-item version has been shown to be a valid measure for the decisional
balance construct in a sample of drug addicts in treatment (Tsoh, 1993). Subjects were asked
to rate each item on a 5-point Likert scale ranging from I = not important to 5 = extremely
important. The items represent PROS and CONS for drug use with 12 items on each
dimension. The psychometric properties of this measure was further examined in the present
study. Items of the measure are shown in Appendix C.
Self-efficacy to avoid drugs

This self-efficacy scale contains 5 items assessing subjects' confidence in their ability to
avoid drug use in high risk situations during the next 3 months. Subjects were asked to respond
on a four point Likert Scale: I =extremely confident to 4=not at all confident. Total score is the
sum of all 5 items reverse scored, with the higher total score indicating higher confidence. The
scale was developed based on the data collected in this study at admission through various
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versions of the instrument with an item pool of 11 or 24 items. The factor structure was refined
using the shorter version (n=3 70) and was confinned using the long version (n=2 l 7). The
internal consistency as indicated by Cronbach's alpha, was .82 (Rubin, 1993). Items are shown
in Appendix D.
Rosenberg Self-Esteem Scale

It contains 10 items assessing individuals' sense of self-worth, satisfaction with self, and
belief in their own capabilities. Each item is scored on a four-point scale with I =strongly agree
and 4=strongly disagree. Test-retest reliability and validity in use with adolescent and young
adult populations has been adequate (Rosenberg, 1965). Improved in self-esteem is a favorable
outcome particularly for those in therapeutic communities .
Beck Depression Inventory

It is a 21-item self-administered questionnaire developed by Aaron Beck (1967). The
number and severity of current depressive symptoms are assessed. Adequate reliability has been
established in studies of psychotherapy.
Shipley-Institute of Living Scale

It is a self-administered test of cognitive functioning (Shipley, 1939). It contains a
verbal and an abstract section. Scores are age-corrected and can be converted to an estimated
WAIS-R IQ score with mean=lO0, SD=l5. The estimated WAIS-R IQ score was used in the
current study. Administration of the instrument was timed and subjects were allowed 15 minutes
to complete each section.
Diagnostic Interview Schedule, Third Edition Revision (DIS-111-R)

An abbreviated version of the DIS-III-R which incorporates items for the DSM-111-R
diagnostic criteria (American Psychiatric Association, 1987) was used. Only questions needed to
ascertain some pre-selected DSM-III-R diagnoses were asked. Those diagnoses include panic

46

disorder , social phobia , major depressive disorder , dysthymia , alcohol abuse and alcohol
dependence , antisocial personality disorder, and pathological gambling. The decision to focus
on these diagnoses was based on considerations of prevalence of these disorders among drug
abusers in treatment and evidence that particular disorders may be associated with treatment
outcomes.
Social Desirability Scale
Jackson 's Social Desirability Scale (Jackson , 1967) was used to assess response bias
due to social desirability. This instrument consists of 20 items that are presented in a true-false
format. It has been found to be a valid and reliable measure to determine if a response set
tends toward the direction of social desirability.

Other variables
Data on other variables that have been associated with outcomes or retention from
previous studies were also collected. Those variables included l-DV status, sources of referrals,
length of stay in treatment, and status of completion.

DataAnalysis
The best stage allocation method was expected to be able to classify subjects into various
stages of change that could be distinguished easily by relevant variables such as the Decisional
Balance Scales, and Self-Efficacy in an interpretable manner. Each method was evaluated by the
following criteria:
1.

proportion of subjects classified successfully;

11.

validation against decisional balance (pros and cons), and self-efficacy to avoid drugs

using MANOV A and follow-up ANOV A;
111.

correct classification rate using pros, cons, and self-efficacy as predictors for stage

membership from Discriminant Function Analysis (DF A).
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After the best stage allocated method was selected, agreement on stage memberships
with the best method and other methods was assessed. Furthermore, the use of the Change
Assessment Scale for Drug Use (CAD) was examined. Validation of CAD total score was
conducted using one-way ANOV A to examine the capability of CAD score to separate different
stages based on the best method of stage allocation found in this study. Lastly, relationships
between stages of change (using the best stage allocation method) and the ASI measures, as well
as other sociodemographic variables at baseline were examined.
Results

ClusterAnalysis
The four scales, PC, C, A & M of the CAD were used as clustering variables . Scale
statistics of the whole sample (n=638) with complete data on all the four CAD scales indicated
that there were 5 individuals with at least one or more CAD scales in the range beyond

± 4 SDs'.

These outliers were excluded since outliers can yield unstable cluster profiles (SAS, 1985).
Participants were randomly split into two independent samples (Sample 1: n=3 l O; Sample 2: n=
324) for cross validation ofresulting cluster profiles. Sample characteristic comparisons
indicated the two samples were very similar and would serve well for validation purposes. Scale
scores were the means of the item scores for each scale, which were converted into standardized
T-scores with a mean of 50 and a standard deviation of 10. Scale scores were standardized in
each sample and cluster analysis was performed on each sample independently. Individuals were
classified into cohesive subgroups based on the similarities they shared on their responses to the
CAD scales. Ward's minimum variance method (Ward, 1963) was used as it has been
demonstrated to be the most desirable method among other cluster analytic procedures (Milligan,
1980; Milligan & Cooper, 1987). Using Ward's procedure, each subject was treated as an

individual cluster and then the clusters are merged into subgroups. The Euclidean distance
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measure of similarity was calculated for merging clusters with the smallest distance. Finally , the
number of clusters was determined by interpretability of distinct clusters, visual inspection of the
cluster dendrogram (Aldenderfer & Blashfield, 1984), as well as the Cubic Clustering Criteria
(Sarle , 1983; Milligan & Cooper , 1985).
In Sample 1, solutions of 4 to 10 clusters were considered. The 6-cluster solution was
the most interpretable.

The clusters were labeled: Uninvolved (n= 48) , Precontemplation

(n=60) ,

Reluctant (n=32) , Contemplation (n=78), Preparation (n = 40), and Action (n = 52). In Sample
2, a 6-cluster solution was found most interpretable among the range of 4 to 10-cluster solutions
considered . The cluster profiles were very similar to those identified in Sample 1 with respect to
level, scatter and shape. The distribution for each clusters were: Uninvolved (n=49),
Precontemplation

(n=73), Reluctant (n=26), Contemplation (n=76), Preparation (n=50), and

Action (n=49). The means and standard deviations for the scale scores of each cluster for
Samples 1 & 2 are shown in Table 2-2 & Table 2-3 respectively.

Each cluster profile is

described below.

Uninvolved Cluster: This subgroup consisted of 15.5% (n=48) of Sample 1 and 15.2%
(n=49) participants of Sample 2 were classified into this cluster. Both profiles were
characterized by below to about average scores on the PC scale and well below average score on
the C, A and M scales (Figure 2-1 ). Individuals in this cluster were not actively participating in
changing or considering about quitting drugs. They seemed to deny their drug use as a problem
and seemed to be "uninvolved" with treatment for drug use . This profile represents a "lack of
endorsement" of most scales.

Precontemplation Cluster: This subgroup consisted of 19.4% (n=60) and 22.6% (n=73)
of Samples 1 & 2 respectively . These individuals featured an elevated score on PC and below to
about average on C, A & and M scales (Figure 2-2) . Individuals in this cluster were not
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-considering or actively engaging in quitting drugs ; rather they seemed to deny their drug use as a
problem and maintained the status quo with respect to their drug use.

Reluctant Cluster : This subgroup consisted of I 0.3% (n=32) and 8.0% (n=26) of
Samples I & 2 respectively. This typology indicated a lack of action profile. Individuals were
characterized by an about average score on PC, C & M scales and an extremely below average
score on the A scales. They seemed to recognized their drug use as a problem and/or even began
to consider changing , yet they were reluctant to make commitment to change or to participate in
treatment. Figure 2-3 presents the profiles of this cluster identified in the two samples.

Contemplation Cluster : The 25.2% (n=78) and 23.5% (n=76) participants of Samples I
and 2 respectively comprising this cluster showed a below average of PC scale and about
average of C, A & M (Figure 2-4). These individuals had recognized drug use as a problem and
were thinking about changing. However, they had not yet actively engaging in quitting.

Preparation Cluster:

There were 16% (n=52) of Sample 1 and 15.2% (n=49) of

Sample 2 participants classified into this cluster. The cluster profile was characterized by a
below average endorsement on both PC and M scales, and above average on the Contemplation
and Action scales (Figure 2-5). These subjects have made a decision to change their drug use
behavior and have started actively participating in changing . However, they have not yet
experienced or recognized the risks ofrelapse (low endorsement ofM) .

Action I Participation Cluster : The 12.9% (n=40) and 15.5% (n=50) of Samples 1 and
2 individuals respectively classified into this cluster were characterized by below average scores
on PC, but well above average scores on C, A and M scales (Figure 2-6). These individuals
reported high investment and involvement in changing their drug use behavior , and have started
to maintain their behavior change and work toward preventing relapse.
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The converging results from the cluster analyses conducted in two independent samples
indicating that the cluster profiles identified in each sample was very similar and that the cluster
solution obtained was stable. Therefore, the external validation of clusters were proceeded with
two samples combined retaining the cluster membership derived from each sample. Table 2-4
presents the distribution of clusters across each sample and the combined sample .
External validation of clusters with decisional balance and self-efficacy measures

A one-way MANOV A was conducted using the stage clusters as the independent
variable on three variables including the Pros and Cons for drug use and self-efficacy to avoid
drugs,. The MANOVA yielded a significant main effect, Wilks' A= .85, F(l5, 1725.75) = 6.80,
p <.001, which accounted for 15% of the variance . Follow-up ANOVAs were conducted for each
of the three scales to determine group differences. Significant main effects were found on all
measures. Summaries of the follow-up univariate tests and the Tukey post-hoc tests are
presented in Table 2-5. On the Pros for drug use, both Reluctant and Action clusters scored
significantly higher than individuals in Preparation, and Action cluster has a higher Pros than
Contemplation and Uninvolved clusters. On the Cons for drug use, the Action cluster endorsed
significantly higher scores than all others; the Contemplation cluster was similar to the
Preparation cluster whereas subjects in the Precontemplation and Uninvolved clusters scored
significantly lower than Contemplation clusters. With respect to Self-efficacy, the Preparation
and Uninvolved clusters reported higher self-efficacy as compared to Contemplation, while the
clusters of Precontemplation, Reluctant and Action did not differ significantly from others in this
measure. Figure 2-7 and Figure 2-8 illustrate the mean values for the Pros and Cons scales of the
Decisional Balance for Drug use and Self-efficacy across clusters respectively.
A stepwise discriminant function analysis (DFA) was performed using the three
measures, Pros, Cons and Self-efficacy as predictors for the cluster membership. Two
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significant discriminant functions were obtained. Cons was the primary predictor (loading= .93)
for function 1 with Wilks' A= .87, x2 (10) = 84.73, p < .0001, Canonical correlation (Rc2) = .32.
Function 2 consisted of Pros as the primary predictor (loading= .89) with Wilks' A= .98, x2 (4)
= 15.24, p < .005, Rc 2 = .15. The inter-group variability as accounted for function 1 (Cons) and
function 2 (Pros) were 82.65% and 17.35% respectively. The jackknifed classification analysis
showed that 24.0% (as compared to 16.7% by chance alone) of the 633 participants were
correctly classified into one of the 6 clusters. The most accurate classification occurred in the
Action cluster, where 53.3% of the sample was correctly classified, while the most
misclassification occurred in Precontemplation cluster, in which only 5.4% was correctly
classified with most participants (31.6%) classified into the Uninvolved cluster.

HighestRawScoreMethod
Of the 638 individuals providing complete responses to CAD, stage membership was
allocated according to the CAD scale with the highest raw score, and in case of ties, a more
"advanced" stage was assigned. Analysis yielded the following stage distribution: 0.6% (n=4) in
Precontemplation, 38.7% (n=247) in Contemplation, 39.0% (n=249) in Action, and 26 .1%
(n=138) in Maintenance. The exceptionally small portion of precontemplators classified by this
allocation method indicated a questionable capability in classifying individuals into
Precontemplation. Therefore, no further external validation of the method was performed.

HighestZ-scoreMethod
Scale scores of each CAD subscales were standardized to the mean of 50 with a standard
deviation of 10 based on the 638 participants provided complete data. Stage membership was
allocated according to the CAD scale with the highest standardized score, similar to the
allocation method using raw scores, in case of ties, a more "advanced" stage was assigned . Of
the 638 participants, stage allocation method yielded the following stages of change (Stage-z)
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distribution : 26.2% (n=167) in Precontemplation , 25 .4% (n=162) in Contemplation , 21.1%
(n=135) in Action , and 27.3% (n=l 74) in maintenance .

External validation of stages with decisional balance measures
A one-way MANOV A using Stage-z as the independent variable was performed on the
Pros, Cons and Self-efficacy as dependent variables. The mean of the item scores of each scale
was used as scale scores for the analysis. Results showed a significant main effect , Wilks' A =
.90, E(9, 1538.3) = 7.79, p <.001, which accounted for 10% of the variance. Follow-up univariate
analyses (ANOVA) were conducted for each of the four scales to determine group differences
for validating the stages based on this stage allocation method (Table 2-6) . Significant main
effects were found in all variables. Tukey post-hoc test on Cons for drug use indicated that
Precontemplators scored significantly lower than all other stages. On the Pros for drug use,
individuals in Maintenance were found to have a higher score than those in Action with no other
significant difference observed between any other two groups. Individuals in Precontemplation
and Action were noted to have significantly higher self-efficacy to avoid drug use than both
contemplators and maintainers. Figure 2-9 & Figure 2-10 illustrate the mean values for the Pros
and Cons scales of the Decisional Balance for Drug Use and Self-efficacy across stages
respectively.
A stepwise discriminant function analysis (DFA) was conducted using Pros, Cons and
Self-efficacy as predictors for the stages of change. Two significant discriminant functions were
obtained. Cons was the primary predictor (loading= .84) for function 1 with Wilks' A= .90,

r..2

(9) = 68 .76, p < .0001, Canonical correlation (Rc2) = .29. Function 2 consisted of Pros as the
primary predictor (loading =-.66) with Wilks' A= .98, x2 (4) = 13.16, p < .01, Rc2 = .14. The
inter-group variability accounted for by function 1 (Pros) and function 2 (Cons) were 81.38%
and 18.50% respectively. The jackknifed classification analysis showed the overall correct
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classification rate was 34.6% (as compared to 25.0% by chance alone) . The most accurate
classification occurred in Precontemplation , where 46.1 % of the sample was correctl y classified.
However , the most misclassification occurred in Contemplation , in which only 4.9% was
correctly classified with most participants (42.0%) misclassified into Maintenance.

ProfileRawScoreMethod
Each CAD scale score was transformed into a range from -2 to +2 from a possible range
of I to 5, and further coded into"+" or"-" according to the sign of the score. Stage membership
was allocated according to the pre-assigned profile as mentioned above. Of the 638 individuals ,
2 I 6 (33 .96%) could not be staged due to invalid profiles, i.e. profiles that did not match any of
the pre-assigned profiles. Table 2-7 presents 4 alternative profiles that could not be assigned
with a stage based on this method . The majority of unstageable subjects presented a profile of",+,+,+" with highest score on C. Of the remaining individuals (n=422) , analysis yielded the
following stage distribution: 0.4% (n=2) in Precontemplation, 6.2% (n=26) in Contemplation,
6.2% (n=26) in Preparation, 57.6% (n=243) in Action, and 29.6% (n=l25) in maintenance.
Similar to the Highest Raw Score Method above, majority of subjects were classified into Action
or Maintenance stage (over 87%) and only an exceptionally small portion of precontemplators
were classified, indicating a questionable capability of this method in classifying individuals into
Precontemplation. Furthermore, owing to the large portion of "unstageable" individuals based
on the current method, no further external validation of the method was performed .

ProfileZ-scoreMethod
Each CAD scale score was transformed into z-score with mean equals Oand was further
coded into"+" or"-" according to the sign of the z-score. Stage membership was allocated
according to the pre-assigned profile as mentioned above. Similar to the Profile-R method, more
than half of the subjects, 316 (49 .5%) could not be staged due to invalid profiles. Table 2-8
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presents 11 alternative profiles that could not be assigned with a stage based on this method.
More prominent alternative profiles were"-,-,-,-" (15.2%), "+,-,-+" (15.2%) and"+,+,+,+"
(14.2%). The remaining individuals (n=322), analysis yielded the following stage distribution:
23.9% (n=77) in Precontemplation, 15.5% (n=S0) in Contemplation, 10.0% (n=32) in
Preparation, 32.9% (n=106) in Action, and 17.7% (n=57) in maintenance. Owing to the large
portion of "unstageable" individuals based on the current method, no further external validation
of the method was perfonned.

Methodevaluation
As indicated earlier, the methods of stage allocation were subjected to the following
criteria for evaluation purposes including proportion of successful classified subjects; MANOV A
results on proportion of variances accounted by pros, cons and self-efficacy; and overall DFA
correct classification rate using pros, cons and self-efficacy as predictors. Comparison results
including stage distribution produced by each allocation method is shown in Table 2-9. Among
the 5 methods of stage allocation, cluster analysis, highest-score methods based on both raw and
standardized scores, and pre-assigned profile methods based on both raw and z-scores, only
cluster analysis and the highest-z-score methods proceeded with external validation due to
failure of other methods in meeting the first evaluation criteria. The highest-raw-score method
lacked sensitivity in classifying precontemplators where over 99% were classified into C, A or
M. Both pre-assigned profile methods, however, yielded a large portion of unclassifiable cases.
Therefore, only the clusters analysis and the highest z-score methods satisfied the first criteria on
the capability in successfully allocating most individuals to various stages of change. Therefore,
these two methods were subjected to further evaluation by other criteria. Comparison based on
the se~ond criteria on MANOVA results (Table 2-9) indicated that the stage allocation method
based on cluster analysis yielded a higher amount of intergroup variability accounted by Pros
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and Cons for Drug use and Self-efficacy (15% vs. 10%). The correct classification rate using
OF A based on pros, cons and self-efficacy as predictors suggested a small difference that
favored cluster analysis. By comparing classification to chance alone, the overall correct
classification rate of24 % for 6 clusters was 44% better than by chance alone (16.7%) as
compared with the rate of 34.6% for 4 stages (from the highest z-score method) which was 38%
better than by chance alone (25% ). Although the OFA overall correct classification rates for
both methods were quite low but were acceptable (better than chance alone), it should be noted
that the classification rates were based on two predictors only.
Comparison of stage memberships derived from cluster analysis and the highest z-score
method is presented in Table 2-10. Majority of subjects in the Uninvolved (57%) and the
Precontemplation clusters (61% ) were classified into the PC stage by the highest z-score method .
Most subjects (77%) in the Preparation clusters were in the A stage and majority of the Action
cluster individuals were allocated with either the stages of A (31 %) or M (56%). The most
disagreement, however, occurred in the Reluctant and the Contemplation clusters, in which most
Reluctant individuals (45%) were allocated to the stage of C, and most Contemplation cluster
subjects (47%) were classified into M stage instead using the highest z-score method. While
both methods appeared to be an acceptable method to assess stages of change among individuals
seeking substance abuse treatment, the current findings comparing these methods suggested that
cluster analysis was a better method. Therefore, stage membership based on cluster analysis was
used to proceed with the following analyses.

Relationshipbetweensta~esandCADscore
CAD score was created by computing the sum of all scale means with the PC scale
reverse-scored. A one-way ANOV A was conducted using the stage clusters as the independent
variable on the total CAD score . Significant differences across clusters were noted with £
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(5,627)

= 284.23, p < .0001.

Follow-up Tukey post-hoc tests indicated that significant

differences across all clusters in the following ascending order : Uninvolved, Precontemplation
and Reluctant, Preparation, Contemplation, and Action, with the exception of PC and R clusters
where both have similar CAD scores Table 2-11.

Relationship
betweenstagesandothermeasures
A series of MANOV A, follow-up ANOV A as well as Chi-square tests were performed
on all participant characteristics (see Table 2-1) including types of programs and settings, age,
gender, education , treatment history, drug use pattern, legal involvement and so on, 7 composite
scores from ASI measures including drug use, alcohol , medical, employment, family and social ,
legal, and psychiatric status, and other psychological measures including Rosenberg Self-Esteem
Scale, Depression (Beck Depression Inventory), psychiatric diagnosis based on the Diagnostic
Interview Schedule. No significant differences were found across clusters on demographic
variables. However, there were significant differences regarding the types of living-environment
before admission , proportion of subjects with social phobia, depression level, self-esteem and the
ASI composite score on drug use.
Types of living-environment before admission across clusters are presented in Table 212. Significantly more individuals in Preparation (PR) and Action (A) were living in a
controlled environment before admission as compared to other clusters

x2(5)=14.99, p < .01.

More specifically, over half of the subjects in Preparation and Action came from detoxification
centers before admission as compared to most other clusters

x2(5)=16.37, p < .01. Of 595

subjects with diagnostic information on social phobia, 33.9% fulfilled the diagnostic criteria of
social phobia using the Diagnostic Interview Schedule . There were significantly less PR subjects
with social phobia as compared to all other clusters, 17.5% (PR) vs. 3 5.2% (U), 3 7 .6% (PC),
49.0% (R), 35.6% (C), & 34.1% (A),

x2 (5)=17.82 , p < .01.
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Table 2-13 summarizes the differences across clusters on other measures including
depression, self-esteem, composite score of drug use (ASI). The relationship between each
measure and stages of change are discussed below.

Depressionand Stagesof Change,

Follow-up one-way ANOV A on depression

level as measured by the Beck Depression Inventory (BDI) across clusters showed that PR
cluster has a significantly lower BDI score than PC, R, C, and A clusters, £(5 ,614) = 5.62, p <
.000 l. Owing to the above finding that there were more social phobic individuals in other
clusters than in PR, and, depression is a common symptom present in social phobia (e.g.,
American Psychiatric Association, 1994), a 2(social phobia)x 6 (clusters) ANOVA on BDI
scores was performed to further investigate the relationship between depression and cluster/stage
membership. Results indicated only a significant main effect on social phobia, E (1,582) =
51.98, p<.001, with social phobic individuals reporting higher BDI scores. There was no
significant main effect on clusters (£(5,582)=1.88, p>0 .05) or interaction effect (£(5 ,582)=1.81,
p>0.05). Therefore , since there was a significantly smaller portion of PR subjects with social
phobia, depression level did not seem to differ across clusters .

Self-esteemand Stagesof Change,

Follow-up one-way ANOV A on self-esteem

level as measured by the Rosenberg Self-esteem Scale across clusters showed that PR cluster has
a significantly higher self-esteem score than R, C, and A clusters , £(5,622) = 5.06, p < .0001 .
Since low self-esteem has been known as highly associated with depression level (e.g., APA,
1994), and given the finding earlier regarding lower depression level found in PR individuals
which in turn may be due to the connection with social phobic diagnosis, an one-wa y ANCOV A
on self-esteem score using depression level (BDI) as covariate was conducted to further examine
the relationship between self-esteem and cluster membership . Results indicated that the
depression was a significant covariate with self-esteem (E( 1,614)=239 .66, p< .00 l) in the
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AN COVA model and the main effect of cluster member was not significant (£(5 ,614)=1 .93,
Jl>.05). Therefore, since there were significantly less reported depressive symptoms by PR
subjects, self-esteem level did not seem to differ across clusters.

ASICompositeScoreof DrugUseand Stagesof Chan"e.

Follow-up one-way

ANOVA on ASI Composite Score of Drug Use across clusters showed that both A and PR
clusters have a significantly higher composite score than the U cluster, E(5,599)

= 4.04, p < .0 I .

The derivation of the composite score was based on the number of days reported with drug
problems during the last 30 days as well as two items on self-perception of the degree of being
troubled by drug problems and the importance of treatment for drug problems. In order to
further understand the relationship between the ASI drug use measure and stages of change,
additional analyses were performed. An one-way ANOV A on self-perception of the degree of
being troubled by drug problems (perceived severity) only showed a significant difference
between U and A, with A cluster subjects reported being more troubled by their drug use. On
perceived importance of treatment for drug problems, A, PR and R reported higher value of
treatment than U, and A was also different from C with A having higher value of treatment.
Second, a new composite score was calculated without the scores from the two self-perception
items, in other words, this new composite score denoted only the proportion of days using drugs
and/or with drug problems. An ANCOV A on this new composite score was conducted using
perceived-trouble and perceived-importance as covariates to further examine the relationship
between ASI composite score and cluster membership. Results indicated that the two selfperception measures were significant covariates with the new ASI composite score
(E(2,599)= 109.70, p<.001) in the ANCOV A model and the main effect of cluster member was
not significant (E(5,599)=0.52, p>.05). Therefore, cluster membership differed in terms of
perceived degree of severity of drug problem and perceived importance of treatment for drug
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use, rather than the number of days using drugs or associated with drug problems during the
previous months .
Discussion
The comparison of stage allocation methods indicated that cluster analysis on
standard ized scale scores was among the best method with the highest validity . Findings
suggested stage assignment should not be based on raw scores of the CAD subscales. The PC
scale tends to have a low score (most drug addicts tend to disagree the items) and A & M scales
tend to be highly endorsed. Therefore, standardized scores have been recommended when
applying a continuous measure of change assessment (e.g. , URlCA) rather than using raw scores
(Prochaska & DiClemente, 1992).
Although the Highest Z-score method appeared to be the second best method for stage
allocation, this method seemed to over-classify contemplators to the stage of Maintenance.
Moreover , as suggested by the findings in Study 1, the content of the M scale items concentrates
mostly on individuals ' awareness and concurrent experience of relapse , but does not reflect
much on individuals ' process and success in sustaining the change. Therefore , the highest score
methods (using raw-or standardized scores) might tend to over-classify individuals who are
aware ofrelapse (e.g ., a good portion of contemplators) into Maintenance (as indicated by the
highest endorsement in M). Nonetheless , the highest z-score method might seem to be quite
capable of identifying precontemplators . This type of approach seems to have lost the unique
advantage of using a continuous measures in identifying cohesive subtypes beyond the five
proposed stages. Instead, the stages assigned are limited by the number of scales .
The profile scores approach assessed staged through matching subjects ' profiles with
pre-assigned profiles , attempted to improve upon the limitations of the highest score approach
yet maintained the advantage of identifying stages quickly without using complicated statistical

60

--

- - .--

techniques . However , current findings suggested that both profile methods (raw or standardized
scores) were not able to capture enough of the variability of profiles among drug addicts in
treatment and only two-thirds to half of the subjects could be staged according to the existing
pre-assigned profiles used in this study. Unless an additional comprehensive set of pre-assigned
profile conditions is available and tested , it is not recommended to use profile score methods for
stage assignment.
Cluster analysis based on standardized scale scores appeared to produce valid stage
profiles consistently as shown by previous studies using this method (e.g., Bellis , 1993;
McConnaughy et al., 1983; 1989, Martin et al., 1994; Tsoh, 1993). Six clusters were identified
among clients admitted to residential substance abuse treatment programs . These profiles were
all identified in previous research on drug addicts in treatment as well as on clients seeking
psychotherapy (e.g., Martin et al., 1994; Mcconnaughy et al., 1983; 1989, Tsoh , 1993.) The
cluster profiles representing various degree of readiness for change were externally validated by
pros and cons for drug use. A classic cross-over of pros and cons across stages were apparent
and consistent with previous studies conducted on different problem behaviors (Prochaska et al.,
1994). The Strong Principle of changing problem behavior (Prochaska , 1994) that proposes a
minimal of 1 SD increase in the Cons of the behavior from stages of PC to A was demonstrated
in the current findings. Individuals who were more ready to quit using drugs reported higher
Cons of drugs use. On the other hand, those who were more reluctant to quit using drugs
indicated higher importance of the Pros. Unexpectedly , while the Action cluster individuals
reported the highest Cons of drug use, they also reported high Pros as well. Although they
indicat~d readiness to change and were actively working through quitting , their high level of
Pros might suggest that these individuals were not "well-prepared" prior to take action and that
they continued to value the benefits of drug use, which might in tum put them at a higher risk of
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relapse. Similar findings of a higher pros among Action were found in cocaine use and other
drug use (Rosenbloom, 1991; Tsoh, 1993).
In addition, the external validation of the clusters also supported two additional distinct
subtypes of precontemplative profiles beyond the "classic" Precontemplation (PC) profile, which
were the profiles of Uninvolved (U) and Reluctant (R). All of these precontemplative clusters
featured higher pros of drug use than cons and were indicative of the lack of intention to change.
Interestingly, although pros of drug use outweighed the cons in all cases, U individuals reported
a general lack of concern for both pros and cons (both below the mean). On the other hand, R
individuals indicated an above mean of the both pros and cons indicating that they were aware of
the cons of drug use, and they valued the pros of drug use even more. This subtype might
represent the "rationalizing" type of precontemplators as proposed by DiClemente ( 1991), where
these individuals were well informed about drug use, yet they rationalized the reasons for
continuing to use drugs and therefore did not desire to change.
The relationship between various clusters and self-efficacy found in the current study
was somewhat unexpected. Generally, a gradual increase of self-efficacy to avoid drug is
expected from early stages to later stages (e.g., Action and Maintenance). Although, as pointed
out in Study I, subjects' self-efficacy was based on their reported confidence to avoid drug use in
the following 3 months, the current assessment of self-efficacy at admission might be
inappropriate/irrelevant because all subjects had presented themselves to a minimal of 3-month
residential program where their environment was controlled. Under this assumption, subjects
should not differ on this dimension, as they would likely be reporting high self-efficacy.
However, the current significant differences noted between Uninvolved (U), Preparation (PR)
and Contemplation (C) might be indicative of some distinctive characteristics of some of these
clusters. The high level of self-efficacy reported by Uninvolved individuals might indeed
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represent a special subtype of precontemplators who were not willing to quit drugs because the y
felt they could stop or avoid using drugs whenever they desired. Because of their reported high
self-efficacy to avoid drug use as they thought they had, they did not necessary view their drug
use was a problem . On the other hand, PR individuals' high self-efficacy might be related to the
fact most of these individuals admitted to the program directly from a controlled environment,
mostly detoxification centers. These individuals had just completed detoxification and had not
yet tested their ability to avoid drug use in a free environment, therefore they reported high selfefficacy without being aware of or experiencing the risks of relapse.
The use of the Change Assessment of Drug Use (CAD) scale as a continuous measure
for degree of readiness was also supported by the current results. The total score of the scale
(with PC items reverse-scored) was able to distinguish most clusters in an expected manner, with
higher scores indicative of increased readiness for change. It seemed capable of distinguishing
the U clusters from the other clusters as well as the other identified precontemplative profiles.
Action individuals also reported the highest score than all their peers in other clusters. The total
score, however could not distinguish the PC and R clusters. More unexpectedly, contemplators
reported higher total CAD score than individuals in PR. Although findings in general were
supportive of the use of CAD as a single continuous index for readiness to change, results
indicated that a continuous index could potentially lose the specificity in identifying and
grouping individuals into cohesive subgroups. Further evaluation of the use of CAD as a
continuous index for readiness is necessary and the application and validity of the index remains
an empirical question.
To conclude, current results suggested that cluster analysis is the most recommended
method to assess stages of change among substance abusers in treatment. Based on the current
findings, six distinct subtypes of individual with various stages of readiness to change were
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identified among addicts who were seeking treatment. More importantly, current findings
indicated that over 45% of the clients who presented themselves to treatment programs were
indeed precontemplative, i.e., not intending to change. These results have clearly indicated that
an assumption of clients presenting themselves to treatment are all ready to change is false at
least 45% of the time. It is not uncommon for treatment providers to "blame" early attrition or
unsuccessful treatment outcome on their clients' lack of readiness for treatment or being too
resistant to change. It seems the question should instead be whether current treatment programs
are "ready" for their clients. Instead of focusing on skill training techniques for "how" to stay
off drugs, perhaps, depending on clients' stages of change, substance abuse treatment programs
should also increase emphasis on "why" quitting drugs. Lastly, the lack of relationship between
stages of change and other demographic and background variables also suggested the uniqueness
of stages of change and implied the potential contribution in understanding treatment retention
and outcome. The following studies have examined the relationship between stages of change
and treatment dropouts, as well as short-term outcome .
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Table 2-1.

ParticipantCharacteristics

Demographic Information
%
Treatment Setting
N
35.3
Residential (3-month)
251
34.1
Residential (6-month)
242
Therapeutic Community (TC)
124
17.5
(6-month)
TC (12-month)
13.1
93
Total
Referral
100
15.1
Legal
84.9
Self
562
missing
48
Gender
Male
495
69.7
Female
215
30.3
Age
under 21
4.4
31
21-25
169
23.6
26-30
197
27.8
31-35
188
26.5
36-40
88
12.5
41 or older
37
5.5
missing
2
Race
Caucasian
526
74.8
Black
128
18.0
Hispanic
41
5.8
Other
8
1.1
missing
7
Marital Status
Single
461
64.9
48
Married / Living together
6.8
Separated
52
7.3
Divorced
122
17.2
Widowed
5
0.7
Missing
22
Education
< 12
237
33.4
46.8
High school
328
Some College
102
14.3
College
22
3.1
Post graduate
10
1.4
missing
9
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Table 2-1. £arti!;;ii;1antCbara~t~risti!;;s(cont'd)
n
Yearly Income
under $5,000
356
$5,000 - 9,999
67
$10,000 - 19,999
75
35
$20,000 - 29,999
49
$30,000 - 39,999
$40,000 or over
119
10
missing
Employment Status
Unemployed
265
Part time
121
Full time / self employed
316
Student / Retired
15
missing
9
Legal Status
Waiting charges
225
Probation / Parole
334
not applicable
141
missing
10
mv positive
Yes
27
No
165
Not sure
325
missing
193
Previous Drug Abuse Treatment
0
94
1
115
2-4
248
5 or more
237
missing
19
Drug of Choice
Alcohol only
32
Alcohol and drug
172
Cocaine only
185
Heroin only
155
Polydrug
153
Other
13
IV Drug Users (used IV during 3

%
50.9
9.5
10.7
5.0
7.0
16.9

37.8
17.2
45.1
2.2

32.1
47.7
20.2

5.2
31.9
62.9

13.6
16.6
35.5
34.3

4.5
24.2
26.1
21.8
21.5
1.8

months prior to admission)

Yes
No

295
415

41.5
58.5
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Table 2-1.

Participant
Characteristics
(cont'd)

Age First Used Drugs
Under 13
13-17
18-20
21-30
31 or older
missing
Age First Used IV
Under 13
13-17
18-20
21-30
31 or older
Total
Types of Living
Situation before Admission
Free-living
Detoxification Centers
Jail
Hospital

159
439
61
40
1
22

23.1
63.8
8.9
5.9
0.1

6
46
91
160
11
409

1.5
34.4
8.9
39.1
2.7

246
277
99
11

38.9
43.8
15.6
1.7
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Table 2-2. Change Assessment Questionnaire for Drug Use CCAD) Scale Scores for Each
Clusters; Sample l Cn=3l Q)

Raw
Clusters / CAD Scales
I. Uninvolved

PC
C
A
M
II. Precontemplation

PC
C
A
M
m. Reluctant

PC
C
A
M
IV. Contemplation

PC
C
A
M
V. Preparation

PC
C
A
M
VI. Action

PC
C
A
M

Standardized

Mean

SD

Mean

SD

1.89
3.87
3.88
3.31

0.54
0.40
0.50
0.44

56.77
38.00
45.39
41.02

8.60
8.89
7.55
5.88

2.16
4.26
4.21
4.06

0.56
0.32
0.34
0.3 I

61.04
46.52
48.70
53.34

9.64
7.05
6.28
4.46

1.61
4.30
3.25
3.76

0.41
0.30
0.51
0.38

51.52
47.60
33.65
47.81

6.68
6.68
8.09
5.62

1.16
4.57
4.10
4.13

0.22
0.36
0.34
0.48

42.86
53.19
48.41
53.46

3.67
7.92
5.32
6.49

1.36
4.58
4.72
3.23

0.41
0.39
0.34
0.62

46.21
53.61
59.30
40.29

6.24
8.71
5.42
10.40

1.15
4.88
4.86
4.67

0.36
0.18
0.20
0.30

42.96
60.19
61.59
63.40

5.62
3.95
3.38
4.06

~

1. CAD scales: PC - Precontemplation, C - Contemplation, A - Action, M - Maintenance
2. Raw scores of scale means range from 1 to 5
3. Standardized scale scores have M=50, SD=l0
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Table 2-3. Change Assessment Ouestjonnaire for DrugUse <CAD)Seate Scores for Each
Clusters; Sample 2 <a=324)
Raw
Clusters / CAD Scales

Standardized

Mean

SD

Mean

SD

1.54
3.83
3.91
3.22

0.40
0.35
0.53
0.55

48.36
36.32
43.04
40.90

7.11
7.70
9.21
8.68

2.23
4.21
4.06
3.83

0.49
0.33
0.27
0.49

61.65
44.66
47 .66
50.20

8.64
7.23
5.35
6.42

1.96
4.57
3.18
3.91

0.57
0.37
0.52
0.74

55.80
52.44
31.92
52.09

9.04
8.13
8.12
8.71

1.34
4.57
4.21
4.10

0.40
0.29
0.27
0.47

46.27
52.53
49.65
55.12

7.08
6.37
4.72
6.56

1.30
4.78
4.80
2.99

0.34
0.24
0.25
0.60

44.81
57.18
59.32
39.46

5.83
5.26
4.09
6.95

1.12
4.87
4.91
4.52

0.20
0.21
0.12
0.41

42.34
59.07
61.03
60.08

3.86
4.60
2.50
5.50

I. Uninvolved

PC
C
A
M
II. Precontemplation

PC
C
A
M
m. Reluctant

PC
C
A
M
IV. Contemplation

PC
C
A
M
V. Preparation

PC
C
A
M
VI. Action

PC
C
A
M
~

1. CAD scales : PC - Precontemplation , C - Contemplation, A - Action, M - Maintenance
2. Raw scores of scale means range from 1 to 5
3. Standardized scale scores have M=50, SD=l0
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Table 2-4. Ch.ist~r Oistribi.!tiQDQf Sampls;s A, B and
Cluster

lb~CQmbins;d Sampl~

Sample 1

Sample 2

Combined

(N=310)

(N=323)

(N=633)

n

%

n

%

n

%

Uninvolved

48

15.5

49

15.2

97

14.6

Precontemplation

60

19.4

73

22.6

133

20.0

Reluctant

32

10.3

26

8.0

58

8.7

Contemplation

78

25.2

76

23.5

154

23.1

Preparation

52

16.8

49

15.2

101

15.2

Action

40

12.9

50

15.5

90

15.5
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Table 2-5. Cluster Differences of the DecjsjonaJ Balance Inventozy and Self Efficacy to Avoid
Drugs; Combined Sample <N-633)
Follow-up
Pattern
(Tukey post-hoc
comparison)

Scales / Clusters

Mean

SD

I. Pros for Drug Use
Uninvolved (U)
Precontemplation (PC)
Reluctant (R)
Contemplation (C)
Preparation (PR)
Action (A)

48.68
49.89
52.89
49.56
47.23
53.57

9.24
9.91
9.66
9.73
9.91
10.50

45.90
47.22
50.36
51.89
49.59
55.53

11.36
10.12
10.23
8.20
10.49
6.74

Self Efficacy to Avoid Drugs
U
52.02
PC
49.67
R
47.89
C
48.20
PR
52.76
A
49.64

9.23
10.14
9.02
10.16
8.99
11.10

Effect
Size

.E(5, 627)

..,2

R>PR
A>PR, C, U

5.39**

.04

C>U,PC

13.11**

.09

3.99*

.03

II. Cons for Drug Use

u

PC
R
C
PR
A

m.

Scale scores are standardized with M=50, SD=l0
* J2< .005; **..J2< .0001
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A > U, PC, R, C,

PR

PC>C
PR> R, C

Table 2-6.

HiibestZ-scoreMethod:Staie Differences
of theDecisionalBalanceInventorvand

SelfEfficacyto AvoidDruis (N=638)
Follow-up
Pattern
(Tukey post-hoc
comparison)

E (3, 634)

Effect
Size

Scales / Stages of Change

Mean

SD

I. Pros for Drug Use
1. Precontemplation
2. Contemplation
3. Action
4. Maintenance

49.21
50.92
48.00
51.45

9.84
9.77
10.17
9.99

M>A

3.87*

.02

II. Cons for Drug Use
1. Precontemplation
2. Contemplation
3. Action
4. Maintenance

45.77
51.56
50.77
52.01

10.28
8.78
10.25
9.47

A,C,M >PC ·

14.81**

.06

Self Efficacy to Avoid Drugs
1. Precontemplation
51.96
2. Contemplation
48.36
3. Action
51.97
48.11
4. Maintenance

9.78
9.59
9.99
10.3

A,PC>C,M

7.63*

.03

m.

Scale scores are standardized with M=50, SD=l0
* p < .01
**p<.001
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Table 2-7

ProfileRawScoreMethod;Unsta~eable
Profiles

Unstageable Profiles
(PC, C, A, M)

- + + + (C > A, M)

n

%

3

1.4

200

92.6

++-+

1

0.5

++++

12

5.6

216

100.00

Total

Note: Profiles scores were based on raw scale scores (PC, C, A, & M) with mean scores linearly
transformed to a range of -2 to +2 and further recoded to"+" for positive mean scores and"-" for
negative mean score and mean of 0.

77

Table 2-8

ECQfil~Z-S~Qr~
M~tbQd;
llnsta~~abl~
:e[Qfil~s

Unstageable Profiles
n

%

48

15.2

---+

22

7.0

- - ++

17

5.4

- + + + (C > A, M)

29

9.2

+- - +

48

15.2

+-+-

27

8.5

+-++

20

6.3

+ +- -

12

3.8

++-+

20

6.3

+++-

28

8.9

++++

45

14.2

316

100.00

(PC, C, A, M)

Total

Note: Profiles scores were based on z-score of each scale (PC, C, A, & M) which were recoded
to "+" for positive mean scores and "-" for negative mean score and mean of 0.
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Table 2-9

StageDistribution
AcrossStageAllocationMethods

Cluster /Stages

Uninvolved
Precontemplation
Reluctant
Contemplation
Preparation
Action
Maintenance
Unstageable
Missing data*
Validation
MANOVA(¾
variance accounted
for)
DFA correct
classification rate
Overall
Uninvolved
PC
Reluctant
C
Prep
A
M

~:

Cluster

Highest Raw

Highest

Profile Raw

Profile Z-

Analysis

Score

Z-score

Score

score

n

%

97
133
58
154
101
90
0

14.6
20.0
8.7
23 . l
15.2
15.5
0.0

0
5

0.0

15%

%

n

%

n

%

167

26.2

2

0.3

77

12. l

38 .7

162

25.4

249
138

39.0
21.6

135
174

21.2
27.3

26
26
243
125

4.1
4.1
38.l
19.6

50
32
106
57

7.8
5.0
16.6
8.9

0

0.0

0
0

216
0

33.9

316
0

49.5

n

%

n

4

0.6

247

o·

0.0

10%

Not
Conducted

24.0%
(vs . 16.7% by
chance)

Not
conducted

Not
Conducted

34.6%
(vs. 25% by
chance)

35.1%
5.3%
13.8%
14.3%
32.7%
53.5%

46 .1%
4.9%
44.4%
43.7%

* missing data - 5 subjects were excluded in cluster analysis due to extreme scores (above
or below 4 SD of the mean) of the CAD scales.
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Table 2-10

Comparison of Stage Membership from Cluster Analysis vs. the Highest Z-score

method
Stages assessed by the Highest Z-score Method
Clusters

PC

C

A

M

Uninvolved

55

14

17

11

56.7%

14.4%

17.5%

11.3%

81

23

2

27

60.9%

17.3%

1.5%

20.3%

19

26

0

13

32.8%

44.8%

0.0%

22.4%

2

68

11

73

1.3%

44.2%

7.1%

47.4%

6

18

77

0

5.9%

17.8%

76.2%

0.0%

0

12

28

50

0.0%

13.3%

31.1%

55.6%

Precontemplation

Reluctant

Contemplation

Preparation

Action

~:

Percentages indicate the proportion of subjects in each clusters who were reclassified by
into one of the stages using the highest z-score method.
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Table 2-11

CAD (Cbimge Ass~ssm~nl for Drng Us~) S1.Qr~a1.rQssCh.1s1~rs

Clusters

n

Mean

SD

Minimum

Maximum

Uninvolved (U)

97

60.81

4.80

42.00

69.00

Precontemplation (PC)

133

64.08

3.38

55.00

71.00

Reluctant (R)

58

62.81

3.42

54.00

69.00

Contemplation (C)

154

70.38

2.33

65.00

77.00

Preparation (PR)

101

68.90

4.09

58.00

76.00

Action (A)

90

76.82

2.04

72.00

80.00

Note :

1 Tukey comparisons are significant at p < .05 with U < PC,R <PR< C < A.
2 Total score is based on the sum all item of CAD with PC items reverse-scored.
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Table 2-12

Types of Livin~ Environment before Admission across Clusters

Clusters /Types of Living

Drug

Free-living

Environment

Jail

Hospitals

Treatment
Centers

Uninvolved

41.23/oa

38 . lo/oe.a

20.6%

0.0%

Precontemplation

37.6%

43.63/o C

18.0%

0.8%

Reluctant

48.33/oa

32.8%

c,d

13.8%

5.2%

Contemplation

46.8% a, b

37.7%

c,d

13.0%

2.6%

Preparation

25.73/oa

56.43/oC

15.8%

2.0%

Action

33.3%

53.3%

12.2%

1.1%

Total

38.9%

15.6%

1.7%

~

a,b,c ,d

a

b

43.8%

d

denote significant results from 2x2 chi-square follow-up tests, p_<.05.

significant differences between Preparation and other clusters based on 2 (clusters) x 2
(free vs. controlled environment) chi-square tests.

b significant

differences between Action and other clusters based on 2 (clusters) x 2 (free

vs. controlled environment) chi-square tests.
c significant

differences between Preparation and other clusters based on 2 (clusters) x 2

(drug tx vs. other) chi-square tests.
d significant

tx

differences between Action and other clusters based on 2 (clusters) x 2 (drug

vs. other) chi-square tests.
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Table 2-13.

ClusterDifferences
relevantVariables:One-wayANOVAandPost-HocTukey
Comparison
Results
Follow-up
Pattern
(Tukey post-hoc
comparison)

Scales / Clusters
Mean
SD
I. Self Esteem (Rosenberg)
Uninvolved (U)
27.46
4.64
PR> R,C, A
Precontemplation (PC)
27.01
4.82
Reluctant (R)
25.34
4.61
Contemplation (C)
25.87
4.61
Preparation (PR)
28.33
5.15
Action (A)
25.98
5.08
II. Depression (Beck Depression Inventory)
PR< PC,R,C,A
U
16.69
8.09
PC
17.79
9.40
R
19.75
9.87
C
18.13
8.90
PR
13.33
8.61
A
18.92
10.36
III. ASI (Addiction Severity Index) Composite Score on Drug Use
U
0.20 .
0.15
A, PR> U
PC
0.26
0.15
R
0.27
0.14
C
0.24
0.15
PR
0.27
0.15
A
0.30
0.16
IV. Perceived severity of Drug problems (ASI)
U
2.18
1.79
A> U
PC
2.72
1.56
R
2.90
1.54
2.74
1.69
C
2.79
1.64
PR
3.24
1.30
A
V. Perceived Importance of Treatment for Drug Problems (ASI)
U
2.51
1.87
A, PR, R > U
PC
3.04
1.58
A> C
R
3.30
1.37
C
2.94
1.74
PR
3.25
1.53
A
3.57
1.23
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E-value

5.06*

5.62*

4.03*

4.02*

4.01*
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STUDY 3

PREDICTORS OF DROPOUTS FROM SUBSTANCE ABUSE
TREATMENT
Introduction

Despite the extensive evidence of the beneficial aspects of drug addiction treatment ,
questions on what contributes to successful treatment outcome continue to arise. Treatment
retention has been shown to be the single most consistent predictor for treatment outcome
(Deleon,

1988; Hubbard, Marsden, Rachal, Harwood, Cavanaugh , & Ginzburg, 1989) .

Unfortunately, like treatment of other psychological problems, the majority of clients dropout of
treatment before allowing treatment to take full effect. No comprehensive profile has yet
emerged that predicts treatment retention (e.g., Condelli & De Leon, 1993; Hubbard et al., 1989).
Furthermore, the true relationship between retention and outcome is not well understood.

It is

important to research who will be more likely to benefit from which modalities of treatment
programs and for what length of treatment. Some systematic investigations that include
individuals' attitudes, intention and behavior towards their drug use will be necessary to better
understand the interaction between individual characteristics and treatment factors as well as
their effects on retention and outcome in order to maximize treatment effectiveness.

The

Transtheoretical Model of Change (Prochaska & DiClemente, 1983, 1984, 1992) offers a
promising systematic framework for this purpose .
Using the Transtheoretical Model of Change , 92% of the clients' continuation and
termination status in psychotherapy was correctly predicted(Medeiros & Prochaska, 1991 ).
Predictors were stages of change, processes of change, and decisional balance which are some of
the core dimensions of behavior change as identified by the model (Prochaska & Di Clemente ,
1983, 1984 , 1992) . Most therapy continuers are found to be in the contemplation stage of
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change (Medeiros & Prochaska, 1991). On the other hand, premature terminators or dropouts
are more likely to be in the precontemplation stage and tend to be more oriented toward
changing their environment than themselves. It is also one of the key features of most
precontemplators that they try to use defenses such as avoidance in order to deny that they have a
problem. Appropriate early terminators were found to highly endorse the action stage and were
ready to take action when entering treatment. Therefore, they required fewer therapy sessions to
achieve their therapeutic goals. Using the stages of change and change processes has also
predicted both attendance and outcome in worksite weight control programs . Both accounted for
over 30% of the attendance variance and over 40% of the variance for the amount of weight loss
during treatment when these var iables were assessed at mid-treatment; higher endorsement in
action stage of change and in the use of action-oriented strategies was found to enhance
attendance and outcome(Prochaska, Norcross , Fowler , Follick & Abrams , 1992).
Research in finding consistent and reliable predictors of treatment dropouts has been
hampered by the lack of consensus on the operational definition of dropouts used among
researchers . In reviewing 20 years ofliterature on dropping out of treatment across a variety of
areas, Baekeland and Lundwall (1975) conceptualized dropout as a patient who fails or refuses to
return to treatment and / or the patient who is expelled from treatment due to lack of cooperation
or poor responses to treatment and so on. Wierzbicki and Pekarik (1993) conducted a metaanalysis of psychotherapy dropout based on 125 studies and summarized 3 categories of
definition of dropouts used in the studies they reviewed. These categories include defining
dropouts by clients failing to attend a scheduled session , therapist judgment, and duration-based
measures using number of sessions or visits or length of stay in treatment. No single definition
has been proven to be the most appropriate and each has inherent limitations . Wierzbicki and
Pekarik (1993) have suggested that therapist judgment may be the best way to define dropouts
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given that the concept of dropout comes from therapists' judgment: dropouts are those who
terminate treatment inappropriately and would be "expected" to have a "less" successful
outcome. That leads to a question of who and for how long clients can benefit from which
treatment, which is the same question that research on treatment effectiveness has been
investigating.
Research on treatment retention and outcome in the area of substance abuse has
attempted to find the "minimal" exposure of treatment to produce successful outcome. For
example, data from DARP (the Drug Abuse Reporting Program), the first large scale national
study on treatment effectiveness for drug abusers, a minimum of 3 months was found to be
necessary to produce positive changes, and the TOPS (Treatment Outcome Perspective Study)
data suggested that treatment length of 6 months or more were necessary to produce reduction in
drug use (Hubbard, Marsden, Rachal, Harwood, Cavanaugh, & Ginzburg, 1994). Condelli and
Hubbard ( 1994) summarized the findings across various studies on treatment retention and
outcome and reported the minimum length of stay in residential treatment programs (primarily
therapeutic communities) for successful outcome ranged from 50 days to 1 year. The purpose of
the present study was to determine if stages of change and other traditional subject
characteristics variables at admission were predictors of treatment dropouts. Previous studies
indicated that most clients dropout from treatment within the first 3 months, with the highest
dropout rates in the first and the second month (Condelli, 1994). Dropouts in this study was
defined as terminating treatment before 60 days.
Methodology

Participants
Participants were 385 clients (33% females) recruited for the study from a substance
abuse residential facility. As participants were admitted to the facility, they were randomly
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assigned to either the 3-month or the 6-month treatment. The treatment programs were based on
a relapse prevention / health education model focusing on teaching coping skills for managing
clients' addictive attitudes and behaviors in order to cope with high risk situations for relapse .
Both " long" and "short" programs had essentially identical components except that the number
of core group sessions of the 6-month program was twice as much as the 3-month program. The
mean age of participants was 29.9 years (SD= 6.0). The ethnicity composition of the sample
was 71.7% Caucasian , 20 .0 African American, 7.3% Hispanic , 1.0% other . The mean
education level was 12th grade. About 34 % of participants had a full time job at the time of
treatment, 45 % were unemployed, and others worked part time, or had retired. The majority
(91 %) of the subjects had previous admissions to drug abuse treatment programs prior to the
study. Main drugs of choice for the sample were heroin only (19%), cocaine only(24%) ,
alcohol and drugs (28%), and polydrug (26%), with 47% IV drug users. Table 3-1 presents
participant characteristics in greater details .

Procedures
Participants were recruited during intake interview at each facility that took place 14
days before or on the day of admission. Clients who were eligible to participate in the present
study were all former drug abusers who completed detoxification or withdrawal and were
admitted to the facility on a voluntary basis. Monetary incentives for participation were offered
at $15 per interview . Admission interviews took place in 2 to 3 sessions that occurred during the
first 8 days after admission. Data at exit were obtained from 7 days before anticipated day of
discharge to 3 weeks after discharge with 77 .7% (N=299) of the total subjects interviewed within
this window.
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Measures
Addiction Severity Index (AS!)
The Addiction Severity Index (ASI) (McLellan, Luborsky, Woody, & O'Brien, 1980;
McLellan et al., 1985; McLellan, et al., 1992) is a semistructured interview that collects data
from substance abusers in seven problems areas: medical, employment, legal, alcohol, drug use,
family-social functioning, and psychological status. The primary goal of developing the ASI
was to provide an instrument to assess treatment outcomes over a broad range of potential areas
which could be affected by substance abuse treatment and can be applied across different
treatment settings (McLellan, et al., 1992). The latest version, the fifth edition of the ASI, was
used (McLellan, et al., 1992), with the addition of questions on personal and family psychiatric
history. ASI covers general sociodemographics, as well as past and present information of each
area. Composite scores can be computed from each area.
ASI is the most widely used clinical and research instrument in the area of substance
abuse. The instrument has been validated across hundreds of studies during the past 14 years
across different populations of substance abusers (e.g. Brown, Alterman, Rutherford, Cacciola &
Zaballero, 1993; Hendriks, Kaplan, Limbeek, & Geer lings, 1989; Hodgins & Guebaly, 1992;
McLellan, et al., 1992). Studies in the area of substance abuse have frequently used ASI scale
scores for evaluation treatment efficacy and to validate newly developed scales for this area (e.g.,
Darke, Ward, Zador, & Swift, 1991; Kang, Kleinman, Woody, & Millman., 1991; Kosten,
Rounsaville & Kleber, 1987).

Change Assessment for Drug Use (CAD)
This 16-item questionnaire refined in Study I was used to assess subjects' readiness to
change their problem behavior. Subjects were asked to respond on a 5-point Likert Scale
ranging from 1 = strongly disagree to 5 =strongly agree. Four items comprised each of the
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four stages of change: Precontemplation (PC), Contemplation (C) , Action (A) and Maintenance
(M). This measure was administered at both admission and discharge interviews . The
psychometric properties of the measure have been demonstrated in Study I with coefficient
alphas ranging from .57 to .73 at baseline and .56 to .83 at exit. Stages of change at admission
among participants were established in Study II. Six clusters were found with three clusters
(Uninvolved, Reluctant and Precontemplation) characterizing having no interest in quitting drug
use, and three other clusters namely Contemplation, Preparation and Action.

Decisional Balance Inventory
The 12-item scale modified from the Cocaine Decisional Balance Inventory (Rossi,
Rosenbloom, Monti, Rohsenow, Prochaska, & Martin, 1993) was used. With some wording
changes replacing "cocaine use" with "drug use", this 12-item version has been shown to be a
valid measure for the decisional balance construct in a sample of drug addicts in treatment
(Tsoh, 1993). Subjects were asked to rate each item on a 5-point Likert scale ranging from 1 =
not important to 5 = extremely important. The items represent PROS and CONS for drug use
with 12 items on each dimension . The psychometric properties of this measure was further
examined in the present study. Items of the measure are shown in Appendix C.

Self-efficacy to avoid drugs
This self-efficacy scale contains 5 items assessing subjects' confidence in their ability to
avoid drug use in high risk situations during the next 3 months. Subjects were asked to respond
on a four point Likert Scale: l =extremely confident to 4=not at all confident. Total score is the
sum of all 5 items reverse scored, with the higher total score indicating higher confidence. The
scale was developed by the data collected in this study at admission through various versions of
the instrument with an item pool of 11 or 24 items. The factor structure was refined using the
shorter version (n=3 70) and was confirmed using the long version (n=217). The internal
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consistency as indicated by Cronbach ' s alpha, was .82 (Rubin, 1993). Items are shown in
AppendixD.
Rosenberg Self-Esteem Scale

It contains IO items assessing individuals' sense of self-worth , satisfaction with self, and
belief in their own capabilities . Each item is scored on a four-point scale with I =strongly agree
and 4=strongly disagree. Test-retest reliability and validity in use with adolescent and young
adult populations has been adequate (Rosenberg, 1965). Improved in self-esteem is a favorable
outcome particularly for those in therapeutic communities.
Beck Depression Inventory

It is a 21-item self-administered questionnaire developed by Aaron Beck (1967). The
number and severity of current depressive symptoms are assessed. Adequate reliability has been
established in studies of psychotherapy.
Shipley-Institute of Living Scale

It is a self-administered test of cognitive functioning (Shipley, 1939). It contains a
verbal and an abstract section . Scores are age-corrected and can be converted to an estimated
WAIS-R IQ score with mean=IO0, SD=l 5. The estimated WAIS-R IQ score was used in the
current study. Administration of the instrument was timed and subjects were allowed 15 minutes
to complete each section.
Diagnostic Interview Schedule, Third Edition Revision (DIS-111-R)

An abbreviated version of the DIS-111-Rwhich incorporates items for the DSM-111-R
diagnostic criteria (American Psychiatric Association , 1987) was used. Only questions needed to
ascertain some pre-selected DSM-111-Rdiagnoses were asked . Those diagnoses include panic
disorder, social phobia , major depressive disorder , dysthymia , alcohol abuse and alcohol
dependence, antisocial personality disorder , and pathological gambling. The decision to focus

on these diagnoses was based on considerations of prevalence of these disorders among drug
abusers in treatment and evidence that particular disorders may be associated with treatment
outcomes.

Social DesirabilityScale
Jackson 's Social Desirability Scale (Jackson , 1967) was used to assess response bias
due to social desirability . This instrument consists of 20 items that are presented in a true-false
format. It has been found to be a valid and reliable measure to determine if a response set
tends toward the direction of social desirability.
Other variables
Data on other variables that have been associated with outcomes or retention from
previous studies were also collected. Those variables included illV status, sources of referrals ,
length of stay in treatment ,

Variablesof interest
Definitionof DropoutsDropout

in this study was defined as by terminating treatment

before 60 days into the program . Previous studies have suggested a range of a minimal of length
of stay of 50 days to 6 months in residential treatment programs in order to produce longer-term
( 12-months or more) benefits. Based on the current data set, Mccusker and colleagues have
found that the two programs (3- vs. 6-month) did not differ in both attrition before 80 days as
well as outcome defined as abstinence of drug use at 3-month posttreatment (McCusker ,
Bigelow, Zorn, Garfield & Love, 1994). In order to maximize the number of subjects in the
analyses , the same definition of dropout (less than 60 days stayed in treatment) was used for both
treatment programs. All subjects from both programs were used and enrollment in either the 3or 6-month program were included as a variable in the analyses .
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PredictorVarjabJes
.

Predictors to be considered in the analyses of this study were

variables collected during admission which include all participant characteristics as listed in
Table 3-1. Other variables included psychiatric diagnoses (as stated above), depression level
(Beck Depression Inventory), self-esteem (Rosenberg Self-Esteem scale), cognitive functioning
(estimated WAIS-R IQ scores converted from Shipley), ASI composite scores of each area
(medical, employment, legal, alcohol, drug use, family-social functioning , and psychological
status), subjective ratings from the ASI measure which included perceived severity of and
perceived importance of treatment for each problem areas . The Transtheoretical Model relevant
variables included in the analyses were pros and cons of drug use, self efficacy to avoid drugs,
and stages of change. To maximize sample size, the Uninvolved, Reluctant and
Precontemplation clusters were grouped as a new combined Precontemplation cluster and was
compared to other clusters, Contemplation, Preparation, and Action.

Analyses
Logistic regression (LR) was used to examine significant predictors of dropouts from
treatment. LR was used to examine the predictability of the predictors on dropout status instead
of discriminant function analysis (DFA) because LR has been demonstrated as a more powerful
technique for binomial variables (e.g., Hosmer & Lemeshow , 1989; Norusis, 1990). In the
current study, the dependent variable was dichotomous, dropouts vs. continuers; furthermore,
many potential predicting variables in this study were categorical in nature. The goal of the
analyses was to seek significant predictors that would yield the most parsimonious model to
predict dropouts within the constraints of the current data. Owing to the large number of
independent variables that could be included in the model, the following variable selection
procedures recommended by Hosmer and Lemeshow (1989) were carried out .
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1). Variables were initially subjected to a series of bivariate analyses such as ANOV A or Chisquares procedures. Only variables that differentiated between dropouts and continuers at a pvalue of .20 (Hosmer & Lemeshow, 1989; Lemeshow, 1993) were included in the Logistic
Regression Analysis followed.
2). The weakness of unnivariate analyses is that they do not examine the combination effect of
multiple variables . Therefore, the subset of variables selected from the bivariate analyses in Step
1 was examined by stepwise LR. A stepwise procedure was recommended as an effective
procedure to select the best subset of predictors from a large number of variables (Hosmer &
Lemeshow, 1989). The stepwise procedure has been criticized for producing models that are not
theoretically plausible containing irrelevant (or noise) variables (see Hosmer & Lemeshow,
1989). However, when variables subjected to LR analysis are considered to be theoretically and
scientifically relevant, a step-wise procedure has the advantage of statistically selecting variable
in a sequential fashion and allowing examination of a collection of variables which has not been
otherwise studied.
In a forward stepwise procedure, it begins with a model that contains only a constant (or
an intercept as in multiple regression). At each step, selection of a variable is based on the
statistical importance of the variable determined by the likelihood ratio chi-square test. The loglikelihood ratio (LL) assesses the overall fit of the model in successfully classifying the observed
data based on the parameters in the model, with a perfect fit equals to 1. The likelihood ratio is
usually smaller than 1 and a log function of that ration is used. Therefore a log likelihood ratio
of O is expected for a perfect fit. Variable selection is based on the change in Log-likelihood
ratio of the model with and without the variable under consideration. A variable is selected
when the largest improvement in LL (overall model-fit) is produced. Similarly, the removal of a
variable in this case is based on the change in the ratios with and without the variables. This
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process of variable selection repeats until no significant change is obtained upon inclusion of
additional variables or exclusion of the model parameters.
3). Variables that remained in the model after the stepwise LR analysis with significant
regression coefficients (p-value of Wald statistics <.05) were selected . All possible first order
interactions between each pair of the selected variables were examined . A series of standard LR
was performed with each interaction term entered in the main effects model. An interaction term
with Wald statistics of p<.01 was selected. The interaction terms selected were then entered
together in the main effects model for further examination . The selection procedure yielded a
final model that consisted of significant predictors and their interactions.
4) . After selection of variable was completed , odds ratio (OR) and its 95% confidence interval

(95% CI) of each predictor were calculated and used to interpret the magnitude of predictability .
For categorical variables , the odds ratio is expressed in terms of the change in the estimated
probability of a targeted outcome (e.g., dropout) to occur when comparing variable in one
category to another. For example, in this study, odds ratio of stages of change for predicting
dropout could be expressed in how much more likely would someone from the PC cluster to
dropout before 60 days as compared to individuals in the A cluster. In case of continuous
predictor, odds ratio is the change probability of the targeted outcome to occur in correspondence
to one unit change in the predictor.
In addition , the relevance of the current definition of dropouts in this study was
examined. MANOV A and ANOV A were conducted to examine the differences between
dropouts and continuers with respect to the measures obtained during exit interview , which
included the CAD (Stages of Change), Decisional Balance Inventory of Drug Use, Self-efficacy
to Avoid Drug Use, self-esteem and depress ion level (BDI).
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Results

Predictorsof Dropouts
Of the 385 participants, 30.4% (n=l 17) dropped out before 60 days in treatment. No
significant difference was found in dropout rates between the 3-month (30.3%) and 6-month
(30.5%) programs. After a series of bivariate analyses of baseline variables, variables with pvalue <.20 were subjected to logistic regression analysis. They included stages of change, selfefficacy to avoid drug use, education, ASI medical subscale, cognitive functioning, legal
involvement, perceived lilV status, race, psychopathology include depression, antisocial
personality, pathological gambling, panic disorder, IV users, and previous treatment history. The
list of variables subjected to stepwise logistic regression are presented in Table 3-2 with
descriptive statistics across the two groups of dropouts vs. continuers. The stepwise logistic
regression model examining all potential predictors for dropouts yielded four significant
predictors: education, stages of change, number of previous treatments and perceived importance
of treatment for social problems. More specifically, less education, being in PC as compared to
C and to PR, having more previous treatment, and perceiving treatment for social problems as
more important were associated with dropout. The regression coefficient for stages of change
when comparing Action to PC in predicting dropout status was not significant in the model (p >
.20). No interactions between stages of change and other variables, or any variable pairs were
found significant. Table 3-3 presents the final model parameters, odds ratios and their 95%
confidence intervals of each significant predictor when other predictors are controlled.

Dropoutsvs Cootiouers
MANOV A conducted on CAD subscales (PC, C, A, M), pros and cons, self-efficacy to
compare dropouts and continuers indicated a significant main effect of dropout status, Wilks A
=.85, £ (9,242) = 4.63, p<.00 I. Table 3-4 presents the follow-up univariate ANOV A results.
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The two groups were significantly different on depression (BDI score), self-esteem, self-efficacy
to avoid drugs, and 3 CAD subscales including PC, C and A. As compared to individuals who
stayed in treatment beyond 60 days, dropouts tended to report more depressive symptoms, lower
self-esteem, lower self-efficacy, higher score on PC, lower scores on C and A scales at
discharge. However, it should be noted that there was a significant decrease in sample size when
the discharge data were analyzed. Only 50% (58 out of 117) of the dropouts as compared to 89%
of the continuers (23 8 out of 268) who had discharge data. The average length of stay of
subjects who had discharge data within the pre-selected window (7 days before discharge to 3
weeks post discharge) was 91.9 days, which was significantly longer than those who did not have
exit data within the window (65.4 days), E (1,383)

= 17.74, p<.001.

Discussion
Current findings indicated that a significant portion (> 30%) of substance abuse patients
in treatment dropped out within the first 60 days and well before full treatment can occur.
Dropout rates found in this study were comparable to other studies on residential treatment
settings (e.g., Hubbard et al., 1989). Interestingly , the two programs (3-month vs. 6-month)
were similar in their attrition rates before 60 days, approximately about one third dropped out
before 60 days. The hypothesis that individuals in PC were more likely to dropout from
treatment prematurely was supported by the current findings. Stages of change was among one
of the strongest predictors of early dropouts. When other parameters of the regression model
were controlled, PC individuals were 2 to 3 times more likely to drop out from treatment before
60 days as compared to Contemplation and Preparation respectively. However, there was no
statistical differences between individuals in PC and A regarding dropout rate. It was unclear
from the current findings, whether the little difference observed was because "less time" was
required by individuals who were more "advanced" in readiness for change. For example, in
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Medeiros and Prochaska's study (1991) on termination and continuation status of psychotherapy
outpatients, individuals endorsed highly in Action were more likely to terminate treatment early
but appropriately, and those individuals needed less time in treatment as compared to others who
might need a relatively longer period of time. Furthermore, findings indicated a sample scenario
of a "mismatch" between client and the philosophy of treatment programs. In the current
sample, a relatively large portion ( over 40%) of clients were not ready to quit drugs, even though
they presented themselves "voluntarily" to treatment. A mismatch occurred when individuals
were not ready to quit using drugs but were presented to an action-oriented program in which
they were introduced to strategies of how to avoid drug use. The likely consequence of such a
mismatch, as supported by the current findings, was premature dropout from treatment. As
indicated from previous studies, the minimum stay of 50 days to 3 months or longer was
necessary to produce treatment benefits (Condelli & Hubbard, 1994; Hubbard et al., 1989).
These dropouts are costly, not only because of high relapse rates associated with early dropouts
and related costs ( e.g., Hubbard et al., 1989), but also the impact on increasing waiting period for
drug addicts who are seeking treatment given the limited resources. Again, these findings have
underscored the importance of recognizing clients' readiness for change, rather than making
assumptions that all patients presenting to treatment are ready to change .
Other significant predictors have been demonstrated in previous studies ( e.g., Conde Iii &
Hubbard, 1994). More educated clients tend to continue treatment, as opposed to less educated
ones. These findings also underscored the importance of special care for less educated
disadvantaged clients in treatment who tended to be more likely to drop out from treatment.
Similar findings also observed in relapse prevention focused programs in this study where more
educated clients might be more capable of benefiting from this form of treatment which tends to
require a higher level of cognitive competency.
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Current findings also suggested that individuals who have more previous treatment
experience tended to dropout treatment early. While a number of previous studies demonstrated
a similar finding (e.g., Beckman & Bardsley, 1986; Condelli & Hubbard, 1994), it is a
confounding variable that covaries with age and duration of drug use (Stark, 1992). Although
previous studies suggested that treatment history variable might be related to readiness of
change, in which individuals who have been treated more frequently previously tend to be more
ready to quite using drugs. Current results indicated no significant interactions between
readiness and any of the predictors. Perhaps , the increase in the number of previous treatment
experience might likely reflect previous treatment failure due to premature dropouts. Therefore ,
individuals who dropped out from treatment previously might be likely to drop out from the
current treatment.
Lastly, perceived importance of treatment for social problems as a significant predictor
was an interesting finding . Previous studies suggested that social support has a positive
relationship with treatment retention (Sidall & Conway, 1988). Current findings might imply
some social support relevant dimensions when individuals indicated desire for assistance on
social problems which might be related to perceived low level of social support . When these
individuals did not feel that treatment has met their needs of coping with interpersonal issues,
with a lack of social support, they may tend to drop out of treatment earlier. Perhaps , by
increasing the focus on social relationships, how to obtain better support, and the benefits of
seeking treatment for their social environment , might improve their adherence and thereby
reducing likelihood of dropout.
Results in comparing dropouts and continuers provided preliminary support for the
relevance in studying dropout before 60 days into treatment in this residential setting. Dropouts
presented more negative prognostic indicators for future outcome . These individuals tended to
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be more depressed , less self-confident in avoiding drug use, less ready to change as denoted by
higher score in PC, and lower scores on both C and A, and have lower self-esteem. Surprisingly ,
the two groups did not differ with respect to their value on the pros and cons of drug use .
Although dropouts displayed a tendenc y of higher pros and lower cons of drug use, the
difference was small and non-significant. However, the current comparisons between dropouts
and continuers were based on the discharge data where dropouts were less likely to have these
data for comparisons (only 50% of dropouts have discharge data vs . 88% of continuers ).
Therefore, interpretation with the current results should be cautious. To what extent these
preliminary differences between dropouts and continues were predicative of future outcome
requires further examination. The following study investigated further these measures in
predicting a short-term 3-month post treatment outcome.
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Table 3-1.

ParticipantCharacteristics

Demographic Information
N
%
Treatment Setting
Residential (3-month)
188
48.8
Residential (6-month)
197
51.2
Total
385
Stages of Change at Admission
Uninvolved
13.2
51
Precontemplation
21.6
83
Reluctant
9.6
37
Contemplation
25.4
98
Preparation
60
15.6
Action
14.5
56
missing
0
Referral
Legal
45
11.7
Self
340
88.3
missing
0
Gender
Male
258
67.0
Female
127
33.0
Age
under 21
14
3.6
21-25
23.2
89
26-30
· 29.2
112
31-35
27.1
104
36-40
11.7
45
41 or older
5.2
20
missing
Race
274
Caucasian
71.7
African American
20.0
76
7.3
Hispanic
28
1.0
4
Other
missing
3
Marital Status
69.8
Single
261
7.0
26
Married / Living together
7.5
28
Separated
15.2
Divorced
57
0.5
Widowed
2
11
Missing
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Table 3-1.

Participant
Characteristics
(cont'd)
Education

< 12
High school
Some College
College
Post graduate
missing
Yearly Income
under $5,000
$5,000 - 9,999
$10,000- 19,999
$20,000 - 29,999
$30,000 - 39,999
$40,000 or over
missing
Employment Status
Unemployed
Part time
Full time / self employed
Student / Retired
missing
Legal Status
Waiting charges
Probation I Parole
not applicable
missing
HIV positive
Yes
Nol.Not sure
m1ssmg
Previous Drug Abuse Treatment
0

I
2-4
5 or more
m1ssmg
Drug of Choice
Alcohol only
Alcohol and drug
Cocaine only
Heroin only
Polydrug
Other

n
120
178
62
14
5
6

%
31.7
47.0
16.2
3.6
1.5

161
46
50
30
32
58
8

42.7
12.2
13.3
8.0
8.5
15.4

193
48
130
8
6

50.9
12.7
34.3
2.1

130
79
170
6

47.3
20.8
44.9

15
295
75

4.8
95.2

34
56
144
137
14

9.2
15.1
38.8
36.9

14

3.6

107

27.8

91
73
98

23.6
19.0
25.5
0.5

2
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Table 3-1 .

Participant
Characteristics
(cont'd)

IV Drug Users (used JV during 3
months prior to admission)

Yes
No
Age First Used Drugs
Under 13
13-17
18-20
21-30
missing
Age First Used IV
Under 13
13- 17
18-20
21-30
31 or older
Total
Types of Living
Situation before Admission
Free-living
Drug Treatment Centers
Jail
Hospital

203
182

52.7
47.3

97
246
21
20

25.3
64.1
5.4
5.2

9
71
50
99
4
152

3.9
30.5
21.5
42.5
1.6

153
202
27
3

39.7
52.5
7.0
0.8
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Table 3-2. Variables included io Loiistjc Reiressjon Analysis for Dropout Status: Univariate
Results Comparini Ireatment Dropouts and Continuers
Demographic

Dropouts

Continuers (stayed in
treatment beyond 60
days)

ii-value

23.1%

31.3%

.10

I 1.05 (2.03)

12.06 (2.06)

.01

5.82 (6.21)

4.43 (4.85)

.02

IV users

52.1%

45 .1%

.20

HIV+

8.0%

3.6%

.11

0.16 (0.31)

0.1 I (0.24)

.09

Perceived severity of social
problems (0-4)

1.56 (1.68)

1.26 (1.66)

.11

Perceived importance of
treatment for social problems (04)

1.51 (1.76)

1.20 (1.69)

.11

Antisocial Personality
disorder

69.1%

53.2%

.01

Pathological gambling

22.2%

14.2%

.05

Panic disorder

4.3%

9.7%

.07

19.29 (9.99)

16.98 (9.47)

.03

/Background Variables
Race (non-white)
Education

Mean (SD)

Number of previous treatment

ASI measures:
Composite score - Medical

Psychiatric Diagnosis/
Functioning

Depression level (BDI)

.02

Stages of Change (Clusters)
Precontemplation

55.6%

39.5%

Contemplation

19.7%

28.0%

9.4%

18.3%

15.3%

14.2%

2.93 (0.68)

2.86 (0.69)

Preparation
Action

Self Efficacy
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Table 3-3

Significant
Predictors
of Dropouts;
WaldStatistics,Oddsratios(OR)and95%

Confid~nc~
Int~r:yals
Predictors

OR

95%CI

.012

2.20

1.19- 4.09

7.02

.008

2.86

1.31 - 6.22

1.15

.283

1.09

0.50 - 2.88

Education (years)

14.42

.001

0.79

0.67 - 0.91

Number of previous treatments

7.36

.007

1.06

1.02 - 1.10

Perceived importance of

3.93

.047

1.15

1.01 - 1.29

Wald

J;L- value

10.65

.014

PC compared to C

6.28

PC compared to PR
PC compared to A

Stages of Change

treatment for social problems
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Table 3-4.

Diff~r!:n!;..!:
b1:lli'.1:1:n
QrQpQuts
andCQntinu1:rs
QDM1:asur1:s
Qbtain1:d
at Dis!;..bar21:

Measures at Exit

Dropouts

Continuers -stayed

E-value

in treatment beyond
60 days
(n=58)

(n=238)

Mean (SD)

Mean (SD)

PC

1.98 (0.72)

1.57 (0.76)

11.78**

C

4.03 (0.91)

4.28 (0.68)

4.86*

A

3.86 (0.90)

4.32 (0.73)

14.43**

M

3.44 (0.91)

3.49 (0.73)

NS

PROS

2.37 (0.99)

2.29 (0.97)

NS

CONS

4.09 (0.92)

4.22 (0.84)

NS

3.15 (0.58)

3.46 (0.39)

22.68***

Sum (SD)

Sum (SD)

Self-esteem (Rosenberg)

29.36 (4.48)

31.86 (4.48)

14.34**

Depression level (BDI)

14.29 (9.16)

8.91 (8.44)

15.64***

Change Assessment Scale
(Mean ranged from 1-5)

Decisional Inventory
(Scale mean ranged from 1-5)

Self-efface
(Scale mean ranged from 1-4)

119

STUDY 4

PREDICTORS FOR TREATMENT OUTCOME

Introduction
The fast growing substance abuse treatment industry over a short history of 30 years
reflects the increasing burdens of substance abuse on society. In 1988, it was estimated that the
costs of alcohol abuse and the abuse of other drugs in the US. were $86 billion and $58 billion
respectively (Stimmel, 1991). As of 1990, the estimated costs have gone up to $99 billion and
$67 billion for alcohol and other drug abuse respectively (Institute for Health Policy, 1993). The
core costs of substance abuse fall in medical expenses, illness, premature deaths, and criminality.
Given the role of IV drug users in the spreading of AIDS and the high association of drug use
and crime, drug addiction is not only a health concern at an individual level but also a broad
social problem. The threat imposed by drug users on both public health and safety has
encouraged civil commitment practices directed toward drug users. Drug abuse treatment
programs nowadays serve purposes of both protecting societies and promoting individual wellbeing (Brown, 1988; Platt, Buhringer, Kaplan, Brown & Taube, 1988).
There has been extensive evidence showing that most drug addiction treatment,
regardless of modality, benefit their clients (e.g., Institute of Medicine, 1990). In summing the
effectiveness of substance abuse treatment, researchers pointed out (Mejta, Naylor & Maslar,
1994) that although treatment seemed to work and yield positive outcome in general, there has
been between 10% to 20% completed treatment and about 70% of drug addicts relapse within the
first year post treatment.

The questions on what contributes to successful treatment, and

successful outcome continue to arise.
Research on predictors for treatment outcome has yielded divergent results.

Some

studies have found that positive outcomes appear to relate to subjects who are older, male,
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white, being employed full time, being first time in treatment, and having lower ratings on
severity of drug use .

However some studies suggested little relationships between most

sociodemographic variables and outcome (e.g,, Gorelick, 1992; Hubbard , Marsden , Rachal ,
Harwood , Cavanaugh, & Ginzburg, 1989; Kosten, Rounsaville , & Kleber, 1987). Regarding
sources of referrals (legal versus self), the literature has not shown consistent support for an
association between legal referral and outcome success (Hubbard, Collins, Rachal, &
Cavanaugh, 1988).

Research has begun to examine relationships between HIV status and

treatment outcome , and no substantial relationship with outcome has been reported. However,
HIV positive individuals appear to be more motivated (McCusker, Bigelow , Frost, Hindin ,
Vickers-Lahti, & Zorn, 1994) and tend to more likely complete treatment (Weddington,
Haertzen, Hess & Brown, 1991). Increased self-efficacy during treatment has been found to be
higher among abstainers than relapsers at follow-up (Burling, Reily, Moltzen, & Ziff, 1989).
However no relationship was found between self-efficacy ratings and outcome status in another
study (Mayer & Koeningsmark, 1991). Other subject characteristics, such as psychiatric status ,
cognitive functioning, and their relationships with outcome have also been studied. Relatively
poor treatment outcomes appear to be related to impaired cognitive functioning , major
depressive disorder, and antisocial personality disorder (e.g ., Fals-Stewart & Schafer, 1992; Kay,
1985).
One of the barriers to converging the findings from a huge literature in the area of
substance abuse treatment is the lack of consensus in defining treatment outcome. Froyd and
Lambert reviewed outcome assessment used in 348 studies published in 20 major journals
between 1983 to 1988. They found that over 1400 distinct measures have been applied in those
studies (see Lambert , 1990). Although no measures of treatment outcome has been used as a
"gold standard" in the area of substance abuse, the common goal underlying most treatment has
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...-

been abstinence of drug use or at least reduction of drug use (e.g. Hubbard et al., 1989; Lambert,
1990). Therefore, one type of the most commonly used indicators for treatment outcome has
focused primarily on drug usage. Wells and colleagues (1988) summarizes five major categories
of measures in outcome studies of substance abuse including consumption measures, categorical
classification, weighted indices of seriousness, composite scores of problem severity, and
patterns of use. Other researchers have conceptualized outcome as multidimensional, where
drug use is only one of the dimensions and recovery from drug addiction should involve
improvement in other areas such as psychosocial function, physical well-being, criminality, selfesteem and so on (e.g., Condelli & Hubbard, 1994; Kosten et al., 1987). Owing to the positive
relationship found between treatment retention and outcome, some studies have also used
treatment retention as an indicator of treatment outcome.
Indeed, the length of stay in treatment has shown to be the single most consistent
predictor of outcome across all treatment modalities (Charuvastra, Dalali, Cassuci, & Ling,
1992; DeLeon, 1988; De Leon & Jainchill, 1986; French, Zarkin, Hubbard, Rachal, 1993;
Hubbard et al., 1989). Research comparing treatment outcome of dropouts versus completors
has been able to consistently yield more favorable outcome for treatment completors (e.g.,
Baekeland & Lundwell, 1975, Hubbard et. al., 1989, Stark, 1992). Unfortunately, like treatment
of other psychological problems, dropout is prevalent in all drug abuse treatment programs (De
Leon & Jain chill, 1986). A large portion of clients drops out of treatment prematurely well
before full treatment can take effect. Thus far, no consistent profile of characteristics have been
identified that predicts treatment outcome. Therefore, even though length of stay in treatment
appears to be a promising and reliable predictor of outcome, this finding has not contributed very
much to the understanding of the process of successful treatment.
A recent trend in research on predictors of outcome has moved from traditional
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fixed/static

background

or

demographic

parameters

to

dynamic/changeable

variables .

Changeable variables can be directly or indirectly intervened upon and thereby it is believed to
be more helpful in understanding the process of recovery. Examples of dynamic variables that
have been studied include motivation , self-esteem , psychological symptoms and so on. One
major problem, however , is the lack of systematic framework and standardized measure in
assessing changeable variables.

The Transtheoretical Model of Change (Prochaska &

DiClemente, 1983, 1984, 1992) offers a promising systematic framework for this purpose . It
provides a useful conceptual framework in understanding how people change behaviors. They
go through a series of stages that include Precontemplation (not intending to change in the
foreseeable future), Contemplation (considering changing in the foreseeable future), Preparation
(intending to change in the near future with a specific plan or some steps towards action taken) ,
Action (actively engaged in changing a behavior) and Maintenance (sustaining the change and
preventing relapse) (Prochaska & DiClemente , 1992). These stages of change capture specific
constellations of attitudes, intentions and behavior of individuals going through the process of
change. Previous studies have found that stages of change, and other dimensions of the model
which include decisional balance, and process of change were strong predictors of behavioral
change. For example, stage differences were found to predict quit attempts in I-month and 6month follow-up with contemplation and preparation individuals more likely to made a quit
attempt at both times (DiClemente, Prochaska, Fairhurst , Velicer , Velasquez , & Rossi, 1991).
Among individuals who enrolled in behavioral weight control programs, individuals' stages and
use of processes of change at admission as well as during treatment were among the strongest
predictors of treatment outcome of weight loss (Prochaska, Norcross , Fowler , Follick & Abrams,
1992).
The purpose of the current study was to examine predictors of treatment outcome which
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included individual characteristics at both pre-treatment (admission) as well as at discharge.
Since there is no "gold standard" for treatment outcome, the most conservative measure -- status
of total abstinence of drug use at 3-month follow-up -- was used as the measure for treatment
outcome for the analyses. It has been evident that treatment is beneficial to drug addicts, yet the
discrepant findings of a large body of literature on treatment retention and treatment outcome
have presented doubts on the efficacy of treatment. In order to understand the elements that
contribute to effective treatment, one question of interest is to identify which "changeable" or
"dynamic" client characteristics can treatment have effects on so as to improve outcome. The
goals of this study included the following: I). examining the pretreatment predictors for
treatment outcome, and 2). investigating potential useful discharge criteria for substance abuse
treatment through assessing the predictive values of some 'dynamic' characteristics of treatment
participants at discharge on treatment outcome.
Methodology

Participants
Participants were 385 clients (33% females) recruited for the study from a substance
abuse residential facility. As participants admitted to the facility, they were randomly assigned
to one of the 3-month and 6-month treatment. The treatment programs were based on a relapse
prevention / health education model focusing on teaching coping skills for managing clients'
addictive attitudes and behaviors in order to cope with high risk situations for relapse. Both
"long" and "short" programs had essentially identical components except that the number of core
group sessions of the 6-month program was twice as much as the 3-month program. The mean
age of participants was 29.9 years (SD = 6.0). The ethnicity composition of the sample was
71.7% Caucasian, 20.0 African American, 7.39% Hispanic, and 1.0% other.

The mean

education level was 12th grade. About 34% of participants had a full time job at the time of
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treatment and 45 % were unemployed, while others worked part time, or had retired.

Almost

all (91 %) of the subjects had previous admissions to drug abuse treatment programs prior to the
study . Main drugs of choice were heroin only (19%), cocaine only(24%), alcohol and drugs
(28%), and polydrug (26%) , with 47% IV drug users .

Procedures
Participants were recruited during intake interviews at each facility that took place 14
days before or on the day of admission. Clients who were eligible to participate in the present
study were all former drug abusers who completed detoxification or withdrawal and were
admitted to the facility on a voluntary basis. Monetary incentives for participation were offered
at $15 per interview at admission and discharge, and $25 for a follow-up interview. Admission
interview took place in 2 to 3 sessions that occurred during the first 8 days after admission. Data
at exit obtained from 7 days before anticipated day of discharge to 3 weeks after discharge,
77.7% (n=299)of the total subjects were interviewed within this window. Follow-up interviews .
took place with a 2- to 6-month window post discharge; 76.6% (n=295)were interviewed.

Measures
Addiction Severity Index (AS])

The Addiction Severity Index (ASI) (McLellan, Luborsky, Woody, & O'Brien, 1980;
McLellan, et al., 1985; McLellan et al., 1992) is a semistructured interview that collects data
from substance abusers in seven problems areas: medical, employment, legal, alcohol, drug use,
family-social functioning, and psychological status. The primary goal of developing the ASI
was to provide an instrument to assess treatment outcomes over a broad range of potential areas
which could be affected by substance abuse treatment and can be applied across different
treatment settings (McLellan et al., 1992). The latest version, the fifth edition of the ASI, was
used (McLellan et al., 1992), with the addition of questions on personal and family psychiatric
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history. ASI covers general sociodemographics , as well as past and present infonnation of each
area. Composite scores can be computed from each area.
ASI is the most widely used clinical and research instrument in the area of substance
abuse . The instrument has been validated across hundreds of studies during the past 14 years
across different populations of substance abusers (e.g. Brown, Altennan, Rutherford, Cacciola &
Zaballero, 1993; Hendriks, Kaplan, Limbeek, & Geerlings, 1989; Hodgins & Guebaly, 1992;
McLellan et al., 1992). Studies in the area of substance abuse have frequently used ASI scale
scores for evaluation treatment efficacy and to validate newly developed scales for this area (e.g.,
Darke, Ward, Zador , & Swift, 1991; Kang, Kleinman , Woody, & Millman, 1991; Kosten et al.,
1987).
Change Assessment for Drug Use (CAD)
This 16-item questionnaire refined in Study 1 was used to assess subjects' readiness to
change their problem behavior. Subjects were asked to respond on a 5-point Likert Scale
ranging from 1 = strongly disagree to 5 =strongly agree. Four items comprised each of the
four stages of change: Precontemplation (PC), Contemplation (C), Action (A) and Maintenance
(M). This measure was administered at both admission and discharge interviews. The
psychometric properties of the measure have been demonstrated in Study I with coefficient
alphas ranging from .57 to .73 at baseline and .56 to .83 at exit. Stages of change at admission
among participants were established in Study 2. Six clusters were found with three clusters
(Uninvolved, Reluctant and Precontemplation) characterizing having no interest in quitting drug
use, and three other clusters namely Contemplation, Preparation and Action . Stage
membership at discharge was established in this study.
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Decisional Balance Inventory
The 12-item scale modified from the Cocaine Decisional Balance Inventory (Rossi,
Rosenbloom, et al. 1993) was used. With some wording changes replacing "cocaine use" with
"drug use" , this 12-item version has been shown to be a valid measure for the decisional
balance construct in a sample of drug addicts in treatment (Tsoh, 1993). Subjects were asked
to rate each item on a 5-point Liken scale ranging from 1 = not important to 5 = extremely
important. The items represent PROS and CONS for drug use with 12 items on each
dimension. The psychometric propenies of this measure was funher examined in the present ·
study. Items of the measure are shown in Appendix C .

Self-efficacy to avoid drugs
This self-efficacy scale contains 5 items assessing subjects' confidence in their ability to
avoid drug use in high risk situations during the next 3 months. Subjects were asked to respond
on a four point Liken Scale : 1=extremely confident to 4=not at all confident . Total score is the
sum of all 5 items reverse scored, with the higher total score indicating higher confidence. The
scale was developed based on data collected in this study at admission through various versions
of the instrument with an item pool of 11 or 24 items. The factor structure was refined using the
shorter version (n=3 70) and was confirmed using the long version (n=2 l 7). The internal
consistency as indicated by Cronbach's alpha, was .82 (Rubin, 1993). Items are shown in
Appendix D.

Rosenberg Self-Esteem Scale
It contains 10 items assessing individuals' sense of self-worth, satisfaction with self, and
belief in their own capabilities. Each item is scored on a four-point scale with 1=strongly agree
and 4=strongly disagree. Test-retest reliability and validity in use with adolescent and young
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adult populations has been adequate (Rosenberg , 1965). Improved in self-esteem is a favorable
outcome particularly for those in therapeutic communities.

Beck Depression Inventory
It is a 21-item self-administered questionnaire developed by Aaron Beck (1967). The
number and severity of current depressive symptoms are assessed. Adequate reliability has been
established in studies of psychotherapy.

Shipley-Institute of Living Scale
It is a self-administered test of cognitive functioning (Shipley, 1939). It contains a
verbal and an abstract section. Scores are age-corrected and can be converted to an estimated
WAIS-R IQ score with mean=IO0, SO=15. The estimated W AIS-R IQ score was used in the
current study. Administration of the instrument was timed and subjects were allowed 15 minutes
to complete each section.

Diagnostic Interview Schedule, Third Edition Revision (DIS-III-R)
An abbreviated version of the DIS-111-Rwhich incorporates items for the DSM-III-R
diagnostic criteria (American Psychiatric Association, 1987) was used. Only questions needed to
ascertain some pre-selected DSM-III-R diagnoses were asked. Those diagnoses include panic
disorder, social phobia, major depressive disorder, dysthymia, alcohol abuse and alcohol
dependence, antisocial personality disorder, and pathological gambling. The decision to focus
on these diagnoses was based on considerations of prevalence of these disorders among drug
abusers in treatment and evidence that particular disorders may be associated with treatment
outcomes.

Social Desirability Scale
Jackson's Social Desirability Scale (Jackson, 1967) was used to assess response bias
due to social desirability . This instrument consists of 20 items that are presented in a true-false
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format. It has been found to be a valid and reliable measure to determine if a response set
tends toward the direction of social desirability.
Biological assay of drug use

Hair analysis of drug use was used to validate against self-reported drug use at followup. Hair specimens of approximately 60 strands of hair were cut from the posterior vertex of the
head as close to the scalp as possible. Radioimmunoassay (RIA) was used for hair analyses. It is
believed to be the most widely used and the most sensitive chromatographic technique for this
purpose (Strang , Black, Marsh & Smith, 1993). Hair, particularly that at the posterior vertex
region, grows at a fairly constant rate of 1 to l .Scm/month regardless of sex and age (see Hindin,
Mccusker, Vickers-Lahti, Bigelow, Garfield, & Lewis, 1994; Strang et al., 1993). The technique
has been developed for cocaine, opiates , morphine, methadone, amphetamines, phencyclidine
and other illicit substances and is the most developed for detecting cocaine and heroin use
(Hindin et al., 1994). The amount of drugs detected through RIA is positively associated with the
amount of drugs used during the relevant time interval (Baumgartner, Black, Jones, & Blahd,
1989, Hindin et al., 1994). Drugs ingested appear to remain for the lifetime of the hair, thus drug
usage across time intervals can be revealed by segments of hair. Other biomarkers such as blood
and urine can only show drug use over 2 to several days. Therefore there is no other measure
that can document drug use over any period of time that can be used to truly validate RIA.
Confirmation rates of positive RIA (indicates drug use) on self-reported drug use have been high
especially at admission across studies (Hindin et al., 1994). Hindin and colleagues (1994) has
found confirmation rates of 89% for cocaine and 96% for heroin and a lower rate at follow-up,
suggesting that under-reporting of drug use at follow-up may be more common as compared to
entering treatment.
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Other variables

Data on other variables that have been associated with outcomes or retention from
previous studies were also collected. Those variables included IDV status, sources of referrals ,
length of stay in treatment,

Variablesof interest
Definitionof OutcomeSuccessful outcome was defined as total abstinence from drug
use since exit from treatment. Outcome data were based on both self-report and biological assay
of drug use from hair analysis. Among 295 individuals whose data were collected within the 2to 6-month post treatment period, hair analysis was available for only 54.6% (n=l61) of the
individuals.

Although findings on relationships between self-report and hair analyses were

encouraging, a significant difference in total abstinence rates across sources of data (self-report
alone vs. biological assay measure and self-report) was noted. Abstinence rate was 32.9%
among individuals who had data on hair analysis as compared to 64.2% among those who did not
provide hair to validate their self-report on drug use, x.2=28.68,p<.001. The significant higher
abstinence rate obtained from the self-report-alone condition implied a high tendency for underreporting of drug use post treatment. Owing to the apparent validity problem from self-report on
the outcome measure (drug use post treatment), a more conservative approach was taken and
only subjects who had data on hair analysis were included in the prediction analysis. Based on
the combination of hair analysis together with self-report, abstinence rates were very similar
between 3-month (33.3%) vs. 6-month (32.5%) programs. In order to maximize the number of
subjects in the analyses, all subjects from both programs were used and enrollment in either the
3- or 6-month program was included as a variable in the analyses. Participant characteristics
(n=l65) included in the prediction analyses are presented in Table 4-1.
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PredictorVariables.
Baseline Predictors.

Predictors considered in the analyses of this study were

collected during admission, which included all participant characteristics as listed in Table 4-1.
Other variables include psychiatric diagnoses, depression level (Beck Depression Inventory),
self-esteem (Rosenberg Self-Esteem scale), cognitive functioning (estimated WAIS-R IQ scores
converted from Shipley), ASI composite scores of each area (medical, employment, legal,
alcohol, drug use, family-social functioning, and psychological status), subjective rating from the
ASI measure which include perceived severity of and perceived importance of treatment for each
problem areas. The Transtheoretical Model relevant variables included in the analyses were pros
and cons, self efficacy to avoid drugs, and stages of change. To maximize sample size, the
Uninvolved,

Reluctant and Precontemplation clusters were grouped

as a combined

Precontemplation cluster and was compared to other clusters, Contemplation, Preparation , and
Action .
Discharge Predictors.

Variables included length of stay in treatment, and other

measures obtained at discharge: stages of change, pros and cons for drug use, self-efficacy to
avoid drugs, self-esteem (Rosenberg self-esteem scale), and depression level (measured by the
Beck Depression Inventory).

Analyses
Establisbio"Sta"esof Chan"eat Djschar"e,To maximize sample size, all subjects that
had discharge data from the facility were included regardless of their follow-up status. Before
establishing stages of change membership at discharge, characteristics of subjects who had
discharge data vs. those who did not have the data were compared through MANOV A, follow-up
ANOV A and chi-square tests. Cluster analysis was used to assess homogenous subtypes of
individuals based on the profile of the subscales of Change Assessment Drug Use (CAD) at exit.
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This stage allocation method was found to be a better and more valid method for assessing stages
of change in a substance abuse treatment client population (see Study 2). It involves grouping
individuals according to their profiles based on these four scales: Precontemplation ,
Contemplation , Action , and Maintenance . Individuals were classified into subgroups based on
the similarities they shared on their responses to the scales. Scale scores were converted into
standardized T-scores with a mean of 50 and a standard deviation of 10. Ward's minimum
variance method (Ward , 1963) was used as it has been demonstrated to be the most desirable
method among other cluster analytic procedures (Milligan, 1980; Milligan & Cooper , 1987).
Using Ward's procedure , each subject is treated as an individual cluster and then the clusters are
merged into subgroups.

The Euclidean distance measure of similarity was calculated for

merging clusters with the smallest distance. Finally, the number of clusters was determined by
the following guidelines: interpretability of distinct clusters, visual inspection of the cluster
dendrogram (Aldenderfer & Blashfield, 1984), as well as the Cubic Clustering Criteria (Sarle, .
1983; Milligan & Cooper, 1985).
To establish the internal validity of resulting cluster profiles, the following procedures
were performed. The sample was first randomly split into an exploratory sample and a "holdout" or calibration sample. After establishing cluster membership in the exploratory sample,
cluster analysis was then conducted on the whole sample together with the calibration/"hold-out"
sample. The stability of the cluster profiles established in the first exploratory analysis was then·
examined by comparing the resulting cluster profiles from the analysis with the additional
subjects of the calibration sample .
The external validity of the clusters was assessed by examining the relationship between
stage clusters and Decisional Balance Inventory , and Self-Efficacy to Avoid Drugs . A classic
"crossover" pattern of Pros and Cons across various stages of change as found in other problem
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behaviors was expected to confinn validity. Individuals in more "advanced" stages of change
(e.g., Action) were expected to have a higher self-efficacy than those in "earlier" stages of
change.
Lastly, the relationship between stages of change at exit and other baseline and exit
variables were examined.

Identjfyjn~Predictorsof TreatmentOutcome. Logistic regression (LR) was used to
examine significant predictors of treatment outcome. Three separate logistic regression models
for predicting treatment outcome were tested: 1) predictors at baseline/pretreatment, 2)
predictors at discharge; and finally 3) an overall model with all significant predictors from
baseline and exit. The first model aimed at examining and identifying significant predictors
presented when clients entered treatment. The regression model identified significant discharge
predictors for outcome targeted to denote potential meaningful discharge criteria which have a
relatively strong association with outcome. Lastly, the overall model aimed at comparing the
predicting power of baseline vs. discharge variables for treatment outcome. LR was used to
examine predictors of outcome instead of discriminant function analyses (DF A) because LR has
been demonstrated as a more powerful technique for binomial variables. In the current study,
outcome was dichotomously defined (abstinent vs. relapse) (e.g., Hosmer & Lemeshow, 1989;
Norusis, 1990). Owing to the large number of variables at baseline/admission, they were
initially subjected to a series of bivariates analyses such as ANOV A or Chi-squares procedures.
Only variables that differentiated between abstainers (no drug use since discharge) and nonabstainers at a p-value of .20 (Hosmer & Lemeshow, 1989; Lemeshow, 1993) were included in
the logistic regression analysis followed. For the analyses for the predictors at discharge for
treatment outcome, all six discharge variables were included. For the LR analyses for model 1 &
2, a stepwise procedure was used. In model 3, significant baseline and exit predictors were
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examined using a standard LR. After the identification of significant predictors in each model,
first order interactions terms were tested . For the purpose of this study, identification of
significant predictors in each model and their odds ratios, denoting predicting relationship
between each variable and outcome were the parameters of interests.
Results

Establishin~Sta~esof Chan~eat Exit
Comparison between subjects who had exit data vs. not

A series of MANOV A and follow-up ANOV A, as well as chi-square tests were
conducted to compare subjects who had exit data and those who did not. These two groups were
very similar statistically in most characteristics except for length of stay in treatment, age,
education level, and cognitive functioning (IQ score) . Subjects whose exit data were available
tended to have stayed in treatment longer (91.9 vs. 65.4 days; E(l,383)=17.74, p< .001), be older
(30.2 vs. 28. 7 years of age; E( 1,382)=4.18, p< 0.04), be slightly more educated ( 11.9 vs. 11.2
years; E(l,377)=7.28, p< 0.01), and have slightly higher level of cognitive functioning (IQ
scores:105 vs. 100; E(l,324)=8.49, p< 0.01). As findings from the previous study (Study 3) on
predictors of treatment dropout indicated an association between some of these variables with
length of stay (particularly education level), a MANCOV A using length of stay as a covariate
was conducted on age, education and IQ score comparing the two groups. Results indicated a
non-significant group effect on these measures when length of stay in treatment was taken into
account as a covariate . Therefore, it appeared that whether or not exit data were available
seemed to associate primarily with the length of stay in treatment. Therefore, interpretation of
the results with exit data should take this finding into consideration.
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Cluster analysis
The four scales, PC, C, A & M of the CAD were used as clustering variables.

Scale

statistics of the whole sample (n=264) with complete data on all the four CAD scales were
included in the analysis . Individuals were classified into cohesive subgroups based on the
similarities they shared on their responses to the CAD scales . Participants were randomly split
into two independent samples (Sample 1: n=l38; Sample 2 -- calibration sample n=l26) for
internal validation of resulting cluster profiles . Sample characteristics comparisons indicated the
two samples were very similar .
In Sample 1 (n=138) , solutions of 3 to 10 clusters were considered. A 4-cluster solution
was the most interpretable.

The clusters were labeled: Immotive (n= 11), Precontemplation

(n=21), Preparation (n=82), and Action (n=24) . When a cluster analysis was performed on the
whole sample (n=264) with the calibration sample(Sample 2; n=l26) added, a 4-cluster solution
was found most interpretable from the range of 3 to 10-cluster solutions considered. The cluster
profiles were very similar to those identified in Sample 1 with respect to level, scatter and shape.
The distribution of each cluster for the whole sample was: Immotive (n=29) , Precontemplation
(n=55), Preparation (n=92), and Action (n=88). The means and standard deviations for the scale
scores of each cluster for Samples 1 and the whole sample are shown in Table 4-2 and Table 4-3
respectively. Each cluster profile is described below.

JmmotiveCluster: This subgroup consisted of 8.0% of Sample 1 and 11.0% of the whole
sample. Both profiles were characterized by high scores on the PC scale and well below average
score on the C, A and M scales (Figure 4-1) . Individuals denied their drug use as a problem and

refused to participate in changing or even consider quitting drugs.
Precontemplation Cluster : This subgroup consisted of 15.4% and 20.8% of Samples I

and the whole sample respectively.

These individuals featured an elevated score on PC and
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below to about average on C, A & and M scales (Figure 4-2). Individuals in this cluster were not
considering or actively engaging in quitting drugs. Instead they seemed to deny their drug use as
a problem and maintained the status quo with respect to their drug use.
Preparation Cluster:

There were 59.4% of Sample 1 and 34.8% of the whole sample

classified into this cluster.

The cluster profile was characterized by a below average

endorsement on both PC and M scales, and above average on the Contemplation and Action
scales (Figure 4-3). These subjects have made a decision to change their drug use behavior and
have started actively participating in changing. However, they have not yet experienced or
recognized the risks of relapse (low endorsement of M).
Action Cluster: The 17.4% and 33.3% of Sample I and the whole sample respectively
were classified into this cluster. The profile was characterized by below average scores on PC,
but well above average scores on C, A and M scales (Figure 4-4). These individuals reported
high investment and involvement in changing their drug use behavior, and have started to
maintain their behavior change and work toward preventing relapse.
Regarding change in cluster membership from Sample I to the whole sample, most
subjects in the Immotive (100%) and PC clusters (90.5%) remained in the same cluster
memberships. In the PR cluster of Sample I, 56.1% remained in the same cluster, 41.5% were
classified into Action and 2.4% into Precontemplation. In the A cluster of Sample I, 79.2%
remained in the same cluster, 4.2% in PR and 16.7% in Precontemplation in the whole sample.
The converging results from the cluster analyses conducted indicated that the cluster profiles
identified were stable and internal valid. Therefore, the external validation of clusters proceeded
with cluster membership derived from whole sample.
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External validation of clusters with decisional balanceand self-efficacy measures at exit
A one-way MANOV A was conducted using the stage clusters as the independent
variable on three variables including the Pros and Cons for drug use and self-efficacy to avoid
drugs. The MANOVA yielded a significant main effect, Wilks' A= .69, F(9, 628.05) = I 1.51, n
<.001, which accounted for 31% of the variance. Follow-up ANOVAs were conducted for each
of the three scales to determine group differences.
measures .

Significant main effects were found on all

Summaries of the follow-up univariate tests and the Tukey post-hoc tests are

presented in Table 4-4. Figure 4-5 and Figure 4-6 illustrate the mean values for the Pros and
Cons scales of the Decisional Balance for Drug Use and Self-efficacy

across clusters

respectively.
A stepwise discriminant function analysis (DFA) was performed using the three
measures, Pros, Cons and Self-efficacy as predictors for the cluster membership. One significant
discriminant function was found. Con was the primary predictor for the discriminant function
with Wilks' A= .69, x2 (9) = 96.34, p < .001, Canonical correlation (Rc2) = .54. The centroid
(score based discriminant function) for the I, PC, PR and A clusters were -1.69, -.18, .27, .38.
The jackknifed classification analysis showed that 40.9% (as compared to 25% by chance alone)
of the 264 participants were correctly classified into one of the 4 clusters. The most accurate
classification occurred in the I cluster, where 72.4% of the sample was correctly classified, while
the most misclassification occurred in A cluster, in which 33.0% was correctly classified with
most participants (35.2%) classified into PR.

RelationshipbetweenSta2esof Chan2eand otherVariables
A series of MANOV A, follow-up ANOV A and chi-square tests were performed to
examine the relationship between stages of change at exit and other variables.

Table 4-5

presents the significant cluster differences across various variables including length of stay in
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treatment, education level, cognitive functioning level , age , self-esteem at discharge and
depression level at discharge. There were no cluster differences on other demographic , drug use
variables, or any of the ASI measures obtained at baseline .

Identification
of Sj~nificantPredictorsof TreatmentOutcome
Baseline predictors of treatment outcome
After a series of bivariate analyses of baseline variables, variables with 12-value <.20
were subjected to logistic regression analysis. The list of baseline measures included in the
logistic regression analysis followed are presented in Table 4-6. A total of 142 participants with
complete data were included in the following analysis. Stepwise logistic regression model
examined all potential baseline/pretreatment predictors for outcome found that stages of change
was the only significant baseline predictor. More specifically, Preparation individuals at
admission were 3-5 times more likely to remain abstinent at 3-month post treatment as compared
to their peers in other clusters. Table 4-7 presents the Wald statistics and odds ratios for the final
LR model of outcome based on baseline predictors.

Discharge predictors of treatment outcome
All discharge variables were included in a stepwise logistic regression analysis for
treatment outcome (abstinence of drug use since exit). The list of discharge measures included
in the logistic regression analysis are presented in Table 4-8. Stepwise logistic regression model
examined all potential discharge predictors for outcome on I 09 participants with complete data ,
found that only the length of stay in treatment and depression level (BDI scores) at exit were
significant predictors with depression level entered at the first step of the analysis . No
significant interaction between length of stay and depression level was found. Table 4-9 presents
the Wald statistics and odds ratios for the final LR model of outcome based on baseline
predictors .
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For interpretation purposes, the magnitude of the association between the length of stay
in treatment, depression level, and abstinence was further examined by categorization of each
predictor. For length of stay in treatment, two ways of dichotomization were tested: 1) stayed
less than 60 days vs. continuers; and 2) stayed less than 80 days vs. continuers. For depression,
three levels were tested according to clinical use of the Beck Depression Inventory: low (scores
< 11), mild (scores between 11 and 17), and high (scores> 17).
When depression level is controlled, using cut off of 60 days stayed in treatment,
continuers were more likely to be abstinent at 3 months (OR=7.68; 95% CI=0.91-64.70). When
using 80 days stayed in treatment as cut off, individuals who stayed beyond 80 days were more
likely to remain abstinent at follow-up (OR=3.50; 95% CI= 1.18-10.37). With length of stay in
treatment controlled, individuals with low level of depression (scores < 11) at discharge were
more likely to remain abstinent at follow-up as compared to those who reported mild depression
(OR=3.09; 95% Cl=0.99-9.63) and those who had high level of depression (OR=13.96; 95%
CI=l.74-85.45).

No significant difference was found between mild and high levels of depression

in terms of their association with treatment outcome.

Baseline and Discharge predictors of treatment outcome
Significant predictors at baseline and discharge were examined in a step-wise logistic
regression analysis to compare the relative power of prediction of treatment outcome. As
indicated earlier, only three significant predictors for treatment outcome were found: stages of
change at baseline, depression level at discharge and length of stay in treatment. Results
indicated that only the discharge variables were significant predictors for outcome (Table 4-10).

In addition, interactions were tested between baseline stages of change and length of stay in
treatment as well as depression at discharge, no significant effects were noted. Therefore, the
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results indicated that variables at discharge were more powerful in predicting outcome then the
best baseline predictor.
Discussion

Sta"esof Chan"eat Djschar"e
Current findings demonstrated the usefulness of the Change Assessment for Drug Use
scale (CAD) to assess stages of change among drug addicts at discharge of treatment. Four
clusters, Immotive (I), Precontemplation (PC), Preparation (PR), and Action (A) were identified
at discharge denoting four major typologies of readiness for change among clients at discharge
from relapse-prevention oriented residential programs. The clusters were externall y validated by
pros and cons for drug use, as well as self-efficacy to avoid drugs . A classic "crossover " pattern
of pros and cons were observed across the clusters , with the precontemplative clusters (I & PC)
having pros of drug use outweighed the cons, and the PR and A clusters reporting higher cons
than pros of drug use. Both the strong and weak principles of behavior change (Prochaska,
1994) were demonstrated. On the cons of drug use, an increase over 15 T-scores (> 1 SD) from I
to A was observed , which demonstrated the strong principle of progress. On the pros of drug
use, a smaller decrease within 5 T-scores (0.5 SD) was observed from PC to PR, which
illustrated the weak principle of progress. In addition, a gradual increase of self-efficacy to
avoid drug use was noted across the clusters from I to A with A individuals reporting a
significantl y higher level of self-efficacy than those in the I cluster.
The significant differences across stages of change at discharge and other variables also
have important implications for better understanding of stages of change and its potential
interactions with treatment. First, findings clearly indicated that individuals who left treatment
in the precontemplative stage of change had significantly shorter lengths of stay . As consistent
with previous findings on predictors of dropouts (Study 3), individuals who were not ready to
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change tended to drop out from treatment early. Second, as opposed to previous findings that no
relationship was found between demographic variables and stages of change at admission (Study
2), current results showed that there were three demographic variables that had a significant
relationship with stages of change at discharge . More specifically, individuals in A and PR at
discharge, tended to be more educated and have a higher cognitive functioning level. Since
education was found to be a significant predictor of treatment retention (Study 3), it might be
that more educated individuals tended to be able to receive more benefits from treatment through
staying longer in treatment. Or in other words, the current type of residential treatment programs
focusing on relapse prevention and health education might tend to serve clients with a higher
education level better. It should be noted that there was no significant difference across stages at
admission on education level, and therefore the current findings are likely to denote the impact
of education level on receiving treatment benefits.
Interestingly, individuals in I (lmmotive) at discharge were younger than all other
clients. Given that there was no evidence as shown in Study 3 that age affected length of stay in
treatment, and they did not seem to drop out from treatment earlier than others, one reason for
these individuals seeking or staying in treatment might be due to coercion rather than intrinsic
motivating factors. Therefore, these individuals might just "go along" with treatment. The
current treatment failed to help them value the cons of drug use or the benefits of staying off
drugs. In addition, this group of individuals (in Immotive cluster) also reported a significant
higher level of depression than all their peers at discharge (not at admission). These findings
together might imply that one of the reasons for these individuals to be more "resistant" to
change by this type of treatment was that treatment did not address their needs regarding dealing
with their depression and negative emotions. To these individuals (young and depressed),
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particularly, drug use may be the only convenient option they have to cope with negative
emotions.
Consistent with the previous finding on self-esteem and stages of change (Study 2), PR
individuals at admission, and those at discharge reported a higher level of self-esteem. These
findings indicated that having higher self-esteem might be the characteristic that distinguished
PR individuals from others, especially those who were not ready to change. For those who have
made a firm decision to quit drugs and have been committed to their decision by actively
participating and making progress in treatment, it is likely that these individuals would feel
better about themselves. However, to what extent that self-esteem affects readiness for change,
treatment retention, and outcome is unclear. Current findings on treatment dropouts and
outcome suggested little influence that self-esteem might have on treatment outcome or
retention .

Predictorsof Treatment
Outcome
Current results showed that there were more than 60% of clients who dropped out from
treatment within the first 3 months. Nevertheless, the findings on predictors of treatment
outcome were encouraging. Results clearly showed that dynamic variables outperformed
static/fixed variables in predicting short-term (3-month) treatment outcome. Dynamic variables
are dimensions that treatment providers can intervene upon and therefore, regardless of the
demographics of the clients who are seeking treatment, they have an equal chance to succeed,
since the parameters that predict outcome more strongly are changeable. Therefore, it appears
that the key to improving treatment is to identify the dynamic parameters that associated with
outcome.
Stages of change at admission was the most and only significant outcome predictor as
compared to all other dynamic and fixed variables at admission used in this study . Findings have
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suggested that only certain types of treatment works for certain types of clients . Based on
research and theories of the Transtheoretical Model, successful change is dependent upon the
appropriate use of a certain set of strategies or skills at each stage of change. Different stages of
change require different strategies to progress to the next stage. For example, experiential
processes of change, such as consciousness raising, and self-evaluation were significant to move
individuals from precontemplation to contemplation, and become ready for action (Prochaska &
DiClemente, 1992).
For individuals who were not ready to change, such as those who were in the
precontemplative clusters, they did not receive treatment benefits probably because they tended
to drop out from treatment early. Furthermore, before these individuals could learn the skills to
quit drugs, they have to have the desire to quit first through understanding and identifying the
benefits of quitting as well as the cons of using drugs. For contemplators, however, their
immediate needs for treatment were to become "ready" for action (or moving on to the
preparation stage). This process of getting ready requires further consolidation of their reasons
for quitting which involves decreasing pros and increasing cons for drug use. Furthermore, they
needed to be informed fully and be prepared for what it would take to quit drugs. Again, current
program targeting behavioral skills for quitting, clearly had not met the immediate needs for
these individuals. Even though these individuals might learn to master some skills for quitting,
since most had not yet worked through the reasons for quitting, or were prepared for what it
might take to stay off drugs, relapse among these individuals might likely result.
Preparation individuals were in fact the only subtype of clients who were more likely to
remain abstinent three months after treatment. The treatment program in this study was based on
a relapse prevention/health education model with emphasis on teaching individuals to identify
high-risk situations on relapse and behavioral skills training for coping. The techniques that the
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programs taught were most essential to prepare individuals for taking "action" . In order words ,
being able to understand well the risks of relapse and master the skills for coping would be
essential prior to moving on to exercising these skills to avoid relapse in a free environment.
Results of this study clearly suggested that PR was a subtype of individuals who were able to
benefit most from this kind of treatment. In other words, a relapse prevention type of programs
might be a better match for those who were in PR at admission but not for others .
Interestingly, current findings indicated that Action individuals, in fact, did not differ
from those precontemplative individuals in terms of outcome, and instead these individuals were
more likely to relapse than those in Preparation. It may seem surprising that an "action-oriented "
program did not seem to benefit individuals in Action but rather those in Preparation were more
able to benefit from it. To investigate this observation, one way was to compare the major
differences in characteristics between these two groups. First, previous findings (Study 2)
indicated that Action individuals reported a significantly higher level of pros of d~g use. Even
though their value of cons still outweighed the pros, the difference between pros and cons was
small. Perhaps because of the high level of pros, these individuals were more aware of risks of
relapse (high endorsement of M scale) as compared to those in Preparation. However, their
awareness of relapse did not necessarily make current treatment a good match for them. In this
case, treatment failed to help them decrease the perceived importance of using drugs and
therefore they continued to be at a high risk for relapse . It appeared that the previous treatment
that those individuals had did not prepare them well tq take action . This finding indeed has
provided some support for the assumption that relapse might occur when moving someone too
fast across stages without preparing them well prior to take acting and letting them master the
specific strategies for each stage.
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Generally , findings have supported the hypothesis that individuals who were more ready
to change tended to have better outcomes than those who were not as ready to change. More
importantly , the findings underscored the importance of a stage-match intervention for
successful outcome. Furthermore , findings also underscored the importance of assessing other
stage dependent construct so as to assess thoroughly the current status and needs of the clients .
These constructs included processes of change, decisional balance , and self-efficacy.
Among all discharge variables, depression level was the strongest predictor. Clients who
have a low level (within normal limit) of depression at discharge were up to 3 to 12 times more
likely to have successful short-term outcomes than those who have mild to higher levels of
depression . Previous studies have found similar results where the presence of psychopathology
such as depression predicted negative treatment outcome ( e.g., Ravndal & Vaglum , 1994 ). The
current findings however, indicated the importance of intervening upon patients' depression
level as well as focusing on teaching them to cope with depression, so that they might be less
likely to relapse due to depressive symptoms .
As consistent with previous research, length of stay in treatment was found predictive of
treatment outcome in this study. Staying longer in treatment tended to produce better outcome .
Individuals who dropped out within the first two months were 7 times more likely to relapse than
those who stayed beyond 60 days. Those who dropped out within the first three months were 3 .5
times more likely to relapse . Thus far, the relationship between treatment retention and outcome
remains unclear. As suggested by researchers, a minimal exposure of treatment is necessary to
produce positive treatment outcome , and beyond that, perhaps, other factors might become
essential to predict outcome . However, as in the case of most treatment programs, the majority
of clients dropped out before treatment could fully take effect. Based on the current data and the
finding on predictors for dropouts (Study 3), only stages of change at admission was the common
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predictor for dropout and outcome. Again, findings have consistently provided support for
stage-match intervention strategies that might reduce dropouts and improve treatment success .
Regarding the goal for setting up potential meaningful discharge criteria associated with
outcome , results have indicated that depression level might be one of them. More specifically,
clients whose depression was mild to high might not be ready to be discharged. However, as
pointed out earlier, because of the limitation of the current available data at discharge, this
finding should be interpreted cautiously. Studies in the future should investigate the role of
stages of change, decisional balance, self-efficacy and processes of change at discharge and
outcome.
In summary, this study has identified several predictors for short-tenn treatment
outcome, which included stages of change at baseline, depression level at discharge, and length
of stay in treatment. The findings have provided support for the importance of assessing stages
of change and potentially intervening upon this dynamic variable to help improve outcome.
Stages of change have been found predictive of both dropouts and outcome. More importantly,
results have suggested that successful outcome requires matching individual needs. Stages of
change represents an appropriate framework for identifying individual needs for recovery.
Lastly, current results also indicated that future research focusing on outcome should include a
biological marker for substance use.
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Table 4-1. Characteristics of Participants with Hair Analysis Available at Follow-up
Demographic Information
N
%
Treatment Setting
Residential (3-month)
81
50.3
88
49.7
Residential (6-month)
Total
161
Referral
Legal
14
8.7
Self
147
91.3
Gender
Male
97
60.2
Female
64
39.8
Age
under 21
7
4.3
34
21-25
25.5
26-30
38
23.6
31-35
45
28.0
36-40
24
14.9
41 or older
13
8.1
Race
Caucasian
127
79.9
African American
15
9.4
14
Hispanic
8.8
Other
1.9
3
missing
2
Marital Status
Single
65.4
100
Married / Living together
15
9.8
Separated
5.2
8
Divorced
19.0
29
Widowed
0.7
1
Missing
8
Education
< 12
30.6
48
44.6
70
High school
17.8
28
Some College
4.5
7
College
2.5
Post graduate
4
missing
4
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Table 4-1.

Characteristics
(cont'd)

Yearly Income
under $5,000
$5,000 - 9,999
$10,000-19 ,999
$20,000 - 29,999
$30,000 - 39,999
$40,000 or over
missing
Employment Status
Unemployed
Part time
Full time / self employed
Student / Retired
missing
Legal Status
Waiting charges
Probation I Parole
not applicable
missing
HIV positive
Yes
Nol.Not sure
missing
Previous Drug Abuse Treatment
0

I
2-4
5 or more
missing
Drug of Choice
Alcohol only
Alcohol and drug
Cocaine only
Heroin only
Polydrug
Other
IV Drug Users (used IV during 3

n

%

63
21
24
7
16
24
6

40.6
13.5
15.5
4.5
10.3
15.5

71
19
56
5
4

45.2
12.1
35.7
3.0

43
30
83
5

27.6
19.2
53.2

6
140
15

4.1
95.9

14
18
58
65
6

9.1
11.6
37.4
41.9

7
57
29
32
35

4.3
35.4
18. l
19.9
21.7
0.6

84
77

52.2
47.8

months prior to admission)

Yes
No

Table 4-1.

Characteristics
(cont'd)

Age First Used Drugs
Under 13
13-17
18-20
21-30
m1ssmg
Age First Used IV
Under 13
13-17
18-20
21-30
Total
Types of Living
Situation before Admission
Free-living
Drug Treatment Centers
Jail
Hospital

72
69
IO
IO
0

44 .7
42.9
6.2
6.2

4
39
17
50
51

3.6
35.5
15.5
44.4

69
88
3
1

42 .9
54.7
1.9
0.6

Table 4-2. Change Assessment Questionnaire for Drug Use <CAD) Scale Scores for Each
Clusters: Sami;2lel <o=l 38)

Raw

Standardized

Clusters / CAD Scales
I. Immotive

Mean

SD

Mean

SD

PC
·C
A
M
II. Precontemplation

2.57
2.67
2.78
3.55

0.94
0.95
0.75
0.68

63.43
26.49
29.05
36.48

12.60
13.53
10.14
9.17

PC
C
A
M
III. Preparation

2.61
3.99
3.65
3.79

0.66
0.42
0.59
0.40

63.96
45.32
40.83
53.34

8.88
6.01
7.93
5.42

PC
C
A
M
IV. Action

1.21
4.54
4.63
3.31

0.31
0.37
0.41
0.51

45.24
53.22
54.02
46.77

6.87
5.24
5.53
6.92

1.41
4.59
4.63
4.60

0.52
0.50
0.40
0.30

47.90
53.85
53.89
64.30

6.89
7.14
5.35
4.10

PC
C
A
M
~

1. CAD scales: PC - Precontemplation, C - Contemplation, A - Action, M - Maintenance
2. Raw scores of scale means range from 1 to 5
3. Standardized scale scores have M=50, SD=l0

157

-

Table 4-3 .

Chan~eAssessment
Questionnaire
forDru~Use(CAD)ScaleScoresforEach
Clusters;WholeSample(n=264)
Standardized

Raw

Clusters / CAD Scales
I. lmmotive

Mean

SD

Mean

SD

PC
C
A
M
II. Precontemplation

2.67
2.76
2.65
2.52

0.85
0.89
0.68
0.79

63.33
29.89
29.79
37.42

11.01
12.12
8.60
10.38

PC
C
A
M
m. Preparation

2.42
4.08
3.94
3.84

0.62
0.37
0.58
0.38

60.01
49 .60
46 .21
54.74

8.11
5.05
7.40
5.00

PC
C
A
M
IV. Action

1.27
4.38
4.52
2.96

0.36
0.46
0.47
0.38

45.14
52.02
53.49
43.13

4.63
6.25
5.96
4.96

44.44
1.22
PC
0.35
55.82
4.66
0.34
C
55.38
4.67
0.35
A
58.36
4.12
0.47
M
No.te.;_
1. CAD scales: PC - Precontemplation , C - Contemplation , A - Action,
2. Raw scores of scale means range from 1 to 5
3. Standardized scale scores have M=50 , S0=10
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4.60
4.70
4.48
6.23
M - Maintenance

Table 4-4. Cluster Differences of the Decisional Balance Inventor:y and Self Efficacy to Avoid
Dnu~s at Discharie : Whole Sample (N=264)

Follow-up
Pattern
(Tukey post-hoc
comparison)

f (3,260)

,,2

Effect
Size

Mean

SD

51.60
52.44
47.56
50.49

10.07
10.29
8.96
10.42

PC>PR

3.32*

.04

36.27
48.86
52.02
53.12

12.05
7.69
7.91
8.69

A, PR, PC> I
A>PC

30.06**

.26

Self Efficacy to Avoid Drugs
1. Immotive (I)
45.57
2. Precontemplation (PC)
49.26
3. Preparation (PR)
50.67
4. Action (A)
51.25

15.20
10.88
8.45
8.41

A>I

2.93*

.03

Scales / Clusters

I. Pros for Drug Use
1. Immotive (I)
2. Precontemplation (PC)
3. Preparation (PR)
4. Action (A)
II. Cons for Drug Use

1. Immotive (I)
2. Precontemplation (PC)
3. Preparation (PR)
4. Action (A)

m.

Scale scores are standardized with M=50 , SD= 10
* 12< .05; •• -12< .0001
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Table 4-5. Clust~r Diff~r~n~~sQDfarti~ii;mnts' Chara~t~risti~s; WbQk Sami2k ili-264
Follow-up
Pattern
(Tukey post-hoc
comparison)

£-value

83.90
50.63
82.00
47.82
104.24 51.72
107.13 47.08

A, PR> PC

4.22*

1. Irnrnotive (I)
2. Precontemplation (PC)
3. Preparation (PR)
4. Action (A)

11.48
11.07
12.43
12.31

1.55
2.96
1.64
2.32

A, PR> PC

5.53*

ID.Age
1. Irnrnotive (I)
2. Precontemplation (PC)
3. Preparation (PR)
4. Action (A)

25.76
29.94
31.84
30.26

5.46
5.92
6.48
5.46

A, PR, PC> I

7.79**

A, PR> PC, I

8.74**

Scales / Clusters

Mean

SD

I. Length of Stay in Treatment (days)
1. Irnrnotive (I)
2. Precontemplation (PC)
3. Preparation (PR)
4. Action (A)
II. Education (years)

IV. Cognitive Functioning (WAIS - IQ
1. Im motive (I)
98.8
2. Preconternplation (PC)
99.76
3. Preparation (PR)
108.59
4. Action (A)
106.76

score)
15.65
13.95
9.29
11.61

V. Self-esteem at Discharge (Rosenberg Self-Esteem Scale)
I . Irnrnotive (I)
29 .41
5.62 PR > PC, I
2. Precontemplation (PC)
30.43
4.10
3. Preparation (PR)
32.54
3.87
4. Action (A)
31.78
4.54
VI. Depression Level at Discharge (Beck Depression Inventory)
I. Irnrnotive (I)
19.08
13.53 I> PC, PR, A
2. Preconternplation (PC)
9.02
7.43
3. Preparation (PR)
7.66
6.47
4. Action (A)
9.16
7.11

*_p < .001, **p < .0001
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5.17*

13.85**

l

Table 4-6. Baseline Varjab!es included io Lo~jstjc Re~ressioo Analysis for Treatment Outcome:
Unjyariate Results Comparin~ Abstainers and Re!apsers
Demographic

Abstainers

Relapsers (any
drug use since
discharge)

12-value

12.24 (2.16)

11.74 (2.46)

.20

4.28 (3.62)

5.73 (5.73)

.15

Legally referred

3.8%

11.1%

.12

Full time employment

54.7%

42.6%

.14

0.70 (0.25)

0.79 (0.26)

.03

Alcohol

1.64 (1.93)

1.22 (1.78)

.17

Drug use

3.70 (1.07)

3.33 (1.38)

.09

Family

1.75 (1.91)

1.34 (1.75)

.17

Social

1.64 (1.88)

1.19 (1.88)

.14

Psychiatric

1.75 (1.85)

2.21 (1.86)

.15

1.66 (1.80)

1.18 (1.63)

.09

Antisocial Personality disorder

50.9%

63.3%

.14

Pathological gambling

11.3%

19.4%

.20

Panic disorder

7.5%

15.3%

.17

Major Depression

15.1%

24.5%

.18

/Background Variables
Education

Mean (SD)

Number of previous treatment

ASI measures:
Composite score - Employment
Perceived importance of
treatment for specific problem areas
(0-4)

Perceived severity of social
problems (0-4)
Psychiatric Diagnosis/ Functioning

.05

Stages of Change (Clusters)
Precontemplation

37.7%

46.3%

Contemplation

20.8%

26.9%

Preparation

24.5%

8.3%

Action

17.0%

18.5%
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Table 4-7 SignificantBaseline Predictorof Abstinence: Wald Statistics, Odds ratios (OR) and
95% ConfidenceIntervals
Predictor

Wald

JL- value

8.13

.043

Precontemplation

5.07

Contemplation
Action

Stages of Change (reference

OR

95% CI

.024

3.51

1.18-10.49

7.11

.007

5.04

1.53 - 16.53

5.77

.016

4.73

1.3 I - 16.84

group= Preparation)
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Table 4-8 . Discharge Variable Included in Logistic Re~ssion

Analysis for Treatment

Outcome : Univariate Results Comparing Abstainers and Re!apsers
Measures at Discharge

Length of stay in treatment (days)

Abstainers

Relapsers

(n=53)

(n=l08)

115.79 (48.89)

84.36 (52.93)

Stages of change at discharge

12-value

.01
.47

Clusters % (n)
Immotive

4.4% (2)

10.3% (7)

Precontemplation

11.1% (5)

17.6% (12)

Preparation

42.2% (19)

38.2% (26)

Action

42.2% (19)

33.8% (23)

PROS

2.13 (0.89)

2.36 (1.01)

.21

CONS

4.39 (0.62)

4.17 (0.96)

.17

3.53 (0.32)

3.35 (0.41)

.01

Self-esteem (Rosenberg)

32.40 (4.17)

31.03 (4.62)

.09

Depression level (BDI)

5.45 (4.50)

10.84 (8.9)

.01

Decisional Inventory
(Scale mean ranged from 1-5)

Self-efficacy
(Scale mean ranged from 1-4)
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Table 4-9

s;~;ficant ExitPredictors
of Abstinence:
WaldStatistics,Oddsratios(OR)and95%

Confidence
Intervals
Wald

12.--value

OR

95% CI

Length of stay (months)

8.20

.004

.71

0.57-0.90

Depression (BDI score)

13.47

.001

1.14

1.06- 1.22

Predictors
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Table 4-10

BaselineandExitPredictorsof Abstinence:
WaldStatistics,Oddsratios(OR)

and95%Confidence
Intervals

Predictors

Wald

Jl_-

value

OR

95% CI

3.66

.30

Contemplation

2.99

.08

Preparation

2.95

.09

Action

1.08

.30

Length of stay (months)

8.20

.004

.71

0.57-0.90

Depression (BDI score)

13.47

.001

1.14

1.06- 1.22

Stages of Change at Baseline
(Reference group: Preparation)

~

Odds ratios were presented for significant predictors only.
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GENERAL DISCUSSION
A 16-item Change Assessment Scale for Drug Use (CAD) was developed with
reasonable psychometric properties . Findings demonstrated the validity of using the CAD at
various time points: admission, discharge and follow-up, to assess stages of change. Cluster
analysis based on standardized scores of the CAD was found to be the best method for
identifying individuals into cohesive subgroups representing various typologies of readiness for
change . Using CAD as a single continuous index for readiness for change also seemed
promising. Based on the current sample of participants seeking treatment from two residential
settings, relapse prevention/health education, and therapeutic community, six cluster profiles
were identified. The profiles identified at admission included three precontemplative
profiles(Uninvolved, Precontemplation, and Reluctant), contemplation, preparation, and action.
Results clearly indicated over 45% of individuals presenting themselves to treatment were not
ready to change. As demonstrated in a previous study (Tsoh, 1993), precontemplators in
treatment reported significantly higher perceived coercion than those who were more ready to
change. Current results showed that even though these precontemplative individuals sought
treatment, they were 2 to 3 times more likely than others to drop out from treatment early.
Therefore, although these individuals admitted themselves to treatment under some form of
external pressure or coercion, once the pressure was ceased, they tended to drop out or have
worse outcome even if they stayed in treatment longer. Consistently, stages of change at
admission also predicted outcome. Indeed, it was the most significant predictor at baseline.
Findings underscored the importance of matching clients' needs in promoting successful
outcome. The results supported the theory on stages of change may be useful in identifying and
understanding the needs of clients in substance abuse treatment for improving outcome. A
"good match" of treatment for clients' needs could increase the odds for short-term treatment
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success from 3 to 5 fold. The findings have suggested that a cognitive-behavioral relapse
prevention focused program seem to benefit individuals in preparation the most.
Although current research showed validity and importance of stages of change among
drug addicts, assessment of stages in this population could be a barrier for developing stagematch intervention for drug addiction treatment. While cluster analysis was shown to be an
excellent research tool to explore cluster profiles of readiness for change, it requires a large
number of subjects in order to obtain stable profiles . Therefore, cluster analysis can not be used
to classify one or two individuals into subgroups based on their profiles. This has made
assessing stages of change using CAD or URI CA impractical in a clinical setting. Therefore,
deriving a mechanism to empirically match individuals' profiles with previously identified
typology profiles is necessary.
Some researchers have been aware of both benefits and barriers in using cluster analysis
to develop typology profiles. Recently, discriminant function analysis (DFA) has been proposed
as a promising approach to help solve the limitation of cluster analysis and to identify
individuals into subgroups based on the clustering variables. Cherry (1993) first suggested the
combination of cluster analysis and DFA to identify topology patterns of run-away-youth. DF A
was conducted to derive discriminant functions based on a linear combination of clustering
variables that maximized the differences among clusters. A 90% rate of correct classification
based on the same sample was reported. Similarly, Carbonari and colleagues (1994) used the
DF A approach to classify alcoholic participants into one of the five profiles that were identified
using cluster analysis in another sample previously obtained (DiClemente & Hughes, 1990).
Over 90% correct classification produced from DF A was reported within the same sample
(DiClemente & Carbonari, personal communication, January 1995). Since no cluster analysis
was performed among the participants recruited for Carbonari et al.' s study ( 1994), it was
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unclear as to the accuracy of the classification as compared to cluster analysis. Although the
preliminary results were encouraging, there has been no validation data available regarding the
accuracy of using DF A approach using two independent samples for cross validation.
Based on the current data, the author attempted to investigate the use of DFA approach
for classification as compared to cluster analyses . The two independent samples from Study 2
were used for cross validation. First, cluster membership of each individuals was established
from previous cluster analysis performed separately on these two samples. The correct
-classification rates ofDFA were 90.4% and 85.8% within the same sample, which were
comparable to previous studies. Second, using the discriminant functions established from one
sample reclassifying individuals from an independent sample into one of the clusters, the correct
classification rates were 72% to 74% as compared to the actual cluster membership based on
cluster analysis. Considering 16.7% by chance alone in predicting 6 clusters, the results obtained
indicated that DF A could be used to generate a reasonably accurate classification rule. Since
DF A is available in most statistical packages and does not have the limitation on sample size
required for the analysis, once the typologies are developed, an individual's profile could be
matched to existing profiles through discriminant functions developed previously. However, the
most important issue then becomes the generalizability of the original typologies developed.
One limitation of the current study is that the typologies developed were based on individuals
who sought treatment in residential settings at admission, as well as at discharge. Further studies
are necessary to further examine subtypes of readiness for change among drug addicts who seek
treatment in other settings.
As consistent with previous findings, this study also found that length of stay in
treatment was predictive of treatment success. However, little is known regarding the
relationship between treatment retention and outcome. Stages of change at admission was found

174

to be the only common predictor for both dropouts and treatment outcome in this study. Further
research will be necessary to examine the role of stages of change as a mediating variable
between retention and outcome, or length of stay in treatment as a mediating variables between
stages and outcome . Furthermore, changes in stages over time in treatment as well as changes in
other dynamic measures such as decision balance, use of processes, and self-efficacy may add
significantly to our understanding of treatment retention and outcome.
Lastly, this study only focused on short-term outcome. Therefore, findings could only
be applicable for short-term outcome prediction. Long-term success or abstinence continues to
be the ultimate goal for substance abuse treatment programs. From the experience of treating
individuals with addictive problems, it is very common for addicts to succeed with at least
several attempts or to recycle through the stages of change several times (e.g., Prochaska &
DiClemente, 1992). Perhaps, as suggested by some researchers, in order to produce long-term
success, individuals would need to effectively progress through each stage of change. The
process of learning may require repetitive trials and through recycling the stages. Nonetheless, it
is important to understand the process of recovery and what it takes to maintain long-term
success. The current study, among many other studies, has provided support for the use of the
Transtheoretical Model of Change as a promising framework to enhance our understanding of
the treatment process that produces long-term success.
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Appendix A

Measurement Administration Schedule
Admission

Exit

Follow-up

Stages of Change Assessment

v

v

v

Dec"isional Balance of Drug Use

v

v

v

Self - Efficacy to Avoid Drugs

v

v

v

Rosenberg Self-Esteem Scale

v

v

v

Beck Depression Inventory

v

v

v

Addiction Severity Index

v

Sociodemographics

v

Shipley Institute of Living Scale

v

Drug treatment history

v

Diagnostic Interview Survey

v

Personality Diagnostic Questionnaire -

v

Measures

Revised
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Appendix B

Stages of Change Assessment Questionnaire

A. Each statement describes how a person might feel about his or her drug problem - .aJ2Wfrom alcohol.
Please indicate the extent to which you tend to agree or disagree with each statement. In each case, make
your choice in tenns of how you feel right now, not what you have felt in the past or would like to feel.
Administration: A cue card was presented to the subject when each item was read.
Cue Card:
There are FIVE possible responses to each of the items in the questionnaire:
I

= Strongly Disagree (SD)

2

= Disagree (D)

3

= Undecided

4

= Agree (A)

(U)

5 = Strongly Agree (SA)
1. As far as I'm concerned, I don't have any problems that need changing.
2. I think I might be ready for some self-improvement.
3. I am doing something about the problems that had been bothering me.
4. It might be worthwhile to work on my problem .
5. I'm not the problem one. It doesn't make much sense for me to be here.
6. It worries me that I might slip back on a problem I have already changed, so I am ready to work on my
problem.
7. I am finally doing some work on my problem .
8. I've been thinking that I might want to change something about myself.
9. I have been successful in working on my problem but I' not sure I can keep up the effort on my own .
10. At times my problem is difficult, but I'm working on it.
11. Working on problems is pretty much ofa waste of time for me because the problem doesn't have to do
with me.
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Appendix B (cont ' d.)
12. I'm working on my problem in order to better understand myself.
13. I guess I have faults, but there's nothing that I really need to change.
14. I am really working hard to change .
15. I have a problem and I really think I should work on it.
16. I'm not following through with what I had already changed as well as I had hoped , and I'm working to
prevent a relapse of my problem.
17. Even though I'm not always successful in changing , I am at least working on my problem .
18. I thought once I had resolved the problem I would be free of it, but sometimes I still find myself
struggling with it.
19. I wish I had moreideas on how to solve my problem .
20. I have started working on my problems but I would like help.
21. Maybe someone will be able to help me.
22. I may need some extra help right now to help me maintain the changes I've already made.
23. I may be part of the problem, but I don't really think I am.
24 . I hope that someone will have some good advice for me.
25. Anyone can talk about changing; I'm actually doing something about it.
26. All this talk about psychology is boring. Why can't people just forget about their problems?
27. I'm working to prevent myself from having a relapse of my problem.
28. It is frustrating, but I feel I might be having a recurrence of a problem I thought I had resolved .
29. I have worries but so does the next guy. Why spend time thinking about them?
30. I am actively working on my problem.
31. I would rather cope with my faults than try to change them.
32. After all I had done to try and change my problem, every now and again it comes back to haunt me.
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Appendix C

Decisional Balance

Instructions (read by interviewers): The following statements represent different opinions about
drug use. Again refers to drug s apart from alcohol. Please rate HOW MUCH each statement
applies to you according to the following 5 point scale with 5= Very Strongly and 1 = Not at all.
Administration: A cue card was presented to the subject when each item was read.
Cue Card:
1 = Not at all
2 = A little
3 = Somewhat
4 = Strongly
5 = Very Strongly
1. I feel better about myself while using drugs.
2. Drugs make me feel more confident and sociable.
3. I am more fun to be with when I use drugs
4. My drug use has led me to act irresponsibly.
5. feel more confident when I use drugs.
6. When using drugs I fail to keep up with bills .
7. Drugs help me relieve tension.
8. As I became more involved with drugs, I pulled away from people I was once close to.
9. When using drugs, I borrow money which I fail to pay back.
10. Drugs give me that extra boost of energy.
11. Buying drugs has contributed to my experiencing some financial strain.
12. I experience sleep problems when I use drugs.
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Appendix D

Self Efficacy to Avoid Drugs

Instructions: (read by interviewers to subjects): Sometimes we really want to do something. At
times we are confident that we can do it; at other times not so confident . I am going to read you
a list of actions. For each one, tell me how confident you are that you~

nextthreemonths.Whenever

act this way in the

I refer to drugs please not that I mean drugs apartfromalcohol.

Would you be:

Administration: A cue card was presented to the subject when each item was read.
Cue Card:
1

Extremely confident

2

Somewhat confident

3

Not very confident

4

Not at all confident

Items (refined)
1. When you feel confident in yourself you could avoid using drugs.
2. When you feel relaxed you could avoid using drugs.
3. When you are very anxious and stressed you could avoid using drugs.
4.

When you are feeling angry or frustrated you could stay off drugs.

5. You could avoid situations and people that remind you of drugs.
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